<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>700</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="700"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=700&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=600&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=800&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927714899"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927714899?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927714899&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927714899&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S001429991500312X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927714899</prism:url><dc:identifier>SCOPUS_ID:84927714899</dc:identifier><eid>2-s2.0-84927714899</eid><dc:title>Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonist</dc:title><dc:creator>Cai T.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>758</prism:volume><prism:pageRange>107-114</prism:pageRange><prism:coverDate>2015-07-05</prism:coverDate><prism:coverDisplayDate>5 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.03.073</prism:doi><pii>S001429991500312X</pii><dc:description>Â© 2015 Elsevier B.V. All rights reserved. Vorapaxar is a novel protease-activated receptor-1 (PAR-1) antagonist recently approved for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction or with peripheral arterial disease. Patients who received vorapaxar in addition to standard of care antiplatelet therapy had an increased incidence of major bleeding events compared with placebo. To assess whether platelet transfusion can restore hemostasis in primates on triple antiplatelet therapy, template bleeding times were assessed concurrently in the buccal mucosa, finger pad, and distolateral tail of anesthetized cynomolgus macaques to evaluate bleeding with vorapaxar as either monotherapy or in combination with aspirin or aspirin and clopidogrel. Aspirin (5 mg/kg, IV) or vorapaxar (1 mg/kg, PO) alone had no significant effect on bleeding times in the three vascular beds examined. A modest (&lt;2-fold) increase in bleeding time was achieved in the three beds with the dual combination of aspirin and vorapaxar. Major increases in bleeding time were achieved in the three beds with the triple combination of aspirin (5 mg/kg, IV), vorapaxar (1 mg/kg, PO), and clopidogrel (1 mg/kg, PO). Transfusion of fresh human platelet rich plasma, but not platelet poor plasma, reversed the increase in bleeding time in the triple therapy group. Transfusion of human platelets may be a viable approach in situations requiring a rapid reversal of platelet function in individuals treated with triple anti-platelet therapy that includes vorapaxar.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103484</affiliation-url><afid>60103484</afid><affilname>Merck Research Laboratories</affilname><name-variant>Merck Research Laboratories</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108445829</affiliation-url><afid>108445829</afid><affilname>Safety Assessment</affilname><name-variant>Safety</name-variant><affiliation-city>West Point</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115157144</affiliation-url><afid>115157144</afid><affilname>Biostatistics</affilname><name-variant>Biostatistics</name-variant><affiliation-city>Kenilworth</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103484</affiliation-url><afid>60103484</afid><affilname>Merck Research Laboratories</affilname><name-variant>Merck Research Laboratories</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102610138</author-url><authid>7102610138</authid><authname>Cai T.</authname><surname>Cai</surname><given-name>Tian Quan</given-name><initials>T.Q.</initials><afid>60103484</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56594679000</author-url><authid>56594679000</authid><authname>Wickham L.</authname><surname>Wickham</surname><given-name>L. Alexandra</given-name><initials>L.A.</initials><afid>60103484</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6604066463</author-url><authid>6604066463</authid><authname>Sitko G.</authname><surname>Sitko</surname><given-name>Gary</given-name><initials>G.</initials><afid>108445829</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56638231000</author-url><authid>56638231000</authid><authname>Michener M.</authname><surname>Michener</surname><given-name>Maria Strainer</given-name><initials>M.S.</initials><afid>108445829</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56569325000</author-url><authid>56569325000</authid><authname>Raubertas R.</authname><surname>Raubertas</surname><given-name>Richard</given-name><initials>R.</initials><afid>115157144</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56594920300</author-url><authid>56594920300</authid><authname>Handt L.</authname><surname>Handt</surname><given-name>Larry</given-name><initials>L.</initials><afid>108445829</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6701560648</author-url><authid>6701560648</authid><authname>Chintala M.</authname><surname>Chintala</surname><given-name>Madhu</given-name><initials>M.</initials><afid>60103484</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006511702</author-url><authid>7006511702</authid><authname>Seiffert D.</authname><surname>Seiffert</surname><given-name>Dietmar</given-name><initials>D.</initials><afid>60103484</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56594510300</author-url><authid>56594510300</authid><authname>Forrest M.</authname><surname>Forrest</surname><given-name>Michael</given-name><initials>M.</initials><afid>60103484</afid></author><authkeywords>Aspirin | Blood platelets | Clopidogrel | Hemorrhage | Vorapaxar</authkeywords><intid>1535665031</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928250842"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928250842?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928250842&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928250842&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X15000803"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928250842</prism:url><dc:identifier>SCOPUS_ID:84928250842</dc:identifier><eid>2-s2.0-84928250842</eid><dc:title>Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity</dc:title><dc:creator>Zhao W.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>333</prism:volume><prism:pageRange>76-88</prism:pageRange><prism:coverDate>2015-07-03</prism:coverDate><prism:coverDisplayDate>July 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.04.009</prism:doi><pii>S0300483X15000803</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. The most well-known cause of chemotherapy-induced cardiotoxicity is doxorubicin (DOX). The ubiquitin-proteasome system (UPS) is the main cellular machinery for protein degradation in eukaryotic cells. However, the expression pattern of the UPS in DOX-induced cardiotoxicity remains unclear. C57BL/6 mice were intraperitoneally injected with a single dose of DOX (15. mg/kg). After 1, 3 and 5 days, cardiac function and apoptosis were detected with echocardiography and TUNEL assay. Microarray assay and qPCR analysis were also performed at day 5. We found that DOX caused a significant decrease in cardiac function at day 5 and increase in cardiomyocyte apoptosis at days 3 and 5. Microarray data revealed that totally 1185 genes were significantly regulated in DOX-treated heart, and genes involved in apoptosis and the UPS were mostly altered. Among them, the expression of 3 immunoproteasome catalytic subunits (Î²1i, Î²2i and Î²5i) was markedly down-regulated. Moreover, DOX significantly decreased proteasome activities and enhanced polyubiquitinated proteins in the heart. Importantly, overexpression of immunoproteasome catalytic subunits (Î²1i, Î²2i or Î²5i) significantly attenuated DOX-induced cardiomyocyte apoptosis and other UPS gene expression while knockdown of them significantly increased DOX-induced cardiomyocyte apoptosis. These effects were partially associated with increased degradation of multiple pro-apoptotic proteins. In conclusion, our studies suggest that immunoproteasome plays an important role in DOX-induced cardiomyocyte apoptosis, and may be a novel therapeutic target for prevention of DOX-induced cardiotoxicity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026707</affiliation-url><afid>60026707</afid><affilname>Capital Medical University China</affilname><name-variant>Capital Medical University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026707</affiliation-url><afid>60026707</afid><affilname>Capital Medical University China</affilname><name-variant>Capital Medical University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100823150</affiliation-url><afid>100823150</afid><affilname>Beijing Institute of Heart</affilname><name-variant>Institute of Heart</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005229</affiliation-url><afid>60005229</afid><affilname>Dalian Medical University</affilname><name-variant>Dalian Medical University</name-variant><affiliation-city>Dalian</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56601998700</author-url><authid>56601998700</authid><authname>Zhao W.</authname><surname>Zhao</surname><given-name>Wen Jie</given-name><initials>W.J.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56601998700</author-url><authid>56601998700</authid><authname>Zhao W.</authname><surname>Zhao</surname><given-name>Wen Jie</given-name><initials>W.J.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56601998700</author-url><authid>56601998700</authid><authname>Zhao W.</authname><surname>Zhao</surname><given-name>Wen Jie</given-name><initials>W.J.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56602133000</author-url><authid>56602133000</authid><authname>Wei S.</authname><surname>Wei</surname><given-name>Sheng Nan</given-name><initials>S.N.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56602133000</author-url><authid>56602133000</authid><authname>Wei S.</authname><surname>Wei</surname><given-name>Sheng Nan</given-name><initials>S.N.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56602133000</author-url><authid>56602133000</authid><authname>Wei S.</authname><surname>Wei</surname><given-name>Sheng Nan</given-name><initials>S.N.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36101948300</author-url><authid>36101948300</authid><authname>Zeng X.</authname><surname>Zeng</surname><given-name>Xiang Jun</given-name><initials>X.J.</initials><afid>60026707</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56495966300</author-url><authid>56495966300</authid><authname>Xia Y.</authname><surname>Xia</surname><given-name>Yun Long</given-name><initials>Y.L.</initials><afid>60005229</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56486511300</author-url><authid>56486511300</authid><authname>Du J.</authname><surname>Du</surname><given-name>Jie</given-name><initials>J.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56486511300</author-url><authid>56486511300</authid><authname>Du J.</authname><surname>Du</surname><given-name>Jie</given-name><initials>J.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56486511300</author-url><authid>56486511300</authid><authname>Du J.</authname><surname>Du</surname><given-name>Jie</given-name><initials>J.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:34974405400</author-url><authid>34974405400</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui Hua</given-name><initials>H.H.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:34974405400</author-url><authid>34974405400</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui Hua</given-name><initials>H.H.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:34974405400</author-url><authid>34974405400</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui Hua</given-name><initials>H.H.</initials><afid>60026707</afid><afid>60026707</afid><afid>100823150</afid></author><authkeywords>Apoptosis | Cardiotoxicity | Doxorubicin | Immunoproteasome | Microarray | Ubiquitin-proteasome system</authkeywords><intid>1535753183</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929321944"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929321944?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929321944&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929321944&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306452215004133"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929321944</prism:url><dc:identifier>SCOPUS_ID:84929321944</dc:identifier><eid>2-s2.0-84929321944</eid><dc:title>Cardiac over-expression of microRNA-1 induces impairment of cognition in mice</dc:title><dc:creator>Ma J.</dc:creator><prism:publicationName>Neuroscience</prism:publicationName><prism:issn>03064522</prism:issn><prism:eIssn>18737544</prism:eIssn><prism:volume>299</prism:volume><prism:pageRange>66-78</prism:pageRange><prism:coverDate>2015-07-03</prism:coverDate><prism:coverDisplayDate>July 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuroscience.2015.04.061</prism:doi><pii>S0306452215004133</pii><dc:description>Â© 2015 IBRO. Large cohort studies have revealed a close relationship between cognitive impairment and cardiovascular diseases, although the mechanism underlying this relationship remains incompletely understood. In this study, using a transgenic (Tg) mouse model of cardiac-specific over-expression of microRNA-1-2 (. miR-1-2), we observed that microRNA-1 (. miR-1) levels were increased not only in the heart but also in the hippocampus and blood, whereas its levels did not change in the skeletal muscle of Tg mice compared with age-matched wild-type (WT) mice. Six-month-old Tg mice showed cognitive impairment compared with age-matched WT mice, as assessed using the Morris Water Maze test. The brain-derived neurotrophic factor (BDNF) level and cyclic AMP-responsive element-binding protein (CREB) phosphorylation were also significantly reduced in the hippocampi of the Tg mice, as evaluated by Western blot. Further examination showed that BDNF protein expression was down- or up-regulated by miR-1 over-expression or inhibition, respectively, and was unchanged by binding site mutations or miRNA-masks for the 3'UTR of Bdnf, indicating that this gene is a potential target of miR-1. Knockdown of miR-1 by hippocampal stereotaxic injection of an anti-. miR-1 oligonucleotide fragment carried by a lentivirus vector (lenti-pre-AMO-. miR-1) led to up-regulation of BDNF expression and prevented the reduction in cognitive performance in the Tg mice without affecting cardiac function. Our findings demonstrate that cardiac over-expression of miR-1 also induces behavioral abnormalities that may be associated, at least in part, with the down-regulation of BDNF expression in the hippocampus. This study definitely contributes to the understanding of the relationship between cardiovascular disease and cognitive impairment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021615</affiliation-url><afid>60021615</afid><affilname>Harbin Medical University</affilname><name-variant>Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643509500</author-url><authid>56643509500</authid><authname>Ma J.</authname><surname>Ma</surname><given-name>J. C.</given-name><initials>J.C.</initials><afid>60021615</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56612883100</author-url><authid>56612883100</authid><authname>Duan M.</authname><surname>Duan</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>60021615</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56514334000</author-url><authid>56514334000</authid><authname>Sun L.</authname><surname>Sun</surname><given-name>L. L.</given-name><initials>L.L.</initials><afid>60021615</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643745100</author-url><authid>56643745100</authid><authname>Yan M.</authname><surname>Yan</surname><given-name>M. L.</given-name><initials>M.L.</initials><afid>60021615</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643713000</author-url><authid>56643713000</authid><authname>Liu T.</authname><surname>Liu</surname><given-name>T.</given-name><initials>T.</initials><afid>60021615</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643454400</author-url><authid>56643454400</authid><authname>Wang Q.</authname><surname>Wang</surname><given-name>Q.</given-name><initials>Q.</initials><afid>60021615</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643311000</author-url><authid>56643311000</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>C. D.</given-name><initials>C.D.</initials><afid>60021615</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56088860000</author-url><authid>56088860000</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>X.</given-name><initials>X.</initials><afid>60021615</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56643941100</author-url><authid>56643941100</authid><authname>Kang X.</authname><surname>Kang</surname><given-name>X. H.</given-name><initials>X.H.</initials><afid>60021615</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56644062500</author-url><authid>56644062500</authid><authname>Pei S.</authname><surname>Pei</surname><given-name>S. C.</given-name><initials>S.C.</initials><afid>60021615</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644461700</author-url><authid>56644461700</authid><authname>Zong D.</authname><surname>Zong</surname><given-name>D. K.</given-name><initials>D.K.</initials><afid>60021615</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56643515300</author-url><authid>56643515300</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>X.</given-name><initials>X.</initials><afid>60021615</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56441907800</author-url><authid>56441907800</authid><authname>Wang N.</authname><surname>Wang</surname><given-name>N.</given-name><initials>N.</initials><afid>60021615</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:8687006900</author-url><authid>8687006900</authid><authname>Ai J.</authname><surname>Ai</surname><given-name>J.</given-name><initials>J.</initials><afid>60021615</afid></author><authkeywords>BDNF | Cognitive impairment | Heart | Hippocampus | MicroRNA-1</authkeywords><intid>1035940736</intid><source-id>18042</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929313455"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929313455?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929313455&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929313455&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X15000815"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929313455</prism:url><dc:identifier>SCOPUS_ID:84929313455</dc:identifier><eid>2-s2.0-84929313455</eid><dc:title>Thresholds in chemical respiratory sensitisation</dc:title><dc:creator>Cochrane S.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>333</prism:volume><prism:pageRange>179-194</prism:pageRange><prism:coverDate>2015-07-03</prism:coverDate><prism:coverDisplayDate>July 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.04.010</prism:doi><pii>S0300483X15000815</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. There is a continuing interest in determining whether it is possible to identify thresholds for chemical allergy. Here allergic sensitisation of the respiratory tract by chemicals is considered in this context. This is an important occupational health problem, being associated with rhinitis and asthma, and in addition provides toxicologists and risk assessors with a number of challenges.In common with all forms of allergic disease chemical respiratory allergy develops in two phases. In the first (induction) phase exposure to a chemical allergen (by an appropriate route of exposure) causes immunological priming and sensitisation of the respiratory tract. The second (elicitation) phase is triggered if a sensitised subject is exposed subsequently to the same chemical allergen via inhalation. A secondary immune response will be provoked in the respiratory tract resulting in inflammation and the signs and symptoms of a respiratory hypersensitivity reaction. In this article attention has focused on the identification of threshold values during the acquisition of sensitisation.Current mechanistic understanding of allergy is such that it can be assumed that the development of sensitisation (and also the elicitation of an allergic reaction) is a threshold phenomenon; there will be levels of exposure below which sensitisation will not be acquired. That is, all immune responses, including allergic sensitisation, have threshold requirement for the availability of antigen/allergen, below which a response will fail to develop. The issue addressed here is whether there are methods available or clinical/epidemiological data that permit the identification of such thresholds. This document reviews briefly relevant human studies of occupational asthma, and experimental models that have been developed (or are being developed) for the identification and characterisation of chemical respiratory allergens.The main conclusion drawn is that although there is evidence that the acquisition of sensitisation to chemical respiratory allergens is a dose-related phenomenon, and that thresholds exist, it is frequently difficult to define accurate numerical values for threshold exposure levels. Nevertheless, based on occupational exposure data it may sometimes be possible to derive levels of exposure in the workplace, which are safe.An additional observation is the lack currently of suitable experimental methods for both routine hazard characterisation and the measurement of thresholds, and that such methods are still some way off. Given the current trajectory of toxicology, and the move towards the use of non-animal in vitro and/or in silico) methods, there is a need to consider the development of alternative approaches for the identification and characterisation of respiratory sensitisation hazards, and for risk assessment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029850</affiliation-url><afid>60029850</afid><affilname>Unilever</affilname><name-variant>Unilever Research</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024415</affiliation-url><afid>60024415</afid><affilname>Akzo Nobel</affilname><name-variant>Akzo Nobel</name-variant><affiliation-city>Arnhem</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>GUP/PB - Z470</affilname><name-variant>BASF SE</name-variant><affiliation-city>Ludwigshafen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069904</affiliation-url><afid>60069904</afid><affilname>Dow Europe GmbH</affilname><name-variant>Dow Europe GmbH</name-variant><affiliation-city>Horgen</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069997</affiliation-url><afid>60069997</afid><affilname>European Centre for Ecotoxicology and Toxicology of Chemicals</affilname><name-variant>ECETOC</name-variant><affiliation-city>Brussels</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032056</affiliation-url><afid>60032056</afid><affilname>Sumitomo Chemical</affilname><name-variant>Sumitomo Chemical Co. Ltd.</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003771</affiliation-url><afid>60003771</afid><affilname>University of Manchester</affilname><name-variant>University of Manchester</name-variant><affiliation-city>Manchester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:21233483700</author-url><authid>21233483700</authid><authname>Cochrane S.</authname><surname>Cochrane</surname><given-name>Stella A.</given-name><initials>S.A.</initials><afid>60029850</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005385025</author-url><authid>7005385025</authid><authname>Arts J.</authname><surname>Arts</surname><given-name>Josje H E</given-name><initials>J.H.E.</initials><afid>60024415</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507010748</author-url><authid>6507010748</authid><authname>Ehnes C.</authname><surname>Ehnes</surname><given-name>Colin</given-name><initials>C.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644545900</author-url><authid>56644545900</authid><authname>Hindle S.</authname><surname>Hindle</surname><given-name>Stuart</given-name><initials>S.</initials><afid>60069904</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35336958300</author-url><authid>35336958300</authid><authname>Hollnagel H.</authname><surname>Hollnagel</surname><given-name>Heli M.</given-name><initials>H.M.</initials><afid>60069904</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7201466316</author-url><authid>7201466316</authid><authname>Poole A.</authname><surname>Poole</surname><given-name>Alan</given-name><initials>A.</initials><afid>60069997</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644242700</author-url><authid>56644242700</authid><authname>Suto H.</authname><surname>Suto</surname><given-name>Hidenori</given-name><initials>H.</initials><afid>60032056</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:25026048300</author-url><authid>25026048300</authid><authname>Kimber I.</authname><surname>Kimber</surname><given-name>Ian</given-name><initials>I.</initials><afid>60003771</afid></author><authkeywords>Chemical respiratory allergy | Hazard characterisation | Occupational asthma | Respiratory sensitisation | Sensitising potency | Thresholds</authkeywords><intid>2035939359</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928265628"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928265628?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928265628&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928265628&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X15000761"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928265628</prism:url><dc:identifier>SCOPUS_ID:84928265628</dc:identifier><eid>2-s2.0-84928265628</eid><dc:title>Amelioration strategies fail to prevent tobacco smoke effects on neurodifferentiation: Nicotinic receptor blockade, antioxidants, methyl donors</dc:title><dc:creator>Slotkin T.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>333</prism:volume><prism:pageRange>63-75</prism:pageRange><prism:coverDate>2015-07-03</prism:coverDate><prism:coverDisplayDate>July 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.04.005</prism:doi><pii>S0300483X15000761</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Tobacco smoke exposure is associated with neurodevelopmental disorders. We used neuronotypic PC12 cells to evaluate the mechanisms by which tobacco smoke extract (TSE) affects neurodifferentiation. In undifferentiated cells, TSE impaired DNA synthesis and cell numbers to a much greater extent than nicotine alone TSE also impaired cell viability to a small extent. In differentiating cells, TSE enhanced cell growth at the expense of cell numbers and promoted emergence of the dopaminergic phenotype. Nicotinic receptor blockade with mecamylamine was ineffective in preventing the adverse effects of TSE and actually enhanced the effect of TSE on the dopamine phenotype. A mixture of antioxidants (vitamin C, vitamin E, N-acetyl-. l-cysteine) provided partial protection against cell loss but also promoted loss of the cholinergic phenotype in response to TSE. Notably, the antioxidants themselves altered neurodifferentiation, reducing cell numbers and promoting the cholinergic phenotype at the expense of the dopaminergic phenotype, an effect that was most prominent for N-acetyl-. l-cysteine. Treatment with methyl donors (vitamin B12, folic acid, choline) had no protectant effect and actually enhanced the cell loss evoked by TSE; they did have a minor, synergistic interaction with antioxidants protecting against TSE effects on growth. Thus, components of tobacco smoke perturb neurodifferentiation through mechanisms that cannot be attributed to the individual effects of nicotine, oxidative stress or interference with one-carbon metabolism. Consequently, attempted amelioration strategies may be partially effective at best, or, as seen here, can actually aggravate injury by interfering with normal developmental signals and/or by sensitizing cells to TSE effects on neurodifferentiation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35444441200</author-url><authid>35444441200</authid><authname>Slotkin T.</authname><surname>Slotkin</surname><given-name>Theodore A.</given-name><initials>T.A.</initials><afid>60005200</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56491133200</author-url><authid>56491133200</authid><authname>Skavicus S.</authname><surname>Skavicus</surname><given-name>Samantha</given-name><initials>S.</initials><afid>60005200</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35069055800</author-url><authid>35069055800</authid><authname>Card J.</authname><surname>Card</surname><given-name>Jennifer</given-name><initials>J.</initials><afid>60005200</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202747042</author-url><authid>7202747042</authid><authname>Levin E.</authname><surname>Levin</surname><given-name>Edward D.</given-name><initials>E.D.</initials><afid>60005200</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55984175700</author-url><authid>55984175700</authid><authname>Seidler F.</authname><surname>Seidler</surname><given-name>Frederic J.</given-name><initials>F.J.</initials><afid>60005200</afid></author><authkeywords>Antioxidants | Methyl donors | Neurodifferentiation | Nicotine | PC12 cells | Tobacco smoke extract</authkeywords><intid>1535752286</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929659056"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929659056?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929659056&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929659056&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X15000876"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929659056</prism:url><dc:identifier>SCOPUS_ID:84929659056</dc:identifier><eid>2-s2.0-84929659056</eid><dc:title>Developmental origins of neurotransmitter and transcriptome alterations in adult female zebrafish exposed to atrazine during embryogenesis</dc:title><dc:creator>Wirbisky S.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>333</prism:volume><prism:pageRange>156-167</prism:pageRange><prism:coverDate>2015-07-03</prism:coverDate><prism:coverDisplayDate>July 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.04.016</prism:doi><pii>S0300483X15000876</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Atrazine is an herbicide applied to agricultural crops and is indicated to be an endocrine disruptor. Atrazine is frequently found to contaminate potable water supplies above the maximum contaminant level of 3. Î¼g/L as defined by the U.S. Environmental Protection Agency. The developmental origin of adult disease hypothesis suggests that toxicant exposure during development can increase the risk of certain diseases during adulthood. However, the molecular mechanisms underlying disease progression are still unknown. In this study, zebrafish embryos were exposed to 0, 0.3, 3, or 30. Î¼g/L atrazine throughout embryogenesis. Larvae were then allowed to mature under normal laboratory conditions with no further chemical treatment until 7 days post fertilization (dpf) or adulthood and neurotransmitter analysis completed. No significant alterations in neurotransmitter levels was observed at 7. dpf or in adult males, but a significant decrease in 5-hydroxyindoleacetic acid (5-HIAA) and serotonin turnover was seen in adult female brain tissue. Transcriptomic analysis was completed on adult female brain tissue to identify molecular pathways underlying the observed neurological alterations. Altered expression of 1928, 89, and 435 genes in the females exposed to 0.3, 3, or 30. Î¼g/L atrazine during embryogenesis were identified, respectively. There was a high level of overlap between the biological processes and molecular pathways in which the altered genes were associated. Moreover, a subset of genes was down regulated throughout the serotonergic pathway. These results provide support of the developmental origins of neurological alterations observed in adult female zebrafish exposed to atrazine during embryogenesis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009254</affiliation-url><afid>60009254</afid><affilname>Purdue University</affilname><name-variant>Purdue University</name-variant><affiliation-city>West Lafayette</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009254</affiliation-url><afid>60009254</afid><affilname>Purdue University</affilname><name-variant>Purdue University</name-variant><affiliation-city>West Lafayette</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56198352100</author-url><authid>56198352100</authid><authname>Wirbisky S.</authname><surname>Wirbisky</surname><given-name>Sara E.</given-name><initials>S.E.</initials><afid>60009254</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:39262751600</author-url><authid>39262751600</authid><authname>Weber G.</authname><surname>Weber</surname><given-name>Gregory J.</given-name><initials>G.J.</initials><afid>60009254</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35498102800</author-url><authid>35498102800</authid><authname>SepÃºlveda M.</authname><surname>SepÃºlveda</surname><given-name>Maria S.</given-name><initials>M.S.</initials><afid>60009254</afid><afid>60009254</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35498102800</author-url><authid>35498102800</authid><authname>SepÃºlveda M.</authname><surname>SepÃºlveda</surname><given-name>Maria S.</given-name><initials>M.S.</initials><afid>60009254</afid><afid>60009254</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56652508200</author-url><authid>56652508200</authid><authname>Xiao C.</authname><surname>Xiao</surname><given-name>Changhe</given-name><initials>C.</initials><afid>60009254</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9037037100</author-url><authid>9037037100</authid><authname>Cannon J.</authname><surname>Cannon</surname><given-name>Jason R.</given-name><initials>J.R.</initials><afid>60009254</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35302522200</author-url><authid>35302522200</authid><authname>Freeman J.</authname><surname>Freeman</surname><given-name>Jennifer L.</given-name><initials>J.L.</initials><afid>60009254</afid></author><authkeywords>Atrazine | Development | Developmental origins of health and disease | Neurotransmitters | Transcriptomics | Zebrafish</authkeywords><intid>2035986403</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928728175"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928728175?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928728175&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928728175&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X15000785"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928728175</prism:url><dc:identifier>SCOPUS_ID:84928728175</dc:identifier><eid>2-s2.0-84928728175</eid><dc:title>Sodium nitrite potentiates renal oxidative stress and injury in hemoglobin exposed guinea pigs</dc:title><dc:creator>Baek J.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>333</prism:volume><prism:pageRange>89-99</prism:pageRange><prism:coverDate>2015-07-03</prism:coverDate><prism:coverDisplayDate>July 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.04.007</prism:doi><pii>S0300483X15000785</pii><dc:description>Â© 2015. Methemoglobin-forming drugs, such as sodium nitrite (NaNO&lt;inf&gt;2&lt;/inf&gt;), may exacerbate oxidative toxicity under certain chronic or acute hemolytic settings. In this study, we evaluated markers of renal oxidative stress and injury in guinea pigs exposed to extracellular hemoglobin (Hb) followed by NaNO&lt;inf&gt;2&lt;/inf&gt; at doses sufficient to simulate clinically relevant acute methemoglobinemia. NaNO&lt;inf&gt;2&lt;/inf&gt; induced rapid and extensive oxidation of plasma Hb in this model. This was accompanied by increased renal expression of the oxidative response effectors nuclear factor erythroid 2-derived-factor 2 (Nrf-2) and heme oxygenase-1 (HO-1), elevated non-heme iron deposition, lipid peroxidation, interstitial inflammatory cell activation, increased expression of tubular injury markers kidney injury-1 marker (KIM-1) and liver-fatty acid binding protein (L-FABP), podocyte injury, and cell death. Importantly, these indicators of renal oxidative stress and injury were minimal or absent following infusion of Hb or NaNO&lt;inf&gt;2&lt;/inf&gt; alone. Together, these results suggest that the exposure to NaNO&lt;inf&gt;2&lt;/inf&gt; in settings associated with increased extracellular Hb may potentiate acute renal toxicity via processes that are independent of NaNO&lt;inf&gt;2&lt;/inf&gt; induced erythrocyte methemoglobinemia.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008780</affiliation-url><afid>60008780</afid><affilname>FDA Center for Biologics Evaluation and Research</affilname><name-variant>FDA</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56611304900</author-url><authid>56611304900</authid><authname>Baek J.</authname><surname>Baek</surname><given-name>Jin Hyen</given-name><initials>J.H.</initials><afid>60008780</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56098125200</author-url><authid>56098125200</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xiaoyuan</given-name><initials>X.</initials><afid>60008780</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55183742400</author-url><authid>55183742400</authid><authname>Williams M.</authname><surname>Williams</surname><given-name>Matthew C.</given-name><initials>M.C.</initials><afid>60008780</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8574233500</author-url><authid>8574233500</authid><authname>Hicks W.</authname><surname>Hicks</surname><given-name>Wayne</given-name><initials>W.</initials><afid>60008780</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701578649</author-url><authid>6701578649</authid><authname>Buehler P.</authname><surname>Buehler</surname><given-name>Paul W.</given-name><initials>P.W.</initials><afid>60008780</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603607426</author-url><authid>6603607426</authid><authname>D'Agnillo F.</authname><surname>D'Agnillo</surname><given-name>Felice</given-name><initials>F.</initials><afid>60008780</afid></author><authkeywords>Biomarkers | Heme | Hemoglobin | Kidney | Nitrite | Oxidative stress</authkeywords><intid>1535839272</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930211780"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930211780?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930211780&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930211780&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930211780</prism:url><dc:identifier>SCOPUS_ID:84930211780</dc:identifier><eid>2-s2.0-84930211780</eid><dc:title>Dyslipidemia and Cardiovascular Disease in Women</dc:title><dc:creator>CÃ­fkovÃ¡ R.</dc:creator><prism:publicationName>Current Cardiology Reports</prism:publicationName><prism:issn>15233782</prism:issn><prism:eIssn>15343170</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>2 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s11886-015-0609-5</prism:doi><dc:description>Â© 2015, Springer Science+Business Media New York. Cardiovascular disease is the major cause of death in women in developed countries. Dyslipidemia is highly prevalent in women, particularly after the menopause. Elevated low-density lipoprotein cholesterol (LDL-C) has been identified as the key lipid parameter in both genders whereas HDL-cholesterol and triglycerides have been more closely associated, in some studies, with cardiovascular risk in women. Menopause has been shown to be associated with an increase in total and LDL-cholesterol and a decrease in HDL-cholesterol (predominantly in the HDL&lt;inf&gt;2&lt;/inf&gt; subfraction). Despite its beneficial effects on the lipid profile, hormone replacement therapy is not recommended for primary or secondary prevention of cardiovascular disease in women. The latest meta-analysis of statin trials with gender-specific outcomes showed a similar benefit in women and men. The addition of ezetimibe to simvastatin in patients with acute coronary syndromes showed a further reduction of the primary endpoint in both genders. While there are no gender-related differences in drug treatment of dyslipidemia, current guidelines, to avoid overtreatment, strongly suggest risk estimation before initiating lipid-lowering treatment in women without manifest cardiovascular disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016605</affiliation-url><afid>60016605</afid><affilname>Charles University in Prague</affilname><name-variant>Charles University in Prague</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004832017</author-url><authid>7004832017</authid><authname>CÃ­fkovÃ¡ R.</authname><surname>CÃ­fkovÃ¡</surname><given-name>Renata</given-name><initials>R.</initials><afid>60016605</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36015426500</author-url><authid>36015426500</authid><authname>KrajÄoviechovÃ¡ A.</authname><surname>KrajÄoviechovÃ¡</surname><given-name>Alena</given-name><initials>A.</initials><afid>60016605</afid></author><authkeywords>Cardiovascular risk factors | Coronary heart disease | Lipid-lowering drugs | Menopause | Oral contraception | Stroke</authkeywords><intid>36085625</intid><article-number>52</article-number><source-id>23118</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930201492"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930201492?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930201492&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930201492&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930201492</prism:url><dc:identifier>SCOPUS_ID:84930201492</dc:identifier><eid>2-s2.0-84930201492</eid><dc:title>Genetics of Sudden Cardiac Death</dc:title><dc:creator>Refaat M.</dc:creator><prism:publicationName>Current Cardiology Reports</prism:publicationName><prism:issn>15233782</prism:issn><prism:eIssn>15343170</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>2 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s11886-015-0606-8</prism:doi><dc:description>Â© 2015, Springer Science+Business Media New York. Sudden cardiac death (SCD) is defined by the World Health Organization (WHO) as death within 1Â h of symptom onset (witnessed) or within 24Â h of being observed alive and symptom free (unwitnessed). It affects more than 3Â million people annually worldwide and affects approximately 1/1000 people each year in the USA. Familial studies of syndromes with Mendelian inheritance, candidate genes analyses, and genome-wide association studies (GWAS) have helped our understanding of the genetics of SCD. We will review the genetics of arrhythmogenic hereditary syndromes with Mendelian inheritance from familial studies with structural heart disease (hypertrophic cardiomyopathy, dilated cardiomyopathy, and arrhythmogenic cardiomyopathy) as well as primary electrical causes (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome). In addition, we will review the genetics of intermediate phenotypes for SCD such as coronary artery disease and electrocardiographic variables (QT interval, QRS duration, and RR interval). Finally, we will review rare and common variants that are associated with SCD in the general population and were identified from candidate gene analyses and GWAS. Our understanding of the genetics of SCD will improve by the use of next-generation sequencing/whole-exome sequencing as well as whole-genome sequencing which have the potential to discover unsuspected common and rare genetic variants that might be associated with SCD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068762</affiliation-url><afid>60068762</afid><affilname>American University of Beirut Medical Center</affilname><name-variant>American University of Beirut Medical Center</name-variant><affiliation-city>Beirut</affiliation-city><affiliation-country>Lebanon</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009788</affiliation-url><afid>60009788</afid><affilname>University of Iowa Caver College of Medicine</affilname><name-variant>University of Iowa College of Medicine</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068761</affiliation-url><afid>60068761</afid><affilname>American University of Beirut</affilname><name-variant>American University of Beirut</name-variant><affiliation-city>Beirut</affiliation-city><affiliation-country>Lebanon</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14018245700</author-url><authid>14018245700</authid><authname>Refaat M.</authname><surname>Refaat</surname><given-name>Marwan M.</given-name><initials>M.M.</initials><afid>60068762</afid><afid>60068761</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14018245700</author-url><authid>14018245700</authid><authname>Refaat M.</authname><surname>Refaat</surname><given-name>Marwan M.</given-name><initials>M.M.</initials><afid>60068762</afid><afid>60068761</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55599642600</author-url><authid>55599642600</authid><authname>Hotait M.</authname><surname>Hotait</surname><given-name>Mostafa</given-name><initials>M.</initials><afid>60068762</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006871194</author-url><authid>7006871194</authid><authname>London B.</authname><surname>London</surname><given-name>Barry</given-name><initials>B.</initials><afid>60009788</afid></author><authkeywords>Arrhythmogenic hereditary syndromes | Arrhythmogenic right ventricular cardiomyopathy/dysplasia | Brugada syndrome | Cardiomyopathies | Catecholaminergic polymorphic ventricular tachycardia | Dilated cardiomyopathy | Genetics | Genome-wide association studies | Hypertrophic cardiomyopathy | Long QT syndrome | Short QT syndrome | Sudden cardiac death</authkeywords><intid>1786088088</intid><article-number>53</article-number><source-id>23118</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930205116"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930205116?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930205116&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930205116&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930205116</prism:url><dc:identifier>SCOPUS_ID:84930205116</dc:identifier><eid>2-s2.0-84930205116</eid><dc:title>Cardiotoxicity due to Chemotherapy: the Role of Biomarkers</dc:title><dc:creator>Stevens P.</dc:creator><prism:publicationName>Current Cardiology Reports</prism:publicationName><prism:issn>15233782</prism:issn><prism:eIssn>15343170</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>2 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s11886-015-0603-y</prism:doi><dc:description>Â© 2015, Springer Science+Business Media New York. An ever-increasing array of chemotherapeutic agents is being used in the treatment of solid organ or hematologic malignancies. The success of many of these agents has led to an increasing survival of patients with cancer. However, many of these agents, particularly anthracyclines and trastuzumab, are associated with the development of cardiotoxicity. The current standard for the evaluation of chemotherapy-associated cardiotoxicity typically involves the use of serial measurements of left ventricular (LV) function by echocardiogram (Echo) and radionuclide ventriculogram (MUGA). Unfortunately, this time-honored method offers low sensitivity to the early prediction or detection of cardiac events. Frequently, by the time cardiotoxicity is detected, significant LV dysfunction has occurred and ultimately this may not respond to standard cardioprotective treatment. Cardiac biomarkers, troponin I and B-type natriuretic peptide, may allow a more accurate and timely monitoring strategy. The current data and a summarized understanding of how to utilize cardiac biomarkers for the prevention and early detection of cardiac dysfunction during chemotherapy are presented.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003915</affiliation-url><afid>60003915</afid><affilname>Vanderbilt University</affilname><name-variant>Vanderbilt University</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115293726</affiliation-url><afid>115293726</afid><affilname>Division of Cardiovascular Medicine, Vanderbilt Heart and Vascular Institute</affilname><name-variant>Division of Cardiovascular Medicine, Vanderbilt Heart and Vascular Institute</name-variant><affiliation-city>Nashville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662749000</author-url><authid>56662749000</authid><authname>Stevens P.</authname><surname>Stevens</surname><given-name>Patrick L.</given-name><initials>P.L.</initials><afid>60003915</afid><afid>115293726</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662749000</author-url><authid>56662749000</authid><authname>Stevens P.</authname><surname>Stevens</surname><given-name>Patrick L.</given-name><initials>P.L.</initials><afid>60003915</afid><afid>115293726</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003853556</author-url><authid>7003853556</authid><authname>Lenihan D.</authname><surname>Lenihan</surname><given-name>Daniel J.</given-name><initials>D.J.</initials><afid>60003915</afid><afid>115293726</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003853556</author-url><authid>7003853556</authid><authname>Lenihan D.</authname><surname>Lenihan</surname><given-name>Daniel J.</given-name><initials>D.J.</initials><afid>60003915</afid><afid>115293726</afid></author><authkeywords>Anthracyclines | B-Type natriuretic peptide | Biomarkers | Cardiotoxicity | Chemotherapy | Trastuzumab | Troponin</authkeywords><intid>1536088274</intid><article-number>49</article-number><source-id>23118</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930209320"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930209320?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930209320&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930209320&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930209320</prism:url><dc:identifier>SCOPUS_ID:84930209320</dc:identifier><eid>2-s2.0-84930209320</eid><dc:title>Safety of Implanted Cardiac Devices in an MRI Environment</dc:title><dc:creator>Ipek E.</dc:creator><prism:publicationName>Current Cardiology Reports</prism:publicationName><prism:issn>15233782</prism:issn><prism:eIssn>15343170</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>2 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s11886-015-0605-9</prism:doi><dc:description>Â© 2015, Springer Science+Business Media New York. Magnetic resonance imaging (MRI) has evolved into an essential diagnostic modality for the evaluation of various conditions. In line with the increase in MRI applications, the use of cardiac implantable electronic devices (CIED) is growing and many of the CEID recipients of today may require MRI examinations in the future. Traditionally, MRI examination of CIED recipients has been considered a contraindication. However, recent studies have provided strong evidence that MRI can safely be performed in selected patients with specific precautions. This review highlights the interactions of MRI with CIEDs, summarizes the literature, and outlines the Johns Hopkins Safety Protocol.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><name-variant>Johns Hopkins School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54926039900</author-url><authid>54926039900</authid><authname>Ipek E.</authname><surname>Ipek</surname><given-name>Esra Gucuk</given-name><initials>E.G.</initials><afid>60001117</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56664697500</author-url><authid>56664697500</authid><authname>Nazarian S.</authname><surname>Nazarian</surname><given-name>Saman</given-name><initials>S.</initials><afid>60001117</afid></author><authkeywords>Cardiac implantable electronic devices | Magnetic resonance imaging | MRI conditional devices</authkeywords><intid>2036082587</intid><article-number>51</article-number><source-id>23118</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930206251"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930206251?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930206251&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930206251&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930206251</prism:url><dc:identifier>SCOPUS_ID:84930206251</dc:identifier><eid>2-s2.0-84930206251</eid><dc:title>Impact of Sex and Ethnicity on Arrhythmic Risk</dc:title><dc:creator>Rane S.</dc:creator><prism:publicationName>Current Cardiology Reports</prism:publicationName><prism:issn>15233782</prism:issn><prism:eIssn>15343170</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>2 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s11886-015-0604-x</prism:doi><dc:description>Â© 2015, Springer Science+Business Media New York. Substantial differences in the risk of common arrhythmia syndromes exist between men and women, as well as in varying ethnic/racial groups. For example, despite an overall lower risk of sudden death and atrial fibrillation in women compared with men, women have longer QT intervals and a higher risk of torsades de pointes due to antiarrhythmic drugs and worse outcomes associated with atrial fibrillation. An ethnicity-related paradox in atrial fibrillation epidemiology is apparent; despite a higher prevalence of medical comorbidities such as hypertension, diabetes, and prolonged PR interval, blacks, Hispanics, and Asians have a lower risk of atrial fibrillation than whites. In this promising era of genomic medicine, an improved understanding of epidemiology and phenotype holds the potential for revealing novel therapeutic targets and preventing disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662823400</author-url><authid>56662823400</authid><authname>Rane S.</authname><surname>Rane</surname><given-name>Santosh</given-name><initials>S.</initials><afid>60015481</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003324711</author-url><authid>7003324711</authid><authname>Patton K.</authname><surname>Patton</surname><given-name>Kristen K.</given-name><initials>K.K.</initials><afid>60015481</afid></author><authkeywords>Arrhythmia | Atrial fibrillation | Ethnicity | Race | Sex | Sudden death</authkeywords><intid>1536087278</intid><article-number>50</article-number><source-id>23118</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927549305"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927549305?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927549305&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927549305&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0045793015000821"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927549305</prism:url><dc:identifier>SCOPUS_ID:84927549305</dc:identifier><eid>2-s2.0-84927549305</eid><dc:title>CFD study of aquatic thrust generation by an octopus-like arm under intense prescribed deformations</dc:title><dc:creator>Kazakidi A.</dc:creator><prism:publicationName>Computers and Fluids</prism:publicationName><prism:issn>00457930</prism:issn><prism:volume>115</prism:volume><prism:pageRange>54-65</prism:pageRange><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>July 02, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compfluid.2015.03.009</prism:doi><pii>S0045793015000821</pii><dc:description>Â© 2015 Elsevier Ltd. The complexity in structure and locomotion of cephalopods, such as the octopus, poses difficulties in modeling and simulation. Their slender arms, being highly agile and dexterous, often involve intense deformations, which are hard to simulate accurately, while simultaneously ensuring numerical stability and low diffusion of the transient motion results. Within the immersed-boundary framework, this paper focuses on an arm geometry performing prescribed motions that reflect octopus locomotion. The method is compared with a finite-volume numerical approach to determine the mesh requirements that must be employed for sufficiently capturing, not only the near wall viscous flow, but also the off-body vortical flow field in intense forced motions. The objective is to demonstrate and exploit the generality of the immersed boundary approach to complex numerical simulations of deforming geometries. Incorporation of arm deformation was found to increase the output thrust of a single-arm system. It was further found that sculling motion combined with arm undulations provides an effective propulsive scheme for an octopus-like arm.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Foundation for Research and Technology - Hellas (FORTH)</affilname><name-variant>Institute of Computer Science</name-variant><affiliation-city>Heraklion, Crete</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Minnesota</affilname><name-variant>St. Anthony Falls Laboratory</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Embry-Riddle Aeronautical University</affilname><name-variant>Department of Aerospace Engineering</name-variant><affiliation-city>Daytona Beach</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>FORTH</affilname><name-variant>Institute of Applied and Computational Mathematics</name-variant><affiliation-city>Heraklion, Crete</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26644221100</author-url><authid>26644221100</authid><authname>Kazakidi A.</authname><surname>Kazakidi</surname><given-name>Asimina</given-name><initials>A.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006082622</author-url><authid>7006082622</authid><authname>Tsakiris D.</authname><surname>Tsakiris</surname><given-name>Dimitris P.</given-name><initials>D.P.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:25648981000</author-url><authid>25648981000</authid><authname>Angelidis D.</authname><surname>Angelidis</surname><given-name>Dionysios</given-name><initials>D.</initials><afid/></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003581647</author-url><authid>7003581647</authid><authname>Sotiropoulos F.</authname><surname>Sotiropoulos</surname><given-name>Fotis</given-name><initials>F.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003772964</author-url><authid>7003772964</authid><authname>Ekaterinaris J.</authname><surname>Ekaterinaris</surname><given-name>John A.</given-name><initials>J.A.</initials><afid/><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003772964</author-url><authid>7003772964</authid><authname>Ekaterinaris J.</authname><surname>Ekaterinaris</surname><given-name>John A.</given-name><initials>J.A.</initials><afid/><afid/></author><authkeywords>Aquatic locomotion | Biological propulsion | Computational fluid dynamics (CFD) | Immersed boundary method | Large deformations</authkeywords><intid>535634477</intid><source-id>18160</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925111628"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925111628?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925111628&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925111628&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0045793015001152"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925111628</prism:url><dc:identifier>SCOPUS_ID:84925111628</dc:identifier><eid>2-s2.0-84925111628</eid><dc:title>Accuracy of finite volume/staggered grid distributed lagrange multiplier/fictitious domain simulations of particulate flows</dc:title><dc:creator>Wachs A.</dc:creator><prism:publicationName>Computers and Fluids</prism:publicationName><prism:issn>00457930</prism:issn><prism:volume>115</prism:volume><prism:pageRange>154-172</prism:pageRange><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>July 02, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compfluid.2015.04.006</prism:doi><pii>S0045793015001152</pii><dc:description>Â© 2015 Elsevier Ltd. Our Distributed Lagrange Multiplier/Fictitious Domain method [1-3] has been recently implemented with a Finite Volume/Staggered Grid discretization scheme [4] and successfully applied to the settling of a single particle in an unbounded domain. Here we scrutinize the space and time accuracy of the computed solution in a broad range of flow configurations of growing complexity. We suggest a 2nd order interpolation operator to impose the rigid body motion constraint at the particle boundary based on Finite Element cubic quadratic basis functions. This enables us to benefit from the best of both discretization schemes: a fast Finite Volume/Staggered Grid Navier &amp; Stokes solver and a high order Finite Element reconstruction at the particle boundary. The resulting space accuracy of the computed solution is improved without the need to employ any hydrodynamic radius calibration procedure for spherical particles. As a result, the method can also accurately be extended to non-spherical and angular particles. The order of space convergence is between linear and quadratic, depending on the flow configuration, and the magnitude of the error has a tendency to increase with the solid volume fraction, the Reynolds number and the angularity of the particles.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006317</affiliation-url><afid>60006317</afid><affilname>IFP Energies nouvelles</affilname><name-variant>Inst Francais du Petrole</name-variant><affiliation-city>Rueil-Malmaison</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006317</affiliation-url><afid>60006317</afid><affilname>IFP Energies nouvelles</affilname><name-variant>Inst Francais du Petrole</name-variant><affiliation-city>Rueil-Malmaison</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:13907903800</author-url><authid>13907903800</authid><authname>Wachs A.</authname><surname>Wachs</surname><given-name>Anthony</given-name><initials>A.</initials><afid>60006317</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56461342600</author-url><authid>56461342600</authid><authname>Hammouti A.</authname><surname>Hammouti</surname><given-name>Abdelkader</given-name><initials>A.</initials><afid>60006317</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8631858800</author-url><authid>8631858800</authid><authname>Vinay G.</authname><surname>Vinay</surname><given-name>Guillaume</given-name><initials>G.</initials><afid>60006317</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56594512100</author-url><authid>56594512100</authid><authname>Rahmani M.</authname><surname>Rahmani</surname><given-name>Mona</given-name><initials>M.</initials><afid>60006317</afid></author><authkeywords>Distributed Lagrange Multiplier/Fictitious Domain method | Finite volume | Parallel computing | Particulate flow | Solution accuracy</authkeywords><intid>535264528</intid><source-id>18160</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924933145"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924933145?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924933145&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924933145&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0045793015000663"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924933145</prism:url><dc:identifier>SCOPUS_ID:84924933145</dc:identifier><eid>2-s2.0-84924933145</eid><dc:title>Large eddy simulation of turbine internal cooling ducts</dc:title><dc:creator>Tyacke J.</dc:creator><prism:publicationName>Computers and Fluids</prism:publicationName><prism:issn>00457930</prism:issn><prism:volume>114</prism:volume><prism:pageRange>130-140</prism:pageRange><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>July 02, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compfluid.2015.02.022</prism:doi><pii>S0045793015000663</pii><dc:description>Â© 2015 The Authors. Large-Eddy Simulation (LES) and hybrid Reynolds-averaged Navier-Stokes-LES (RANS-LES) methods are applied to a turbine blade ribbed internal duct with a 180Â° bend containing 24 pairs of ribs. Flow and heat transfer predictions are compared with experimental data and found to be in agreement. The choice of LES model is found to be of minor importance as the flow is dominated by large geometric scale structures. This is in contrast to several linear and nonlinear RANS models, which display turbulence model sensitivity. For LES, the influence of inlet turbulence is also tested and has a minor impact due to the strong turbulence generated by the ribs. Large scale turbulent motions destroy any classical boundary layer reducing near wall grid requirements. The wake-type flow structure makes this and similar flows nearly Reynolds number independent, allowing a range of flows to be studied at similar cost. Hence LES is a relatively cheap method for obtaining accurate heat transfer predictions in these types of flows.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Cambridge</affilname><name-variant>Whittle Laboratory</name-variant><name-variant>Department of Engineering</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23010351800</author-url><authid>23010351800</authid><authname>Tyacke J.</authname><surname>Tyacke</surname><given-name>J.</given-name><initials>J.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7202804764</author-url><authid>7202804764</authid><authname>Tucker P.</authname><surname>Tucker</surname><given-name>P. G.</given-name><initials>P.G.</initials><afid/></author><authkeywords>Heat transfer | LES | RANS | SGS | Turbine</authkeywords><intid>2035228481</intid><source-id>18160</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928138113"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928138113?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928138113&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928138113&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0045793015001188"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928138113</prism:url><dc:identifier>SCOPUS_ID:84928138113</dc:identifier><eid>2-s2.0-84928138113</eid><dc:title>Validation of immersed boundary method for the numerical simulation of flapping wing flight</dc:title><dc:creator>Tay W.</dc:creator><prism:publicationName>Computers and Fluids</prism:publicationName><prism:issn>00457930</prism:issn><prism:volume>115</prism:volume><prism:pageRange>226-242</prism:pageRange><prism:coverDate>2015-07-02</prism:coverDate><prism:coverDisplayDate>July 02, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compfluid.2015.04.009</prism:doi><pii>S0045793015001188</pii><dc:description>Â© 2015 Elsevier Ltd. The two classes (continuous and discrete forcing) of the immersed boundary method (IBM) is tested for its suitability as a simulation tool for the analysis of the moving wings of the flapping micro aerial vehicles (FMAVs), for flows at Re = 5000-10,000. Comparison is made between numerical and experimental results of moving airfoils/wings from literature. Results obtained with body-conforming grid flow solvers are included for comparison. We show that both the continuous and discrete forcing IBM solvers give reasonably accurate results in terms of thrust coefficient, although the discrete forcing IBM solver gives smoother results at a lower grid resolution. This indicates that it is indeed able to capture the thin boundary layer better. From visual comparison, flow field patterns as represented by vorticity contours plots of both IBM solvers show good agreement compared to the referenced results. In one test case, there is a disagreement in the lift coefficient with respect to the experimental results, but it applies to all the numerical solvers. This could be due to turbulent effects in the experiment. Finally, the discrete forcing IBM solver is able to simulate a 3D NACA0012 and fruitfly wing undergoing plunging and complex flapping motion respectively at a Re of 10,000. The results compare well, which shows that the IBM solvers are suitable for 3D flapping wing simulations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006288</affiliation-url><afid>60006288</afid><affilname>Delft University of Technology</affilname><name-variant>Delft University of Technology</name-variant><affiliation-city>Delft</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017161</affiliation-url><afid>60017161</afid><affilname>National University of Singapore</affilname><name-variant>National University of Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56597690800</author-url><authid>56597690800</authid><authname>Tay W.</authname><surname>Tay</surname><given-name>W. B.</given-name><initials>W.B.</initials><afid>60006288</afid><afid>60017161</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56597690800</author-url><authid>56597690800</authid><authname>Tay W.</authname><surname>Tay</surname><given-name>W. B.</given-name><initials>W.B.</initials><afid>60006288</afid><afid>60017161</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56599672500</author-url><authid>56599672500</authid><authname>Deng S.</authname><surname>Deng</surname><given-name>S.</given-name><initials>S.</initials><afid>60006288</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004823224</author-url><authid>7004823224</authid><authname>van Oudheusden B.</authname><surname>van Oudheusden</surname><given-name>B. W.</given-name><initials>B.W.</initials><afid>60006288</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56264310600</author-url><authid>56264310600</authid><authname>Bijl H.</authname><surname>Bijl</surname><given-name>H.</given-name><initials>H.</initials><afid>60006288</afid></author><authkeywords>Flapping wing | Immersed boundary method | Numerical | Validation</authkeywords><intid>35734404</intid><source-id>18160</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930206951"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930206951?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930206951&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930206951&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001522"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930206951</prism:url><dc:identifier>SCOPUS_ID:84930206951</dc:identifier><eid>2-s2.0-84930206951</eid><dc:title>Degradation systems in heart failure</dc:title><dc:creator>Nishida K.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>212-222</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.004</prism:doi><pii>S0022282815001522</pii><dc:description>Â© 2015 Elsevier Ltd. Heart failure is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or the ejection of blood, and is a leading cause of morbidity and mortality in industrialized countries. The mechanisms underlying the development of heart failure are multiple, complex and not well understood. Cardiac mass and its homeostasis are maintained by the balance between protein synthesis and degradation, and an imbalance is likely to result in cellular dysfunction and disease. The protein degradation systems are the principle mechanisms for maintaining cellular homeostasis via protein quality control. Three major protein degradation systems have been identified, namely the calpain system, autophagy, and the ubiquitin proteasome system. Proinflammatory mediators involve the development and progression of heart failure. DNA and RNA degradation systems play a critical role in regulating inflammation and maintaining cellular homeostasis mediated by damaged DNA clearance and posttranscriptional regulation, respectively. This review discusses some recent advances in understanding the role of these degradation systems in heart failure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011520</affiliation-url><afid>60011520</afid><affilname>King's College London</affilname><name-variant>King's College London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024322</affiliation-url><afid>60024322</afid><affilname>Osaka University</affilname><name-variant>Osaka University</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402624784</author-url><authid>7402624784</authid><authname>Nishida K.</authname><surname>Nishida</surname><given-name>Kazuhiko</given-name><initials>K.</initials><afid>60011520</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55712028800</author-url><authid>55712028800</authid><authname>Yamaguchi O.</authname><surname>Yamaguchi</surname><given-name>Osamu</given-name><initials>O.</initials><afid>60024322</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005456155</author-url><authid>7005456155</authid><authname>Otsu K.</authname><surname>Otsu</surname><given-name>Kinya</given-name><initials>K.</initials><afid>60011520</afid></author><authkeywords>Autophagy | Calpain | Heart failure | Inflammation | Ubiquitin proteasome system</authkeywords><intid>1786088404</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929088095"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929088095?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929088095&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929088095&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929088095</prism:url><dc:identifier>SCOPUS_ID:84929088095</dc:identifier><eid>2-s2.0-84929088095</eid><dc:title>SIRT3 deficiency impairs mitochondrial and contractile function in the heart</dc:title><dc:creator>Koentges C.</dc:creator><prism:publicationName>Basic Research in Cardiology</prism:publicationName><prism:issn>03008428</prism:issn><prism:eIssn>14351803</prism:eIssn><prism:volume>110</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>1-20</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1007/s00395-015-0493-6</prism:doi><dc:description>Â© 2015, Springer-Verlag Berlin Heidelberg. Sirtuin 3 (SIRT3) is a mitochondrial NAD&lt;sup&gt;+&lt;/sup&gt;-dependent deacetylase that regulates energy metabolic enzymes by reversible protein lysine acetylation in various extracardiac tissues. The role of SIRT3 in myocardial energetics and in the development of mitochondrial dysfunction in cardiac pathologies, such as the failing heart, remains to be elucidated. To investigate the role of SIRT3 in the regulation of myocardial energetics and function SIRT3&lt;sup&gt;â/â&lt;/sup&gt; mice developed progressive age-related deterioration of cardiac function, as evidenced by a decrease in ejection fraction and an increase in enddiastolic volume at 24 but not 8Â weeks of age using echocardiography. Four weeks following transverse aortic constriction, ejection fraction was further decreased in SIRT3&lt;sup&gt;â/â&lt;/sup&gt; mice compared to WT mice, accompanied by a greater degree of cardiac hypertrophy and fibrosis. In isolated working hearts, a decrease in cardiac function in SIRT3&lt;sup&gt;â/â&lt;/sup&gt; mice was accompanied by a decrease in palmitate oxidation, glucose oxidation, and oxygen consumption, whereas rates of glycolysis were increased. Respiratory capacity and ATP synthesis were decreased in cardiac mitochondria of SIRT3&lt;sup&gt;â/â&lt;/sup&gt; mice. HPLC measurements revealed a decrease of the myocardial ATP/AMP ratio and of myocardial energy charge. Using LCâMS/MS, we identified increased acetylation of 84 mitochondrial proteins, including 6 enzymes of fatty acid import and oxidation, 50 subunits of the electron transport chain, and 3 enzymes of the tricarboxylic acid cycle. Lack of SIRT3 impairs mitochondrial and contractile function in the heart, likely due to increased acetylation of various energy metabolic proteins and subsequent myocardial energy depletion.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>UniversitÃ¤t Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>UniversitÃ¤t Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025641</affiliation-url><afid>60025641</afid><affilname>Universitat Freiburg im Breisgau</affilname><name-variant>UniversitÃ¤t Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024805</affiliation-url><afid>60024805</afid><affilname>Universitats Klinikum Freiburg und Medizinische Fakultat</affilname><name-variant>University Hospital Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:43461304500</author-url><authid>43461304500</authid><authname>Koentges C.</authname><surname>Koentges</surname><given-name>Christoph</given-name><initials>C.</initials><afid>60025641</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56573985600</author-url><authid>56573985600</authid><authname>Pfeil K.</authname><surname>Pfeil</surname><given-name>Katharina</given-name><initials>K.</initials><afid>60025641</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54411397900</author-url><authid>54411397900</authid><authname>Schnick T.</authname><surname>Schnick</surname><given-name>Tilman</given-name><initials>T.</initials><afid>60025641</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24469484400</author-url><authid>24469484400</authid><authname>Wiese S.</authname><surname>Wiese</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60025641</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56638468000</author-url><authid>56638468000</authid><authname>Dahlbock R.</authname><surname>Dahlbock</surname><given-name>Rabea</given-name><initials>R.</initials><afid>60025641</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:25824781900</author-url><authid>25824781900</authid><authname>Cimolai M.</authname><surname>Cimolai</surname><given-name>Maria C.</given-name><initials>M.C.</initials><afid>60025641</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56638602500</author-url><authid>56638602500</authid><authname>Meyer-Steenbuck M.</authname><surname>Meyer-Steenbuck</surname><given-name>Maximilian</given-name><initials>M.</initials><afid>60025641</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56638457400</author-url><authid>56638457400</authid><authname>Cenkerova K.</authname><surname>Cenkerova</surname><given-name>Katarina</given-name><initials>K.</initials><afid>60025641</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56573314000</author-url><authid>56573314000</authid><authname>Hoffmann M.</authname><surname>Hoffmann</surname><given-name>Michael M.</given-name><initials>M.M.</initials><afid>60025641</afid><afid>60024805</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56573314000</author-url><authid>56573314000</authid><authname>Hoffmann M.</authname><surname>Hoffmann</surname><given-name>Michael M.</given-name><initials>M.M.</initials><afid>60025641</afid><afid>60024805</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:53663645400</author-url><authid>53663645400</authid><authname>Jaeger C.</authname><surname>Jaeger</surname><given-name>Carsten</given-name><initials>C.</initials><afid>60025641</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:24399452400</author-url><authid>24399452400</authid><authname>Odening K.</authname><surname>Odening</surname><given-name>Katja E.</given-name><initials>K.E.</initials><afid>60025641</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003512383</author-url><authid>7003512383</authid><authname>Kammerer B.</authname><surname>Kammerer</surname><given-name>Bernd</given-name><initials>B.</initials><afid>60025641</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55851623900</author-url><authid>55851623900</authid><authname>Hein L.</authname><surname>Hein</surname><given-name>Lutz</given-name><initials>L.</initials><afid>60025641</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56465466300</author-url><authid>56465466300</authid><authname>Bode C.</authname><surname>Bode</surname><given-name>Christoph</given-name><initials>C.</initials><afid>60025641</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:22233449600</author-url><authid>22233449600</authid><authname>Bugger H.</authname><surname>Bugger</surname><given-name>Heiko</given-name><initials>H.</initials><afid>60025641</afid></author><authkeywords>Cardiac function | Energetics | Mitochondria | Sirtuin 3</authkeywords><intid>35900398</intid><source-id>22488</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929190774"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929190774?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929190774&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929190774&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008098"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929190774</prism:url><dc:identifier>SCOPUS_ID:84929190774</dc:identifier><eid>2-s2.0-84929190774</eid><dc:title>Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure</dc:title><dc:creator>Booth L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>220-226</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.440</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Objectives: Sympathetic drive, especially to the heart, is elevated in heart failure and is strongly associated with poor outcome. The mechanisms causing the increased sympathetic drive to the heart remain poorly understood. Catheter-based renal denervation (RDN),which reduces blood pressure (BP) and sympathetic drive in hypertensive patients, is a potential treatment in heart failure. The aim of this study was to investigate the short-term effects of catheter-based RDN on BP, heart rate (HR) and cardiac sympathetic nerve activity (CSNA) and on baroreflex function in a conscious, large animal model of heart failure. Methods: Adult Merino ewes were paced into heart failure (ejection fraction b 40%) and then instrumented to directly record CSNA. The resting levels and baroreflex control of CSNA and HR were measured before and 24 h after bilateral renal (n = 6) or sham (n = 6) denervation. RDN was performed using the Symplicity Flex Catheter SystemÂ® (Medtronic) using the same algorithm as in patients. Results: Catheter-based RDNsignificantly reduced resting diastolic BP (P b 0.01) and mean arterial blood pressure (P b 0.05), but did not change resting HR or CSNA comparedwith sham denervation. Renal denervation reduced the BP at which CSNA was at 50% of maximum (BP50; P b 0.005) compared with sham denervation. Conclusions: In an ovine model of heart failure, catheter-based RDN did not reduce resting CSNA in the shortterm. There was, however, a lack of a reflex increase in CSNA in response to the fall in arterial pressure due to a leftward shift in the baroreflex control of CSNA, which may be due to denervation of renal efferent and/or afferent nerves.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114353065</affiliation-url><afid>114353065</afid><affilname>Florey Institute of Neuroscience and Mental Health</affilname><name-variant>The Florey Institute of Neuroscience and Mental Health</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033409</affiliation-url><afid>60033409</afid><affilname>Baker IDI Heart and Diabetes Institute</affilname><name-variant>Baker Heart Research Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014992</affiliation-url><afid>60014992</afid><affilname>Universidade Federal de Sao Paulo</affilname><name-variant>Federal University of SÃ£o Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024452</affiliation-url><afid>60024452</afid><affilname>Ruijin Hospital</affilname><name-variant>Ruijin Hospital</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:17341933400</author-url><authid>17341933400</authid><authname>Booth L.</authname><surname>Booth</surname><given-name>Lindsea C.</given-name><initials>L.C.</initials><afid>114353065</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003349164</author-url><authid>7003349164</authid><authname>Schlaich M.</authname><surname>Schlaich</surname><given-name>Markus P.</given-name><initials>M.P.</initials><afid>60033409</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56427767800</author-url><authid>56427767800</authid><authname>Nishi E.</authname><surname>Nishi</surname><given-name>Erika E.</given-name><initials>E.E.</initials><afid>114353065</afid><afid>60014992</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56427767800</author-url><authid>56427767800</authid><authname>Nishi E.</authname><surname>Nishi</surname><given-name>Erika E.</given-name><initials>E.E.</initials><afid>114353065</afid><afid>60014992</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640392100</author-url><authid>56640392100</authid><authname>Yao S.</authname><surname>Yao</surname><given-name>Song T.</given-name><initials>S.T.</initials><afid>114353065</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55617195800</author-url><authid>55617195800</authid><authname>Xu J.</authname><surname>Xu</surname><given-name>Jianzhong</given-name><initials>J.</initials><afid>60033409</afid><afid>60024452</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55617195800</author-url><authid>55617195800</authid><authname>Xu J.</authname><surname>Xu</surname><given-name>Jianzhong</given-name><initials>J.</initials><afid>60033409</afid><afid>60024452</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507279062</author-url><authid>6507279062</authid><authname>Ramchandra R.</authname><surname>Ramchandra</surname><given-name>Rohit</given-name><initials>R.</initials><afid>114353065</afid><afid>60005686</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507279062</author-url><authid>6507279062</authid><authname>Ramchandra R.</authname><surname>Ramchandra</surname><given-name>Rohit</given-name><initials>R.</initials><afid>114353065</afid><afid>60005686</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7201789930</author-url><authid>7201789930</authid><authname>Lambert G.</authname><surname>Lambert</surname><given-name>Gavin W.</given-name><initials>G.W.</initials><afid>60033409</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56427556300</author-url><authid>56427556300</authid><authname>May C.</authname><surname>May</surname><given-name>Clive N.</given-name><initials>C.N.</initials><afid>114353065</afid></author><authkeywords>Animal model | Arterial baroreflex | Cardiac sympathetic nerve activity | Radiofrequency-ablation | Renal denervation</authkeywords><intid>1785917328</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377899"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377899?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377899&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377899&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010205"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377899</prism:url><dc:identifier>SCOPUS_ID:84929377899</dc:identifier><eid>2-s2.0-84929377899</eid><dc:title>Sex differences in mechanisms, presentation and management of ischaemic heart disease</dc:title><dc:creator>Crea F.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>157-168</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.802</prism:doi><pii>S0021915015010205</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Ischaemic heart disease (IHD) is the leading cause of death in women as in men, although presentation in women is on average 7-10 years later. Recent temporal trends show declining IHD incidence and mortality among men but not among women. Other gender differences concern the prevalence of underlying mechanisms. Women more frequently than men have nonobstructive epicardial artery disease, nonatherosclerotic spontaneous coronary artery dissection, stress cardiomyopathy, plaque erosion, microvascular dysfunction, and a heavier risk factor burden, even after adjustment for age. Atypical symptoms of IHD are more common in women. The crude outcomes of both chronic and acute coronary syndromes are worse in women than in men, in relation to older age and comorbidities. After adjustments, in-hospital mortality after acute myocardial infarction is reported to remain higher among younger women compared to male peers. Such female vulnerability, in apparent contrast with the delayed average onset and lesser extent of epicardial atherosclerosis, likely reflects gender differences in early presentation, as well as in mechanisms, prevention, diagnosis, comorbidities, management, and response to treatment. Recognition and quality of care of IHD are still not the same for women and men.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031984</affiliation-url><afid>60031984</afid><affilname>Universita Cattolica del Sacro Cuore, Rome</affilname><name-variant>Catholic University</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35371766500</author-url><authid>35371766500</authid><authname>Crea F.</authname><surname>Crea</surname><given-name>Filippo</given-name><initials>F.</initials><afid>60031984</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36599945100</author-url><authid>36599945100</authid><authname>Battipaglia I.</authname><surname>Battipaglia</surname><given-name>Irma</given-name><initials>I.</initials><afid>60031984</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7007058761</author-url><authid>7007058761</authid><authname>Andreotti F.</authname><surname>Andreotti</surname><given-name>Felicita</given-name><initials>F.</initials><afid>60031984</afid></author><authkeywords>Ischaemic heart disease | Management | Mechanisms | Men | Presentation | Sex | Women</authkeywords><intid>1035940308</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929223397"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929223397?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929223397&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929223397&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008840"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929223397</prism:url><dc:identifier>SCOPUS_ID:84929223397</dc:identifier><eid>2-s2.0-84929223397</eid><dc:title>Family history of premature myocardial infarction, life course socioeconomic position and coronary heart disease mortality - A Cohort of Norway (CONOR) study</dc:title><dc:creator>FiskÃ¥ B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>302-307</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.160</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. Background/objectives: To investigate self-reported family history (FH) of premature myocardial infarction (MI) in first-degree relatives as a risk factor for coronary heart disease (CHD) mortality, and assess whether any observed effect could be explained by current or life course socioeconomic position. Methods: 130,066 participants from Cohort of Norway were examined during 1994-2003. A subgroup (n = 84,631) had additional life course socioeconomic data. Using Cox proportional hazard analyses, we calculated hazard ratios (HR) for CHD mortality, assessed by linkages to the Norwegian Cause of Death Registry through 2009. For subgroup analyses, we created an index of life course socioeconomic position, and assessed its role as a potential confounder in the association of FH with CHD. Results: Formen, MI in parents and siblingswere both a significant risk factor for CHD mortality after adjusting for established risk factors and current socioeconomic conditions; the highest risk was with MI in siblings (HR: 1.44 [1.19-1.75]). For women, FH constituted significant risk after similar adjustment only for those with MI in parents plus siblings (HR: 1.78 [1.16-2.73]). Adjusting for current and life course socioeconomic conditions only marginally lowered the estimates, and those with FH did not have worse life course socioeconomic position than those without. Conclusions: FH of premature MI is an independent risk factor for CHD mortality that differs inmagnitude of effect by the sex of the index person and type of familial relationship. Life course socioeconomic position has little impact on the association between FH and CHD, suggesting the effect is not confounded by this.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010348</affiliation-url><afid>60010348</afid><affilname>Universitetet i Oslo</affilname><name-variant>University of Oslo</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011916</affiliation-url><afid>60011916</afid><affilname>Norwegian Institute of Public Health</affilname><name-variant>National Institute of Public Health</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029622</affiliation-url><afid>60029622</afid><affilname>Universitetet i Bergen</affilname><name-variant>University of Bergen</name-variant><affiliation-city>Bergen</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011916</affiliation-url><afid>60011916</afid><affilname>Norwegian Institute of Public Health</affilname><name-variant>National Institute of Public Health</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641872700</author-url><authid>56641872700</authid><authname>FiskÃ¥ B.</authname><surname>FiskÃ¥</surname><given-name>Bendik S.</given-name><initials>B.S.</initials><afid>60010348</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36083917100</author-url><authid>36083917100</authid><authname>Ariansen I.</authname><surname>Ariansen</surname><given-name>Inger</given-name><initials>I.</initials><afid>60011916</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004361524</author-url><authid>7004361524</authid><authname>Graff-Iversen S.</authname><surname>Graff-Iversen</surname><given-name>Sidsel</given-name><initials>S.</initials><afid>60011916</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56564949700</author-url><authid>56564949700</authid><authname>Tell G.</authname><surname>Tell</surname><given-name>Grethe S.</given-name><initials>G.S.</initials><afid>60029622</afid><afid>60011916</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56564949700</author-url><authid>56564949700</authid><authname>Tell G.</authname><surname>Tell</surname><given-name>Grethe S.</given-name><initials>G.S.</initials><afid>60029622</afid><afid>60011916</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003274023</author-url><authid>7003274023</authid><authname>Egeland G.</authname><surname>Egeland</surname><given-name>Grace M.</given-name><initials>G.M.</initials><afid>60029622</afid><afid>60011916</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003274023</author-url><authid>7003274023</authid><authname>Egeland G.</authname><surname>Egeland</surname><given-name>Grace M.</given-name><initials>G.M.</initials><afid>60029622</afid><afid>60011916</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9733265900</author-url><authid>9733265900</authid><authname>NÃ¦ss Ã.</authname><surname>NÃ¦ss</surname><given-name>Ãyvind</given-name><initials>Ã.</initials><afid>60010348</afid><afid>60011916</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9733265900</author-url><authid>9733265900</authid><authname>NÃ¦ss Ã.</authname><surname>NÃ¦ss</surname><given-name>Ãyvind</given-name><initials>Ã.</initials><afid>60010348</afid><afid>60011916</afid></author><authkeywords>Coronary heart disease | Coronary heart disease mortality | Family history | Life course socioeconomic position | Myocardial infarction</authkeywords><intid>1785916937</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928798984"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928798984?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928798984&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928798984&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010217"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928798984</prism:url><dc:identifier>SCOPUS_ID:84928798984</dc:identifier><eid>2-s2.0-84928798984</eid><dc:title>25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: The ARIC study</dc:title><dc:creator>Michos E.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>12-17</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.803</prism:doi><pii>S0021915015010217</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Background: In observational studies, low 25-hydroxyvitamin D (25(OH)D) has been associated with increased risk of coronary heart disease (CHD), and this association may vary by race. Racial differences in the frequency of vitamin D binding protein (DBP) single nucleotide polymorphisms (SNPs) might account for similar bioavailable vitamin D in blacks despite lower mean 25(OH)D. We hypothesized that the associations of low 25(OH)D with CHD risk would be stronger among whites and among persons with genotypes associated with higher DBP levels. Methods: We measured 25(OH)D by mass spectroscopy in 11,945 participants in the ARIC Study (baseline 1990-1992, mean age 57 years, 59% women, 24% black). Two DBP SNPs (rs7041; rs4588) were genotyped. We used adjusted Cox proportional hazards models to examine the association of 25(OH)D with adjudicated CHD events through December 2011. Results: Over a median of 20 years, there were 1230 incident CHD events. Whites in the lowest quintile of 25(OH)D (&lt;17ng/ml) compared to the upper 4 quintiles had an increased risk of incident CHD (HR 1.28, 95% CI 1.05-1.56), but blacks did not (1.03, 0.82-1.28), after adjustment for demographics and behavioral/socioeconomic factors (p-interaction with race=0.22). Results among whites were no longer significant after further adjustment for potential mediators of this association (i.e. diabetes, hypertension). There was no statistically significant interaction of 25(OH)D with the DBP SNPs rs4588 (p=0.92) or rs7041 (p=0.87) in relation to CHD risk. Conclusions: Low 25(OH)D was associated with incident CHD in whites, but no interactions of 25(OH)D with key DBP genotypes was found.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><name-variant>Johns Hopkins School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006183</affiliation-url><afid>60006183</afid><affilname>Johns Hopkins Bloomberg School of Public Health</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506845117</author-url><authid>6506845117</authid><authname>Michos E.</authname><surname>Michos</surname><given-name>Erin D.</given-name><initials>E.D.</initials><afid>60001117</afid><afid>60006183</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506845117</author-url><authid>6506845117</authid><authname>Michos E.</authname><surname>Michos</surname><given-name>Erin D.</given-name><initials>E.D.</initials><afid>60001117</afid><afid>60006183</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55595408100</author-url><authid>55595408100</authid><authname>Misialek J.</authname><surname>Misialek</surname><given-name>Jeffrey R.</given-name><initials>J.R.</initials><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602453920</author-url><authid>6602453920</authid><authname>Selvin E.</authname><surname>Selvin</surname><given-name>Elizabeth</given-name><initials>E.</initials><afid>60006183</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36043809200</author-url><authid>36043809200</authid><authname>Folsom A.</authname><surname>Folsom</surname><given-name>Aaron R.</given-name><initials>A.R.</initials><afid>60005745</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101854959</author-url><authid>7101854959</authid><authname>Pankow J.</authname><surname>Pankow</surname><given-name>James S.</given-name><initials>J.S.</initials><afid>60005745</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005941996</author-url><authid>7005941996</authid><authname>Post W.</authname><surname>Post</surname><given-name>Wendy S.</given-name><initials>W.S.</initials><afid>60001117</afid><afid>60006183</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005941996</author-url><authid>7005941996</authid><authname>Post W.</authname><surname>Post</surname><given-name>Wendy S.</given-name><initials>W.S.</initials><afid>60001117</afid><afid>60006183</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35237937500</author-url><authid>35237937500</authid><authname>Lutsey P.</authname><surname>Lutsey</surname><given-name>Pamela L.</given-name><initials>P.L.</initials><afid>60005745</afid></author><authkeywords>Coronary heart disease | Epidemiology | Race | Vitamin D | Vitamin D binding protein</authkeywords><intid>535850861</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929155622"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929155622?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929155622&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929155622&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0005796715000765"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929155622</prism:url><dc:identifier>SCOPUS_ID:84929155622</dc:identifier><eid>2-s2.0-84929155622</eid><dc:title>Randomized controlled trial of heart rate variability biofeedback in cardiac autonomic and hostility among patients with coronary artery disease</dc:title><dc:creator>Lin I.</dc:creator><prism:publicationName>Behaviour Research and Therapy</prism:publicationName><prism:issn>00057967</prism:issn><prism:eIssn>1873622X</prism:eIssn><prism:volume>70</prism:volume><prism:pageRange>38-46</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.brat.2015.05.001</prism:doi><pii>S0005796715000765</pii><dc:description>Â© 2015 Elsevier Ltd. Hostility is a psychosocial risk factor that may decrease heart rate variability (HRV) in coronary artery disease (CAD) through cardiac autonomic imbalance. Heart rate variability biofeedback (HRV-BF) increases HRV indices and baroreflex gain. This study examines the effectiveness of HRV-BF in restoring cardiac autonomic balance and decreasing hostility among patients with CAD. One hundred and fifty-four patients with CAD were assigned randomly to receive 6 weeks of HRV-BF, in addition to the standard medical care received by the wait-list control (WLC) group. A 5-min electrocardiogram, blood pressure, and hostility were assessed pre-intervention, post-intervention, and at 1-month follow-up. The standard deviation of normal-to-normal intervals (SDNN), low frequency (LF), and log LF at post-intervention was significantly higher than that at pre-intervention in the HRV-BF group. Baseline log LF was significantly higher post-intervention and at follow-up after HRV-BF training than at pre-intervention. The treatment curve of log LF pre-session increased significantly after session 2, which was maintained to post-intervention. Expressive hostility, suppressive hostility, and hostility total score at post-intervention and one-month follow-up after HRV-BF were significantly lower than at pre-intervention. This study showed increased HRV and decreased expressive and suppressive hostility behavior in patients with CAD following HRV-BF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014982</affiliation-url><afid>60014982</afid><affilname>National Cheng Kung University</affilname><name-variant>National Cheng Kung University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073387</affiliation-url><afid>60073387</afid><affilname>Kaohsiung Medical University Chung-Ho Memorial Hospital</affilname><name-variant>Kaohsiung Medical University Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109914547</affiliation-url><afid>109914547</afid><affilname>Kaohsiung Municipal Ta-Tung Hospital</affilname><name-variant>Kaohsiung Municipal Ta-Tung Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25029776100</author-url><authid>25029776100</authid><authname>Lin I.</authname><surname>Lin</surname><given-name>I. Mei</given-name><initials>I.M.</initials><afid>60012256</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:28067683000</author-url><authid>28067683000</authid><authname>Fan S.</authname><surname>Fan</surname><given-name>Sheng Yu</given-name><initials>S.Y.</initials><afid>60014982</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640162000</author-url><authid>56640162000</authid><authname>Lu H.</authname><surname>Lu</surname><given-name>Hsueh Chen</given-name><initials>H.C.</initials><afid>60012256</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640237100</author-url><authid>56640237100</authid><authname>Lin T.</authname><surname>Lin</surname><given-name>Tsung Hsien</given-name><initials>T.H.</initials><afid>60073387</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640334800</author-url><authid>56640334800</authid><authname>Chu C.</authname><surname>Chu</surname><given-name>Chih Sheng</given-name><initials>C.S.</initials><afid>60073387</afid><afid>109914547</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640334800</author-url><authid>56640334800</authid><authname>Chu C.</authname><surname>Chu</surname><given-name>Chih Sheng</given-name><initials>C.S.</initials><afid>60073387</afid><afid>109914547</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640522100</author-url><authid>56640522100</authid><authname>Kuo H.</authname><surname>Kuo</surname><given-name>Hsuan Fu</given-name><initials>H.F.</initials><afid>109914547</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56155667300</author-url><authid>56155667300</authid><authname>Lee C.</authname><surname>Lee</surname><given-name>Chee Siong</given-name><initials>C.S.</initials><afid>60073387</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640059300</author-url><authid>56640059300</authid><authname>Lu Y.</authname><surname>Lu</surname><given-name>Ye Hsu</given-name><initials>Y.H.</initials><afid>60073387</afid></author><authkeywords>Cardiac autonomic | Coronary artery disease | Heart rate variability biofeedback | Hostility</authkeywords><intid>1535915522</intid><source-id>12127</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929624993"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929624993?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929624993&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929624993&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0379073815001917"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929624993</prism:url><dc:identifier>SCOPUS_ID:84929624993</dc:identifier><eid>2-s2.0-84929624993</eid><dc:title>Postmortem heart weight modelled using piecewise linear regression in 27,645 medicolegal autopsy cases</dc:title><dc:creator>Wingren C.</dc:creator><prism:publicationName>Forensic Science International</prism:publicationName><prism:issn>03790738</prism:issn><prism:eIssn>18726283</prism:eIssn><prism:volume>252</prism:volume><prism:pageRange>157-162</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.forsciint.2015.04.036</prism:doi><pii>S0379073815001917</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. The interpretation of postmortem heart weight is often difficult, and references for normal heart weight are important. However, to assess the cause of death at a medicolegal autopsy it is also important to have references based on an unselected population of medicolegal autopsy cases with non-natural causes of death (not due directly to disease). We aimed at studying and deriving references for adult heart weight by considering sex, age and body size in cases with an external cause of death. We identified all medicolegal autopsies in Sweden from 1999 to 2013 (n = 79,778) and included 27,645 cases. We applied multivariate piecewise linear regression models in three strata of body mass-underweight, normal-/overweight and obesity. We observed that approximately 50% of the variation in heart weight was explained by age, sex and body size. These variables were slightly less important in explaining the variation in heart weight in the underweight and obese compared to in those normal or overweight. Based on the linear regression models we present equations to calculate the predicted heart weight with reference intervals using age, sex, body weight and height. We provide an online heart weight calculator (http://lundforensicmedicine.com) based on these equations. In the forensic interpretation of postmortem heart weights, we suggest that heart weight references derived in cases with an external cause of death is an important complement to references solely based on healthy and normal hearts. Furthermore, the heart weight references presented are derived from a large population, with sufficient numbers for separate models in underweight, normal-/overweight and obese populations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009358</affiliation-url><afid>60009358</afid><affilname>Linkopings universitet</affilname><name-variant>LinkÃ¶ping University</name-variant><affiliation-city>Linkoping</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:49862271400</author-url><authid>49862271400</authid><authname>Wingren C.</authname><surname>Wingren</surname><given-name>Carl Johan</given-name><initials>C.J.</initials><afid>60009358</afid><afid>60029170</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:49862271400</author-url><authid>49862271400</authid><authname>Wingren C.</authname><surname>Wingren</surname><given-name>Carl Johan</given-name><initials>C.J.</initials><afid>60009358</afid><afid>60029170</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603855607</author-url><authid>6603855607</authid><authname>Ottosson A.</authname><surname>Ottosson</surname><given-name>Anders</given-name><initials>A.</initials><afid>60009358</afid><afid>60029170</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603855607</author-url><authid>6603855607</authid><authname>Ottosson A.</authname><surname>Ottosson</surname><given-name>Anders</given-name><initials>A.</initials><afid>60009358</afid><afid>60029170</afid></author><authkeywords>Autopsy | Epidemiology | Forensic medicine | Heart weight | Medicolegal | Reference values</authkeywords><intid>535989632</intid><source-id>27743</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928751411"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928751411?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928751411&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928751411&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0531556515001291"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928751411</prism:url><dc:identifier>SCOPUS_ID:84928751411</dc:identifier><eid>2-s2.0-84928751411</eid><dc:title>Differences in ischemic damage between young and old hearts - Effects of blood cardioplegia</dc:title><dc:creator>BÃ¶ning A.</dc:creator><prism:publicationName>Experimental Gerontology</prism:publicationName><prism:issn>05315565</prism:issn><prism:eIssn>18736815</prism:eIssn><prism:volume>67</prism:volume><prism:pageRange>3-8</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exger.2015.04.012</prism:doi><pii>S0531556515001291</pii><dc:description>Â© 2015 Elsevier Inc. Objective: Senescent patients exhibit an elevated perioperative risk for cardiac dysfunction, hemodynamic depression and subsequent cardiac death compared to young patients. Despite the fact that a growing proportion of cardiac surgery patients are octogenarians, cardioplegic regimes remain comparable across patients of all ages. We compared the hemodynamic performance, metabolic parameters and ultrastructural changes in adult and senescent rat hearts after application of Buckberg's blood cardioplegia (BCP) to evaluate differences between the age groups regarding postischemic myocardial function and cellular ultrastructure. Methods: Hearts of adult (young adult group, 3-4. months) and senescent (old group, 24. months) male Wistar rats were excised and inserted into a blood perfused isolated heart apparatus (Langendorff perfusion). After a stabilization period of 30. min, in 16 adult and 16 senescent hearts, Buckberg BCP was administered antegradely and repeated every 20. min. Six young adult and 3 senescent hearts served as ischemia control. After an aortic clamping time of 90. min an antegrade hot shot was administered. During reperfusion ex vivo cardiac functional parameters were recorded, including coronary blood flow, left ventricular developed pressure (LVDP) and velocity of myocardial contraction or relaxation (+/-. dp/dt). Oxygen consumption and lactate production of the hearts were calculated. After perfusion fixation, the hearts of five rats in each BCP group and 3 rats in each ischemia group were investigated for cellular edema and mitochondrial damage by morphometry using transmission electron microscopy. Results: While recovery of cardiac function after 90. min of unprotected ischemia was significantly impaired in senescent hearts, functional recovery after ischemia protected by BCP was similar in adult and senescent hearts. Mitochondrial ultrastructure was severely damaged in both age groups after 90. min ischemia, but well preserved in both BCP groups. The qualitative analysis was confirmed by the morphometric cellular edema index and the volume-to-surface ratio of the mitochondria. Myocardial oxygen consumption was highest and lactate production was lowest in senescent hearts. Conclusion: Senescent rat hearts were more susceptible to unprotected ischemia/reperfusion injury than young adult hearts. When protected by BCP, we found no difference in hemodynamic performance between adult and senescent hearts indicating preserved myocardial protection even in senescent individuals.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017134</affiliation-url><afid>60017134</afid><affilname>Justus Liebig University Giessen</affilname><affiliation-city>Giessen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017134</affiliation-url><afid>60017134</afid><affilname>Justus Liebig University Giessen</affilname><affiliation-city>Giessen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024052</affiliation-url><afid>60024052</afid><affilname>Medizinische Hochschule Hannover (MHH)</affilname><name-variant>Hannover Medical School</name-variant><affiliation-city>Hannover</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603371086</author-url><authid>6603371086</authid><authname>BÃ¶ning A.</authname><surname>BÃ¶ning</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60017134</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701838514</author-url><authid>6701838514</authid><authname>Rohrbach S.</authname><surname>Rohrbach</surname><given-name>Susanne</given-name><initials>S.</initials><afid>60017134</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56611992600</author-url><authid>56611992600</authid><authname>Kohlhepp L.</authname><surname>Kohlhepp</surname><given-name>Lukas</given-name><initials>L.</initials><afid>60017134</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701431562</author-url><authid>6701431562</authid><authname>Heep M.</authname><surname>Heep</surname><given-name>Martina</given-name><initials>M.</initials><afid>60017134</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56293270500</author-url><authid>56293270500</authid><authname>HagmÃ¼ller S.</authname><surname>HagmÃ¼ller</surname><given-name>Stefanie</given-name><initials>S.</initials><afid>60017134</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005254570</author-url><authid>7005254570</authid><authname>Niemann B.</authname><surname>Niemann</surname><given-name>Bernd</given-name><initials>B.</initials><afid>60017134</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56243294700</author-url><authid>56243294700</authid><authname>MÃ¼hlfeld C.</authname><surname>MÃ¼hlfeld</surname><given-name>Christian</given-name><initials>C.</initials><afid>60024052</afid></author><authkeywords>Aging | Cardiac surgery | Cardioplegia | Ischemia/reperfusion</authkeywords><intid>1785840487</intid><source-id>29003</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929223688"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929223688?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929223688&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929223688&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500916X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929223688</prism:url><dc:identifier>SCOPUS_ID:84929223688</dc:identifier><eid>2-s2.0-84929223688</eid><dc:title>Determinants and covariates of central pressures and wave reflections in systolic heart failure</dc:title><dc:creator>Parragh S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>308-314</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.183</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: In general, higher blood pressure levels and increased central pulsatility are indicators for increased cardiovascular risk. However, in systolic heart failure (SHF), this relationship is reversed. Therefore, the aim of this work is to compare pulsatile hemodynamics between patients with SHF and controls and to clarify the relationships between measures of cardiac and arterial function in the two groups. Methods: We used parameters derived from angiography, echocardiography, as well asfrom pulse wave analysis (PWA) and wave separation analysis (WSA) based on non-invasively assessed pressure and flow waves to quantify cardiac function, aortic stiffness and arterial wave reflection in 61 patients with highly reduced (rEF) and 122 matched control-patients with normal ejection fraction (nEF). Results: Invasively measured pulse wave velocity was comparable between the groups (8.6/8.05 m/s rEF/nEF, P = 0.24), whereas all measures derived by PWA and WSA were significantly decreased (augmentation index: 18.1/24.8 rEF/nEF, P b 0.01; reflection magnitude: 56.3/62.1 rEF/nEF, P b 0.01). However, these differences could be explained by the shortened ejection duration (ED) in rEF (ED: 269/308 ms rEF/nEF, P b 0.01; AIx: 22.2/22.8 rEF/nEF, P = 0.7; RM: 59.3/60.6 rEF/nEF, P = 0.47 after adjustment for ED). Ventricular function was positively associated with central pulse pressures in SHF in contrast to no or even a slightly negative association in controls. Conclusions: The results suggest that the decreased measures of pulsatile function may be caused by impaired systolic function and altered interplay of left ventricle and vascular system rather than by a real reduction of wave reflections or aortic stiffness in SHF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103936</affiliation-url><afid>60103936</afid><affilname>Austrian Institute of Technology</affilname><name-variant>AIT Austrian Institute of Technology</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018163</affiliation-url><afid>60018163</afid><affilname>Technische Universitat Wien</affilname><name-variant>Technische UniversitÃ¤t Wien</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107252853</affiliation-url><afid>107252853</afid><affilname>Klinikum Wels-Grieskirchen</affilname><name-variant>Klinikum Wels-Grieskirchen</name-variant><affiliation-city>Wels</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55535792300</author-url><authid>55535792300</authid><authname>Parragh S.</authname><surname>Parragh</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60103936</afid><afid>60018163</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55535792300</author-url><authid>55535792300</authid><authname>Parragh S.</authname><surname>Parragh</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60103936</afid><afid>60018163</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:49963411500</author-url><authid>49963411500</authid><authname>Hametner B.</authname><surname>Hametner</surname><given-name>Bernhard</given-name><initials>B.</initials><afid>60103936</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55535772800</author-url><authid>55535772800</authid><authname>Bachler M.</authname><surname>Bachler</surname><given-name>Martin</given-name><initials>M.</initials><afid>60103936</afid><afid>60018163</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55535772800</author-url><authid>55535772800</authid><authname>Bachler M.</authname><surname>Bachler</surname><given-name>Martin</given-name><initials>M.</initials><afid>60103936</afid><afid>60018163</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55987632300</author-url><authid>55987632300</authid><authname>Kellermair J.</authname><surname>Kellermair</surname><given-name>JÃ¶rg</given-name><initials>J.</initials><afid>107252853</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56496476000</author-url><authid>56496476000</authid><authname>Eber B.</authname><surname>Eber</surname><given-name>Bernd</given-name><initials>B.</initials><afid>107252853</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23398848300</author-url><authid>23398848300</authid><authname>Wassertheurer S.</authname><surname>Wassertheurer</surname><given-name>Siegfried</given-name><initials>S.</initials><afid>60103936</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55643847300</author-url><authid>55643847300</authid><authname>Weber T.</authname><surname>Weber</surname><given-name>Thomas</given-name><initials>T.</initials><afid>107252853</afid></author><authkeywords>Arterial wave reflections | Pulse wave analysis | Pulse wave velocity | Reduced ejection fraction | Systolic heart failure | Wave separation</authkeywords><intid>2035911871</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927731883"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927731883?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927731883&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927731883&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915001040"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927731883</prism:url><dc:identifier>SCOPUS_ID:84927731883</dc:identifier><eid>2-s2.0-84927731883</eid><dc:title>Involvement of activated SUMO-2 conjugation in cardiomyopathy</dc:title><dc:creator>Kim E.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1388-1399</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.03.013</prism:doi><pii>S0925443915001040</pii><dc:description>Â© 2015 Elsevier B.V. Sumoylation is a posttranslational modification that regulates a wide spectrum of cellular activities. Cardiomyopathy is the leading cause of heart failure. Whether sumoylation, particularly SUMO-2/3 conjugation, is involved in cardiomyopathy has not been investigated. We report here that SUMO-2/3 conjugation was elevated in the human failing hearts, and we investigated the impact of increased SUMO-2 conjugation on heart function by using the gain-of-function approach in mice, in which cardiac specific expression of constitutively active SUMO-2 was governed by alpha myosin heavy chain promoter (MHC-SUMO-2 transgenic, SUMO-2-Tg). Four of five independent SUMO-2-Tg mouse lines exhibited cardiomyopathy with various severities, ranging from acute heart failure leading to early death to the development of chronic cardiomyopathy with aging. We further revealed that SUMO-2 directly regulated apoptotic process by at least partially targeting calpain 2 and its natural inhibitor calpastatin. SUMO conjugation to calpain 2 promoted its enzymatic activity, and SUMO attachment to calpastatin mainly promoted its turnover and altered its subcellular distribution. Thus, enhanced SUMO-2 conjugation led to increased apoptosis and played a pathogenic role in the development of cardiomyopathy and heart failure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023304</affiliation-url><afid>60023304</afid><affilname>Texas Heart Institute</affilname><name-variant>Texas Heart Institute</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112627728</affiliation-url><afid>112627728</afid><affilname>Affiliated Hospital of Hainan Medical University</affilname><name-variant>The Affiliated Hospital of Hainan Medical University</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024746</affiliation-url><afid>60024746</afid><affilname>University of Rochester Medical Center</affilname><name-variant>Univ. of Rochester Medical Center</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023304</affiliation-url><afid>60023304</afid><affilname>Texas Heart Institute</affilname><name-variant>Texas Heart Institute</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023304</affiliation-url><afid>60023304</afid><affilname>Texas Heart Institute</affilname><name-variant>Texas Heart Institute</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005837</affiliation-url><afid>60005837</afid><affilname>University of Houston</affilname><name-variant>University of Houston</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028671</affiliation-url><afid>60028671</afid><affilname>Texas A and M Health Science Center</affilname><name-variant>Texas A and M Health Science Center</name-variant><affiliation-city>College Station</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56344129000</author-url><authid>56344129000</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eun Young</given-name><initials>E.Y.</initials><afid>60023304</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56075134200</author-url><authid>56075134200</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>112627728</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36916264900</author-url><authid>36916264900</authid><authname>Ye B.</authname><surname>Ye</surname><given-name>Bo</given-name><initials>B.</initials><afid>60024746</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102067224</author-url><authid>7102067224</authid><authname>Segura A.</authname><surname>Segura</surname><given-name>Ana Maria</given-name><initials>A.M.</initials><afid>60023304</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56074887300</author-url><authid>56074887300</authid><authname>Beketaev I.</authname><surname>Beketaev</surname><given-name>Ilimbek</given-name><initials>I.</initials><afid>60023304</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9533453400</author-url><authid>9533453400</authid><authname>Xi Y.</authname><surname>Xi</surname><given-name>Yutao</given-name><initials>Y.</initials><afid>60023304</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56441897300</author-url><authid>56441897300</authid><authname>Yu W.</authname><surname>Yu</surname><given-name>Wei</given-name><initials>W.</initials><afid>60005837</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:18834507300</author-url><authid>18834507300</authid><authname>Chang J.</authname><surname>Chang</surname><given-name>Jiang</given-name><initials>J.</initials><afid>60028671</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7406053991</author-url><authid>7406053991</authid><authname>Li F.</authname><surname>Li</surname><given-name>Faqian</given-name><initials>F.</initials><afid>60024746</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56075129900</author-url><authid>56075129900</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jun</given-name><initials>J.</initials><afid>60023304</afid></author><authkeywords>Apoptosis | Calpain 2 | Calpastatin | Cardiomyopathy | SUMO</authkeywords><intid>1785666659</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929223687"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929223687?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929223687&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929223687&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009122"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929223687</prism:url><dc:identifier>SCOPUS_ID:84929223687</dc:identifier><eid>2-s2.0-84929223687</eid><dc:title>Morbidity and mortality in systolic heart failure also associated with raised serum neprilysin levels. Reply</dc:title><dc:creator>LupÃ³n J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>201</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.179</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028462</affiliation-url><afid>60028462</afid><affilname>Hospital Universitari Germans Trias i Pujol</affilname><name-variant>Hospital Germans Trias i Pujol</name-variant><affiliation-city>Badalona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018312</affiliation-url><afid>60018312</afid><affilname>Universidad Autonoma de Barcelona, Facultad de Medicina</affilname><name-variant>Universitat AutÃ²noma de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028462</affiliation-url><afid>60028462</afid><affilname>Hospital Universitari Germans Trias i Pujol</affilname><name-variant>Hospital Germans Trias i Pujol</name-variant><affiliation-city>Badalona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603285283</author-url><authid>6603285283</authid><authname>LupÃ³n J.</authname><surname>LupÃ³n</surname><given-name>Josep</given-name><initials>J.</initials><afid>60028462</afid><afid>60018312</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603285283</author-url><authid>6603285283</authid><authname>LupÃ³n J.</authname><surname>LupÃ³n</surname><given-name>Josep</given-name><initials>J.</initials><afid>60028462</afid><afid>60018312</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36460593200</author-url><authid>36460593200</authid><authname>Barallat J.</authname><surname>Barallat</surname><given-name>Jaume</given-name><initials>J.</initials><afid>60028462</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004094140</author-url><authid>7004094140</authid><authname>Bayes-Genis A.</authname><surname>Bayes-Genis</surname><given-name>Antoni</given-name><initials>A.</initials><afid>60028462</afid><afid>60018312</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004094140</author-url><authid>7004094140</authid><authname>Bayes-Genis A.</authname><surname>Bayes-Genis</surname><given-name>Antoni</given-name><initials>A.</initials><afid>60028462</afid><afid>60018312</afid></author><authkeywords>Heart failure | Neprilysin</authkeywords><intid>1535918090</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929207358"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929207358?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929207358&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929207358&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008712"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929207358</prism:url><dc:identifier>SCOPUS_ID:84929207358</dc:identifier><eid>2-s2.0-84929207358</eid><dc:title>Coronary artery calcification is not related to coronary heart disease isolated family history</dc:title><dc:creator>Koulaouzidis G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>271-272</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.147</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031040</affiliation-url><afid>60031040</afid><affilname>Umea universitet</affilname><name-variant>UmeÃ¥ University</name-variant><affiliation-city>Umea</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025144</affiliation-url><afid>60025144</afid><affilname>Castle Hill Hospital</affilname><name-variant>Castle Hill Hospital</name-variant><affiliation-city>Cottingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112877313</affiliation-url><afid>112877313</afid><affilname>European Scanning Centre</affilname><name-variant>European Scanning Centre</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23668060600</author-url><authid>23668060600</authid><authname>Koulaouzidis G.</authname><surname>Koulaouzidis</surname><given-name>G.</given-name><initials>G.</initials><afid>60031040</afid><afid>60025144</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23668060600</author-url><authid>23668060600</authid><authname>Koulaouzidis G.</authname><surname>Koulaouzidis</surname><given-name>G.</given-name><initials>G.</initials><afid>60031040</afid><afid>60025144</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640263700</author-url><authid>56640263700</authid><authname>Wong K.</authname><surname>Wong</surname><given-name>K.</given-name><initials>K.</initials><afid>60025144</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55249724600</author-url><authid>55249724600</authid><authname>Charisopoulou D.</authname><surname>Charisopoulou</surname><given-name>D.</given-name><initials>D.</initials><afid>60031040</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8673712900</author-url><authid>8673712900</authid><authname>McArthur T.</authname><surname>McArthur</surname><given-name>T.</given-name><initials>T.</initials><afid>112877313</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8876525900</author-url><authid>8876525900</authid><authname>Jenkins P.</authname><surname>Jenkins</surname><given-name>P. J.</given-name><initials>P.J.</initials><afid>112877313</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006300845</author-url><authid>7006300845</authid><authname>Henein M.</authname><surname>Henein</surname><given-name>M. Y.</given-name><initials>M.Y.</initials><afid>60031040</afid></author><authkeywords>Coronary artery calcification | Coronary calcium score | Family history of premature coronary heart disease | Parents | Siblings</authkeywords><intid>1785917636</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929150351"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929150351?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929150351&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929150351&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008384"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929150351</prism:url><dc:identifier>SCOPUS_ID:84929150351</dc:identifier><eid>2-s2.0-84929150351</eid><dc:title>Heart failure with reduced ejection fraction: Should we submit patients without angina to coronary angiography?</dc:title><dc:creator>Silva F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>131-132</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.115</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:110925037</affiliation-url><afid>110925037</afid><affilname>EPE</affilname><name-variant>E.P.E.</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113306992</affiliation-url><afid>113306992</afid><affilname>Centro Hospitalar de SÃ£o JoÃ£o</affilname><name-variant>Centro Hospitalar de SÃ£o JoÃ£o</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">24</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640556500</author-url><authid>56640556500</authid><authname>Silva F.</authname><surname>Silva</surname><given-name>Filipa</given-name><initials>F.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640556500</author-url><authid>56640556500</authid><authname>Silva F.</authname><surname>Silva</surname><given-name>Filipa</given-name><initials>F.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640556500</author-url><authid>56640556500</authid><authname>Silva F.</authname><surname>Silva</surname><given-name>Filipa</given-name><initials>F.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641049700</author-url><authid>56641049700</authid><authname>Borges T.</authname><surname>Borges</surname><given-name>Tiago</given-name><initials>T.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641049700</author-url><authid>56641049700</authid><authname>Borges T.</authname><surname>Borges</surname><given-name>Tiago</given-name><initials>T.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641049700</author-url><authid>56641049700</authid><authname>Borges T.</authname><surname>Borges</surname><given-name>Tiago</given-name><initials>T.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56438693300</author-url><authid>56438693300</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Ana</given-name><initials>A.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56438693300</author-url><authid>56438693300</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Ana</given-name><initials>A.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56438693300</author-url><authid>56438693300</authid><authname>Ribeiro A.</authname><surname>Ribeiro</surname><given-name>Ana</given-name><initials>A.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640911500</author-url><authid>56640911500</authid><authname>Mesquita R.</authname><surname>Mesquita</surname><given-name>Raquel</given-name><initials>R.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640911500</author-url><authid>56640911500</authid><authname>Mesquita R.</authname><surname>Mesquita</surname><given-name>Raquel</given-name><initials>R.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640911500</author-url><authid>56640911500</authid><authname>Mesquita R.</authname><surname>Mesquita</surname><given-name>Raquel</given-name><initials>R.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:38061547700</author-url><authid>38061547700</authid><authname>Laszczynska O.</authname><surname>Laszczynska</surname><given-name>Olga</given-name><initials>O.</initials><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35877117200</author-url><authid>35877117200</authid><authname>MagalhÃ£es D.</authname><surname>MagalhÃ£es</surname><given-name>Domingos</given-name><initials>D.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35877117200</author-url><authid>35877117200</authid><authname>MagalhÃ£es D.</authname><surname>MagalhÃ£es</surname><given-name>Domingos</given-name><initials>D.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35877117200</author-url><authid>35877117200</authid><authname>MagalhÃ£es D.</authname><surname>MagalhÃ£es</surname><given-name>Domingos</given-name><initials>D.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55447839500</author-url><authid>55447839500</authid><authname>Silva J.</authname><surname>Silva</surname><given-name>JoÃ£o Carlos</given-name><initials>J.C.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55447839500</author-url><authid>55447839500</authid><authname>Silva J.</authname><surname>Silva</surname><given-name>JoÃ£o Carlos</given-name><initials>J.C.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55447839500</author-url><authid>55447839500</authid><authname>Silva J.</authname><surname>Silva</surname><given-name>JoÃ£o Carlos</given-name><initials>J.C.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35563377100</author-url><authid>35563377100</authid><authname>Azevedo A.</authname><surname>Azevedo</surname><given-name>Ana</given-name><initials>A.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35563377100</author-url><authid>35563377100</authid><authname>Azevedo A.</authname><surname>Azevedo</surname><given-name>Ana</given-name><initials>A.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003402615</author-url><authid>7003402615</authid><authname>Bettencourt P.</authname><surname>Bettencourt</surname><given-name>Paulo</given-name><initials>P.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003402615</author-url><authid>7003402615</authid><authname>Bettencourt P.</authname><surname>Bettencourt</surname><given-name>Paulo</given-name><initials>P.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003402615</author-url><authid>7003402615</authid><authname>Bettencourt P.</authname><surname>Bettencourt</surname><given-name>Paulo</given-name><initials>P.</initials><afid>110925037</afid><afid>113306992</afid><afid>60007249</afid></author><authkeywords>Angiography | Coronary artery disease | Diagnosis | Heart failure | Systolic dysfunction</authkeywords><intid>535919640</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926452629"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926452629?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926452629&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926452629&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815000942"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926452629</prism:url><dc:identifier>SCOPUS_ID:84926452629</dc:identifier><eid>2-s2.0-84926452629</eid><dc:title>Cardiac myocyte alternans in intact heart: Influence of cell-cell coupling and Î²-adrenergic stimulation</dc:title><dc:creator>Hammer K.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.03.012</prism:doi><pii>S0022282815000942</pii><dc:description>Â© 2015 Elsevier Ltd. Background: Cardiac alternans are proarrhythmic and mechanistically link cardiac mechanical dysfunction and sudden cardiac death. Beat-to-beat alternans occur when beats with large Ca&lt;sup&gt;2+&lt;/sup&gt; transients and long action potential duration (APD) alternate with the converse. APD alternans are typically driven by Ca&lt;sup&gt;2+&lt;/sup&gt; alternans and sarcoplasmic reticulum (SR) Ca&lt;sup&gt;2+&lt;/sup&gt; release alternans. But the effect of intercellular communication via gap junctions (GJ) on alternans in the intact heart remains unknown. Objective: We assessed the effects of cell-to-cell coupling on local alternans in intact Langendorff-perfused mouse hearts, measuring single myocyte [Ca&lt;sup&gt;2+&lt;/sup&gt;] alternans synchronization among neighboring cells, and effects of Î²-adrenergic receptor (Î²-AR) activation and reduced GJ coupling. Methods and results: Mouse hearts (C57BL/6) were retrogradely perfused and loaded with Fluo8-AM to record cardiac myocyte [Ca&lt;sup&gt;2+&lt;/sup&gt;] in situ with confocal microscopy. Single cell resolution allowed analysis of alternans within the intact organ during alternans induction. Carbenoxolone (25Î¼M), a GJ inhibitor, significantly increased the occurrence and amplitude of alternans in single cells within the intact heart. Alternans were concordant between neighboring cells throughout the field of view, except transiently during onset. Î²-AR stimulation only reduced Ca&lt;sup&gt;2+&lt;/sup&gt; alternans in tissue that had reduced GJ coupling, matching effects seen in isolated myocytes. Conclusions: Ca&lt;sup&gt;2+&lt;/sup&gt; alternans among neighboring myocytes is predominantly concordant, likely because of electrical coupling between cells. Consistent with this, partial GJ uncoupling increased propensity and amplitude of Ca&lt;sup&gt;2+&lt;/sup&gt; alternans, and made them more sensitive to reversal by Î²-AR activation, as in isolated myocytes. Electrical coupling between myocytes may thus limit the alternans initiation, but also allow alternans to be more stable once established.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014439</affiliation-url><afid>60014439</afid><affilname>UC Davis</affilname><name-variant>University of California</name-variant><affiliation-city>Davis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006224</affiliation-url><afid>60006224</afid><affilname>Medizinische Universitat Graz</affilname><name-variant>Medical University Graz</name-variant><affiliation-city>Graz</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026245</affiliation-url><afid>60026245</afid><affilname>Charite - Universitatsmedizin Berlin</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020016</affiliation-url><afid>60020016</afid><affilname>Klinikum der Universitat Regensburg und Medizinische Fakultat</affilname><name-variant>UniversitÃ¤tsklinikum Regensburg</name-variant><affiliation-city>Regensburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36453041500</author-url><authid>36453041500</authid><authname>Hammer K.</authname><surname>Hammer</surname><given-name>Karin P.</given-name><initials>K.P.</initials><afid>60014439</afid><afid>60020016</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36453041500</author-url><authid>36453041500</authid><authname>Hammer K.</authname><surname>Hammer</surname><given-name>Karin P.</given-name><initials>K.P.</initials><afid>60014439</afid><afid>60020016</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:42961965500</author-url><authid>42961965500</authid><authname>Ljubojevic S.</authname><surname>Ljubojevic</surname><given-name>Senka</given-name><initials>S.</initials><afid>60006224</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8728216400</author-url><authid>8728216400</authid><authname>Ripplinger C.</authname><surname>Ripplinger</surname><given-name>Crystal M.</given-name><initials>C.M.</initials><afid>60014439</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35499467500</author-url><authid>35499467500</authid><authname>Pieske B.</authname><surname>Pieske</surname><given-name>Burkert M.</given-name><initials>B.M.</initials><afid>60006224</afid><afid>60026245</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35499467500</author-url><authid>35499467500</authid><authname>Pieske B.</authname><surname>Pieske</surname><given-name>Burkert M.</given-name><initials>B.M.</initials><afid>60006224</afid><afid>60026245</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101600393</author-url><authid>7101600393</authid><authname>Bers D.</authname><surname>Bers</surname><given-name>Donald M.</given-name><initials>D.M.</initials><afid>60014439</afid></author><authkeywords>Alternans | Calcium | Whole heart | Î²-Adrenergic receptor activation</authkeywords><intid>35455708</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928136094"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928136094?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928136094&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928136094&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002228281500125X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928136094</prism:url><dc:identifier>SCOPUS_ID:84928136094</dc:identifier><eid>2-s2.0-84928136094</eid><dc:title>Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization</dc:title><dc:creator>Cordeiro J.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>52-60</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.010</prism:doi><pii>S002228281500125X</pii><dc:description>Â© 2015 Elsevier Ltd. The inward rectifier potassium current, I&lt;inf&gt;K1&lt;/inf&gt;, contributes to the terminal phase of repolarization of the action potential (AP), as well as the value and stability of the resting membrane potential. Regional variation in I&lt;inf&gt;K1&lt;/inf&gt; has been noted in the canine heart, but the biophysical properties have not been directly compared. We examined the properties and functional contribution of I&lt;inf&gt;K1&lt;/inf&gt; in isolated myocytes from ventricular, atrial and Purkinje tissue. APs were recorded from canine left ventricular midmyocardium, left atrial and Purkinje tissue. The terminal rate of repolarization of the AP in ventricle, but not in Purkinje, depended on changes in external K&lt;sup&gt;+&lt;/sup&gt; ([K&lt;sup&gt;+&lt;/sup&gt;]&lt;inf&gt;o&lt;/inf&gt;). Isolated ventricular myocytes had the greatest density of I&lt;inf&gt;K1&lt;/inf&gt; while atrial myocytes had the lowest. Furthermore, the outward component of I&lt;inf&gt;K1&lt;/inf&gt; in ventricular cells exhibited a prominent outward component and steep negative slope conductance, which was also enhanced in 10mM [K&lt;sup&gt;+&lt;/sup&gt;]&lt;inf&gt;o&lt;/inf&gt;. In contrast, both Purkinje and atrial cells exhibited little outward I&lt;inf&gt;K1&lt;/inf&gt;, even in the presence of 10mM [K&lt;sup&gt;+&lt;/sup&gt;]&lt;inf&gt;o&lt;/inf&gt;, and both cell types showed more persistent current at positive potentials. Expression of Kir2.1 in the ventricle was 76.9-fold higher than that of atria and 5.8-fold higher than that of Purkinje, whereas the expression of Kir2.2 and Kir2.3 subunits was more evenly distributed in Purkinje and atria. Finally, AP clamp data showed distinct contributions of I&lt;inf&gt;K1&lt;/inf&gt; for each cell type. I&lt;inf&gt;K1&lt;/inf&gt; and Kir2 subunit expression varies dramatically in regions of the canine heart and these regional differences in Kir2 expression likely underlie regional distinctions in I&lt;inf&gt;K1&lt;/inf&gt; characteristics, contributing to variations in repolarization in response to in [K&lt;sup&gt;+&lt;/sup&gt;]&lt;inf&gt;o&lt;/inf&gt; changes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008231</affiliation-url><afid>60008231</afid><affilname>Masonic Medical Research Laboratory</affilname><name-variant>Masonic Medical Research Laboratory</name-variant><affiliation-city>Utica</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029526</affiliation-url><afid>60029526</afid><affilname>University of California, Riverside</affilname><name-variant>University of California</name-variant><affiliation-city>Riverside</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032083</affiliation-url><afid>60032083</afid><affilname>University at Buffalo State University of New York</affilname><name-variant>State University of New York at Buffalo</name-variant><affiliation-city>Buffalo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004586535</author-url><authid>7004586535</authid><authname>Cordeiro J.</authname><surname>Cordeiro</surname><given-name>Jonathan M.</given-name><initials>J.M.</initials><afid>60008231</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55864807800</author-url><authid>55864807800</authid><authname>Zeina T.</authname><surname>Zeina</surname><given-name>Tanya</given-name><initials>T.</initials><afid>60008231</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506020617</author-url><authid>6506020617</authid><authname>Goodrow R.</authname><surname>Goodrow</surname><given-name>Robert</given-name><initials>R.</initials><afid>60008231</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36113932400</author-url><authid>36113932400</authid><authname>Kaplan A.</authname><surname>Kaplan</surname><given-name>Aaron D.</given-name><initials>A.D.</initials><afid>60032083</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56599725100</author-url><authid>56599725100</authid><authname>Thomas L.</authname><surname>Thomas</surname><given-name>Lini M.</given-name><initials>L.M.</initials><afid>60008231</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101621991</author-url><authid>7101621991</authid><authname>Nesterenko V.</authname><surname>Nesterenko</surname><given-name>Vladislav V.</given-name><initials>V.V.</initials><afid>60008231</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55305798000</author-url><authid>55305798000</authid><authname>Treat J.</authname><surname>Treat</surname><given-name>Jacqueline A.</given-name><initials>J.A.</initials><afid>60008231</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603206919</author-url><authid>6603206919</authid><authname>Hawel L.</authname><surname>Hawel</surname><given-name>Leo</given-name><initials>L.</initials><afid>60029526</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004973332</author-url><authid>7004973332</authid><authname>Byus C.</authname><surname>Byus</surname><given-name>Craig</given-name><initials>C.</initials><afid>60029526</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603571432</author-url><authid>6603571432</authid><authname>Bett G.</authname><surname>Bett</surname><given-name>Glenna C.</given-name><initials>G.C.</initials><afid>60032083</afid><afid>60032083</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603571432</author-url><authid>6603571432</authid><authname>Bett G.</authname><surname>Bett</surname><given-name>Glenna C.</given-name><initials>G.C.</initials><afid>60032083</afid><afid>60032083</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003389561</author-url><authid>7003389561</authid><authname>Rasmusson R.</authname><surname>Rasmusson</surname><given-name>Randall L.</given-name><initials>R.L.</initials><afid>60032083</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:13004537200</author-url><authid>13004537200</authid><authname>Panama B.</authname><surname>Panama</surname><given-name>Brian K.</given-name><initials>B.K.</initials><afid>60008231</afid></author><authkeywords>Atria | Electrophysiology | Potassium channel | Purkinje | Ventricle</authkeywords><intid>1535731851</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929150590"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929150590?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929150590&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929150590&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008700"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929150590</prism:url><dc:identifier>SCOPUS_ID:84929150590</dc:identifier><eid>2-s2.0-84929150590</eid><dc:title>Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure</dc:title><dc:creator>Pasternak B.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>4-6</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.441</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025543</affiliation-url><afid>60025543</afid><affilname>Statens Serum Institut</affilname><name-variant>Statens Serum Institut</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100333143</affiliation-url><afid>100333143</afid><affilname>Visby Hospital</affilname><name-variant>Visby Hospital</name-variant><affiliation-city>Uppsala</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36779221700</author-url><authid>36779221700</authid><authname>Pasternak B.</authname><surname>Pasternak</surname><given-name>BjÃ¶rn</given-name><initials>B.</initials><afid>60025543</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641147100</author-url><authid>56641147100</authid><authname>Mattsson A.</authname><surname>Mattsson</surname><given-name>Anders</given-name><initials>A.</initials><afid>100333143</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26430098300</author-url><authid>26430098300</authid><authname>SvanstrÃ¶m H.</authname><surname>SvanstrÃ¶m</surname><given-name>Henrik</given-name><initials>H.</initials><afid>60025543</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603342797</author-url><authid>6603342797</authid><authname>Hviid A.</authname><surname>Hviid</surname><given-name>Anders</given-name><initials>A.</initials><afid>60025543</afid></author><authkeywords>Beta-blockers | Heart failure | Mortality | Pharmacoepidemiology</authkeywords><intid>1785918289</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192298"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192298?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192298&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192298&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009110"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192298</prism:url><dc:identifier>SCOPUS_ID:84929192298</dc:identifier><eid>2-s2.0-84929192298</eid><dc:title>Fried food consumption and ischemic heart disease A systematic literature review</dc:title><dc:creator>Lippi G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>210-211</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.178</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113846140</affiliation-url><afid>113846140</afid><affilname>Laboratory of Clinical Chemistry and Hematology</affilname><name-variant>Laboratory of Clinical Chemistry and Hematology</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106971243</affiliation-url><afid>106971243</afid><affilname>General Hospital of Trento</affilname><name-variant>General Hospital of Trento</name-variant><affiliation-city>Trento</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100875651</affiliation-url><afid>100875651</afid><affilname>Academic Hospital of Parma</affilname><name-variant>Academic Hospital of Parma</name-variant><affiliation-city>Parma</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23989140600</author-url><authid>23989140600</authid><authname>Lippi G.</authname><surname>Lippi</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>113846140</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23987406000</author-url><authid>23987406000</authid><authname>Mattiuzzi C.</authname><surname>Mattiuzzi</surname><given-name>Camilla</given-name><initials>C.</initials><afid>106971243</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602404093</author-url><authid>6602404093</authid><authname>Cervellin G.</authname><surname>Cervellin</surname><given-name>Gianfranco</given-name><initials>G.</initials><afid>100875651</afid></author><authkeywords>Acute coronary syndrome | Acute myocardial infarction | Coronary heart disease | Fried food | Ischemic heart disease</authkeywords><intid>1785918486</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930201946"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930201946?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930201946&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930201946&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001406"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930201946</prism:url><dc:identifier>SCOPUS_ID:84930201946</dc:identifier><eid>2-s2.0-84930201946</eid><dc:title>A novel path of improving heart function after infarction</dc:title><dc:creator>Pritchard K.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>200-201</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.024</prism:doi><pii>S0022282815001406</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012553</affiliation-url><afid>60012553</afid><affilname>Medical College of Wisconsin</affilname><name-variant>Medical College of Wisconsin</name-variant><affiliation-city>Milwaukee</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012553</affiliation-url><afid>60012553</afid><affilname>Medical College of Wisconsin</affilname><name-variant>Medical College of Wisconsin</name-variant><affiliation-city>Milwaukee</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102528879</author-url><authid>7102528879</authid><authname>Pritchard K.</authname><surname>Pritchard</surname><given-name>Kirkwood A.</given-name><initials>K.A.</initials><afid>60012553</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004350652</author-url><authid>7004350652</authid><authname>Weihrauch D.</authname><surname>Weihrauch</surname><given-name>Dorothee</given-name><initials>D.</initials><afid>60012553</afid></author><intid>1036081967</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928940495"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928940495?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928940495&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928940495&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S001048251500150X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928940495</prism:url><dc:identifier>SCOPUS_ID:84928940495</dc:identifier><eid>2-s2.0-84928940495</eid><dc:title>Model of unidirectional block formation leading to reentrant ventricular tachycardia in the infarct border zone of postinfarction canine hearts</dc:title><dc:creator>Ciaccio E.</dc:creator><prism:publicationName>Computers in Biology and Medicine</prism:publicationName><prism:issn>00104825</prism:issn><prism:eIssn>18790534</prism:eIssn><prism:volume>62</prism:volume><prism:pageRange>254-263</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiomed.2015.04.032</prism:doi><pii>S001048251500150X</pii><dc:description>Â© 2015 Elsevier Ltd. Background: When the infarct border zone is stimulated prematurely, a unidirectional block line (UBL) can form and lead to double-loop (figure-of-eight) reentrant ventricular tachycardia (VT) with a central isthmus. The isthmus is composed of an entrance, center, and exit. It was hypothesized that for certain stimulus site locations and coupling intervals, the UBL would coincide with the isthmus entrance boundary, where infarct border zone thickness changes from thin-to-thick in the travel direction of the premature stimulus wavefront. Method: A quantitative model was developed to describe how thin-to-thick changes in the border zone result in critically convex wavefront curvature leading to conduction block, which is dependent upon coupling interval. The model was tested in 12 retrospectively analyzed postinfarction canine experiments. Electrical activation was mapped for premature stimulation and for the first reentrant VT cycle. The relationship of functional conduction block forming during premature stimulation to functional block during reentrant VT was quantified. Results: For an appropriately placed stimulus, in accord with model predictions: (1) The UBL and reentrant VT isthmus lateral boundaries overlapped (error: 4.8Â±5.7. mm). (2) The UBL leading edge coincided with the distal isthmus where the center-entrance boundary would be expected to occur. (3) The mean coupling interval was 164.6Â±11.0. ms during premature stimulation and 190.7Â±20.4. ms during the first reentrant VT cycle, in accord with model calculations, which resulted in critically convex wavefront curvature with functional conduction block, respectively, at the location of the isthmus entrance boundary and at the lateral isthmus edges. Discussion: Reentrant VT onset following premature stimulation can be explained by the presence of critically convex wavefront curvature and unidirectional block at the isthmus entrance boundary when the premature stimulation interval is sufficiently short. The double-loop reentrant circuit pattern is a consequence of wavefront bifurcation around this UBL followed by coalescence, and then impulse propagation through the isthmus. The wavefront is blocked from propagating laterally away from the isthmus by sharp increases in border zone thickness, which results in critically convex wavefront curvature at VT cycle lengths.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027565</affiliation-url><afid>60027565</afid><affilname>Columbia University Medical Center</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027565</affiliation-url><afid>60027565</afid><affilname>Columbia University Medical Center</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023403</affiliation-url><afid>60023403</afid><affilname>UMDNJ Robert Wood Johnson Medical School at New Brunswick</affilname><name-variant>University of Medicine and Dentistry of New Jersey</name-variant><affiliation-city>New Brunswick</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005248</affiliation-url><afid>60005248</afid><affilname>Johns Hopkins University</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005248</affiliation-url><afid>60005248</afid><affilname>Johns Hopkins University</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112348999</affiliation-url><afid>112348999</afid><affilname>ARMGO Pharma, Inc.</affilname><name-variant>ARMGO Pharma</name-variant><affiliation-city>Tarrytown</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007904</affiliation-url><afid>60007904</afid><affilname>National Health Service</affilname><name-variant>NHS Trust</name-variant><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004846604</author-url><authid>7004846604</authid><authname>Ciaccio E.</authname><surname>Ciaccio</surname><given-name>Edward J.</given-name><initials>E.J.</initials><afid>60027565</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003883503</author-url><authid>7003883503</authid><authname>Coromilas J.</authname><surname>Coromilas</surname><given-name>James</given-name><initials>J.</initials><afid>60023403</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55957494700</author-url><authid>55957494700</authid><authname>Ashikaga H.</authname><surname>Ashikaga</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60005248</afid><afid>60005248</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55957494700</author-url><authid>55957494700</authid><authname>Ashikaga H.</authname><surname>Ashikaga</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60005248</afid><afid>60005248</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55978860000</author-url><authid>55978860000</authid><authname>Cervantes D.</authname><surname>Cervantes</surname><given-name>Daniel O.</given-name><initials>D.O.</initials><afid>112348999</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004986899</author-url><authid>7004986899</authid><authname>Wit A.</authname><surname>Wit</surname><given-name>Andrew L.</given-name><initials>A.L.</initials><afid>60027565</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56623992400</author-url><authid>56623992400</authid><authname>Peters N.</authname><surname>Peters</surname><given-name>Nicholas S.</given-name><initials>N.S.</initials><afid>60007904</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004392958</author-url><authid>7004392958</authid><authname>McVeigh E.</authname><surname>McVeigh</surname><given-name>Elliot R.</given-name><initials>E.R.</initials><afid>60005248</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006329052</author-url><authid>7006329052</authid><authname>Garan H.</authname><surname>Garan</surname><given-name>Hasan</given-name><initials>H.</initials><afid>60027565</afid></author><authkeywords>Activation mapping | Isthmus | Unidirectional block | Ventricular tachycardia | Wavefront curvature</authkeywords><intid>535877548</intid><source-id>17957</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929223686"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929223686?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929223686&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929223686&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009080"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929223686</prism:url><dc:identifier>SCOPUS_ID:84929223686</dc:identifier><eid>2-s2.0-84929223686</eid><dc:title>On the binaural brain entrainment indicating lower heart rate variability</dc:title><dc:creator>Palaniappan R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>262-263</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.175</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010818</affiliation-url><afid>60010818</afid><affilname>University of Kent</affilname><name-variant>University of Kent</name-variant><affiliation-city>Canterbury</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60072090</affiliation-url><afid>60072090</afid><affilname>Institut Teknologi Brunei</affilname><name-variant>Institute Technology Brunei</name-variant><affiliation-city>Gadong</affiliation-city><affiliation-country>Brunei Darussalam</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012005</affiliation-url><afid>60012005</afid><affilname>Multimedia University</affilname><name-variant>Multimedia University</name-variant><affiliation-city>Malacca Town</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:11141606600</author-url><authid>11141606600</authid><authname>Palaniappan R.</authname><surname>Palaniappan</surname><given-name>Ramaswamy</given-name><initials>R.</initials><afid>60010818</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13607919000</author-url><authid>13607919000</authid><authname>Phon-Amnuaisuk S.</authname><surname>Phon-Amnuaisuk</surname><given-name>Somnuk</given-name><initials>S.</initials><afid>60072090</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003844258</author-url><authid>7003844258</authid><authname>Eswaran C.</authname><surname>Eswaran</surname><given-name>C.</given-name><initials>C.</initials><afid>60012005</afid></author><authkeywords>Binaural beats | Electrocardiogram | Heart rate variability</authkeywords><intid>35916817</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929413403"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929413403?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929413403&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929413403&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010278"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929413403</prism:url><dc:identifier>SCOPUS_ID:84929413403</dc:identifier><eid>2-s2.0-84929413403</eid><dc:title>Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology</dc:title><dc:creator>De Backer G.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>169-175</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.809</prism:doi><pii>S0021915015010278</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Background: Familial hypercholesterolaemia (FH) is a hereditary disorder predisposing to premature coronary heart disease (CHD) and is until now mainly diagnosed clinically on the basis of a classical phenotype. Its prevalence varies and is estimated around 1 in 200-500; in patients with established CHD the prevalence is less well documented. Methods and results: In EUROASPIRE IV data were collected in coronary patients from 24 European countries by means of a standardized interview, bioclinical examination and venous blood sampling. Potential FH was estimated using an adapted version of the Dutch Lipid Clinic Network Criteria.Among the 7044 patients eligible for analysis, the prevalence of potential FH was 8.3%; 7.5% in men and 11.1% in women. The prevalence was inversely related to age with a putative prevalence of 1:5 in those with CHD &lt;50yrs of age in both sexes. Even among women aged 70 the prevalence was 1:10. Irrespective of age and gender, prevalence differed substantially between European regions; potential FH patients were more likely to smoke, had higher triglycerides levels and their blood pressure was less well controlled. The use of cardioprotective drugs and the prevalences of diabetes, obesity and central obesity were similar. Conclusions: The prevalence of potential FH in coronary patients is high; the results underscore the need to promote identification of FH in CHD patients and to improve their risk factor profile.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001157</affiliation-url><afid>60001157</afid><affilname>Academic Medical Centre, University of Amsterdam</affilname><name-variant>University of Amsterdam</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>UniversitÃ© Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029329</affiliation-url><afid>60029329</afid><affilname>St George's University of London</affilname><name-variant>St. George's University of London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006461</affiliation-url><afid>60006461</afid><affilname>University of Zagreb School of Medicine</affilname><name-variant>University of Zagreb Medical School</name-variant><affiliation-city>Zagreb</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24288352300</author-url><authid>24288352300</authid><authname>De Backer G.</authname><surname>De Backer</surname><given-name>Guy</given-name><initials>G.</initials><afid>60033316</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55750748300</author-url><authid>55750748300</authid><authname>Besseling J.</authname><surname>Besseling</surname><given-name>Joost</given-name><initials>J.</initials><afid>60001157</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7402661078</author-url><authid>7402661078</authid><authname>Chapman J.</authname><surname>Chapman</surname><given-name>John</given-name><initials>J.</initials><afid>60001422</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602780482</author-url><authid>6602780482</authid><authname>Hovingh G.</authname><surname>Hovingh</surname><given-name>G. Kees</given-name><initials>G.K.</initials><afid>60001157</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36044888200</author-url><authid>36044888200</authid><authname>Kastelein J.</authname><surname>Kastelein</surname><given-name>John J P</given-name><initials>J.J.P.</initials><afid>60001157</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602089871</author-url><authid>6602089871</authid><authname>Kotseva K.</authname><surname>Kotseva</surname><given-name>Kornelia</given-name><initials>K.</initials><afid>60010719</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35303190300</author-url><authid>35303190300</authid><authname>Ray K.</authname><surname>Ray</surname><given-name>Kausik</given-name><initials>K.</initials><afid>60029329</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55411641000</author-url><authid>55411641000</authid><authname>Reiner Å½.</authname><surname>Reiner</surname><given-name>Å½eljko</given-name><initials>Å½.</initials><afid>60006461</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:14627040300</author-url><authid>14627040300</authid><authname>Wood D.</authname><surname>Wood</surname><given-name>David</given-name><initials>D.</initials><afid>60010719</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:35393397100</author-url><authid>35393397100</authid><authname>De Bacquer D.</authname><surname>De Bacquer</surname><given-name>Dirk</given-name><initials>D.</initials><afid>60033316</afid></author><authkeywords>Coronary heart disease | Familial hypercholesterolaemia | Prevalence | Risk factors</authkeywords><intid>1035951793</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928724755"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928724755?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928724755&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928724755&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001327"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928724755</prism:url><dc:identifier>SCOPUS_ID:84928724755</dc:identifier><eid>2-s2.0-84928724755</eid><dc:title>The atypical 'b' splice variant of phospholipase CÎ²1 promotes cardiac contractile dysfunction</dc:title><dc:creator>Grubb D.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>95-103</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.016</prism:doi><pii>S0022282815001327</pii><dc:description>Â© 2015. The activity of the early signaling enzyme, phospholipase CÎ²1b (PLCÎ²1b), is selectively elevated in diseased myocardium and activity increases with disease progression. We aimed to establish the contribution of heightened PLCÎ²1b activity to cardiac pathology. PLCÎ²1b, the alternative splice variant, PLCÎ²1a, and a blank virus were expressed in mouse hearts using adeno-associated viral vectors (rAAV6-FLAG-PLCÎ²1b, rAAV6-FLAG-PLCÎ²1a, or rAAV6-blank) delivered intravenously (IV). Following viral delivery, FLAG-PLCÎ²1b was expressed in all of the chambers of the mouse heart and was localized to the sarcolemma. Heightened PLCÎ²1b expression caused a rapid loss of contractility, 4-6weeks, that was fully reversed, within 5days, by inhibition of protein kinase CÎ± (PKCÎ±). PLCÎ²1a did not localize to the sarcolemma and did not affect contractile function. Expression of PLCÎ²1b, but not PLCÎ²1a, caused downstream dephosphorylation of phospholamban and depletion of the Ca&lt;sup&gt;2+&lt;/sup&gt; stores of the sarcoplasmic reticulum. We conclude that heightened PLCÎ²1b activity observed in diseased myocardium contributes to pathology by PKCÎ±-mediated contractile dysfunction. PLCÎ²1b is a cardiac-specific signaling system, and thus provides a potential therapeutic target for the development of well-tolerated inotropic agents for use in failing myocardium.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033409</affiliation-url><afid>60033409</afid><affilname>Baker IDI Heart and Diabetes Institute</affilname><name-variant>Baker Heart Research Institute</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54948462400</author-url><authid>54948462400</authid><authname>Grubb D.</authname><surname>Grubb</surname><given-name>David R.</given-name><initials>D.R.</initials><afid>60033409</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56611634600</author-url><authid>56611634600</authid><authname>Crook B.</authname><surname>Crook</surname><given-name>Bryony</given-name><initials>B.</initials><afid>60033409</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56610953100</author-url><authid>56610953100</authid><authname>Ma Y.</authname><surname>Ma</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60033409</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24597850100</author-url><authid>24597850100</authid><authname>Luo J.</authname><surname>Luo</surname><given-name>Jieting</given-name><initials>J.</initials><afid>60033409</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56520870300</author-url><authid>56520870300</authid><authname>Qian H.</authname><surname>Qian</surname><given-name>Hong Wei</given-name><initials>H.W.</initials><afid>60033409</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56611000900</author-url><authid>56611000900</authid><authname>Gao X.</authname><surname>Gao</surname><given-name>Xiao Ming</given-name><initials>X.M.</initials><afid>60033409</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603266975</author-url><authid>6603266975</authid><authname>Kiriazis H.</authname><surname>Kiriazis</surname><given-name>Helen</given-name><initials>H.</initials><afid>60033409</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7402551956</author-url><authid>7402551956</authid><authname>Du X.</authname><surname>Du</surname><given-name>Xiao Jun</given-name><initials>X.J.</initials><afid>60033409</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602073852</author-url><authid>6602073852</authid><authname>Gregorevic P.</authname><surname>Gregorevic</surname><given-name>Paul</given-name><initials>P.</initials><afid>60033409</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004517156</author-url><authid>7004517156</authid><authname>Woodcock E.</authname><surname>Woodcock</surname><given-name>Elizabeth A.</given-name><initials>E.A.</initials><afid>60033409</afid></author><authkeywords>AAV | Cardiac contractility | Gene therapy | Signaling pathways</authkeywords><intid>2035834277</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378350"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378350?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378350&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378350&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002228281500142X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378350</prism:url><dc:identifier>SCOPUS_ID:84929378350</dc:identifier><eid>2-s2.0-84929378350</eid><dc:title>Interplay between the E2F pathway and Î²-adrenergic signaling in the pathological hypertrophic response of myocardium</dc:title><dc:creator>Major J.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>179-190</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.026</prism:doi><pii>S002228281500142X</pii><dc:description>Â© 2015 Elsevier Ltd. The E2F/Pocket protein (Rb) pathway regulates cell growth, differentiation, and death by modulating gene expression. We previously examined this pathway in the myocardium via manipulation of the unique E2F repressor, E2F6, which is believed to repress gene activity independently of Rb. Mice with targeted expression of E2F6 in postnatal myocardium developed dilated cardiomyopathy (DCM) without hypertrophic growth. We assessed the mechanisms of the apparent failure of compensatory hypertrophic growth as well as their response to the Î²-adrenergic agonist isoproterenol. As early as 2weeks, E2F6 transgenic (Tg) mice present with dilated thinner left ventricles and significantly reduced ejection fraction and fractional shortening which persists at 6weeks of age, but with no apparent increase in left ventricle weight: body weight (LVW:BW). E2F6-Tg mice treated with isoproterenol (6.1mg/kg/day) show double the increase in LVW:BW than their Wt counterparts (32% vs 16%, p-value: 0.007). Western blot analysis revealed the activation of the adrenergic pathway in Tg heart tissue under basal conditions with ~2-fold increase in the level of Î²&lt;inf&gt;2&lt;/inf&gt;-adrenergic receptors (p-value: 8.9E-05), protein kinase A catalytic subunit (PKA-C) (p-value: 0.0176), activated c-Src tyrosine-protein kinase (p-value: 0.0002), extracellular receptor kinase 2 (ERK2) (p-value: 0.0005), and induction of the anti-apoptotic protein Bcl2 (p-value 0. 0.00001). In contrast, a ~60% decrease in the cardiac growth regulator: AKT1 (p-value 0.0001) and a ~four fold increase in cyclic AMP dependent phosphodiesterase 4D (PDE4D), the negative regulator of PKA activity, were evident in the myocardium of E2F6-Tg mice. The expression of E2F3 was down-regulated by E2F6, but was restored by isoproterenol. Further, Rb expression was down-regulated in Tg mice in response to isoproterenol implying a net activation of the E2F pathway. Thus the unique regulation of E2F activity by E2F6 renders the myocardium hypersensitive to adrenergic stimulus resulting in robust hypertrophic growth.These data reveal a novel interplay between the E2F pathway, Î²&lt;inf&gt;2&lt;/inf&gt;-adrenergic/PKA/PDE4D, and ERK/c-Src axis in fine tuning the pathological hypertrophic growth response. E2F6 deregulates E2F3 such that pro-hypertrophic growth and survival are enhanced via Î²&lt;inf&gt;2&lt;/inf&gt;-adrenergic signaling however this response is outweighed by the induction of anti-hypertrophic signals so that left ventricle dilation proceeds without any increase in muscle mass.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011635</affiliation-url><afid>60011635</afid><affilname>University of Ottawa Heart Institute</affilname><name-variant>University of Ottawa Heart Institute</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55237799700</author-url><authid>55237799700</authid><authname>Major J.</authname><surname>Major</surname><given-name>Jennifer L.</given-name><initials>J.L.</initials><afid>60028897</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006029493</author-url><authid>7006029493</authid><authname>Salih M.</authname><surname>Salih</surname><given-name>Maysoon</given-name><initials>M.</initials><afid>60028897</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004137988</author-url><authid>7004137988</authid><authname>Tuana B.</authname><surname>Tuana</surname><given-name>Balwant S.</given-name><initials>B.S.</initials><afid>60028897</afid><afid>60011635</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004137988</author-url><authid>7004137988</authid><authname>Tuana B.</authname><surname>Tuana</surname><given-name>Balwant S.</given-name><initials>B.S.</initials><afid>60028897</afid><afid>60011635</afid></author><authkeywords>E2Fs | Hypertrophy | Phosphodiesterase | Protein kinase | Î²-Adrenergic receptors</authkeywords><intid>35945004</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929224493"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929224493?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929224493&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929224493&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008347"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929224493</prism:url><dc:identifier>SCOPUS_ID:84929224493</dc:identifier><eid>2-s2.0-84929224493</eid><dc:title>An overview of the applied definitions and diagnostic methods to assess exercise oscillatory ventilation - A systematic review</dc:title><dc:creator>Cornelis J.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>161-169</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.111</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. The variable "exercise oscillatory ventilation" (EOV), assessed during cardiopulmonary exercise test (CPET), recently becamea fundamental prognostic parameter in patients with heart failure. In literature, various definitions are suggested, but an uniformly accepted description to identify EOV still lacks. We performed a systematic review of the literature in order to determine the different definitions and diagnostic techniques to assess EOV. A systematic search strategy was established and executed in seven databases (PubMed, Google Scholar, Cochrane Clinical Trials, Science Direct, Pedro, Web Of Science library and Medline (Ovid)) resulting in 605 citations after de-duplication. Full-text articles (n = 124) were assessed for eligibility, resulting in 75 citations. The review accounted 17,440 patients of whom 4,638 subjects presented EOV. Seven studies described EOV in a non-heart failure population accounting 168 EOV subjects. The definitions could be categorized in nine subdivisions of which four (n=43) referred to an original description. The other subdivisionswere combinations of the original definitions (n=11), quantifications (n=4), computational (n=3), vaguely described (n=8) or not defined (n=6). Symptom limited maximal exercise tests were conducted to assess EOV, however the modes, protocols, software and data sampling were divers. Heterogeneity in the numerous definitions to identify EOV and the vaguely described assessment methods are hindering the evolution to a standardized uniformly accepted definition and technique to identify this abnormal breathing pattern. Unity in definition and international adopted assessment is warranted to strengthen its validity as a prognostic marker and could promote communication. It may facilitate clinical trials on pathophysiology and origin of EOV.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013703</affiliation-url><afid>60013703</afid><affilname>Universitair Ziekenhuis Antwerpen</affilname><name-variant>Antwerp University Hospital</name-variant><affiliation-city>Edegem</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025063</affiliation-url><afid>60025063</afid><affilname>Katholieke Universiteit Leuven</affilname><name-variant>University of Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56577703600</author-url><authid>56577703600</authid><authname>Cornelis J.</authname><surname>Cornelis</surname><given-name>Justien</given-name><initials>J.</initials><afid>60012937</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003930083</author-url><authid>7003930083</authid><authname>Beckers P.</authname><surname>Beckers</surname><given-name>Paul</given-name><initials>P.</initials><afid>60012937</afid><afid>60013703</afid><afid>60012937</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003930083</author-url><authid>7003930083</authid><authname>Beckers P.</authname><surname>Beckers</surname><given-name>Paul</given-name><initials>P.</initials><afid>60012937</afid><afid>60013703</afid><afid>60012937</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003930083</author-url><authid>7003930083</authid><authname>Beckers P.</authname><surname>Beckers</surname><given-name>Paul</given-name><initials>P.</initials><afid>60012937</afid><afid>60013703</afid><afid>60012937</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23006562000</author-url><authid>23006562000</authid><authname>Vanroy C.</authname><surname>Vanroy</surname><given-name>Christel</given-name><initials>C.</initials><afid>60012937</afid><afid>60025063</afid><afid>60012937</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23006562000</author-url><authid>23006562000</authid><authname>Vanroy C.</authname><surname>Vanroy</surname><given-name>Christel</given-name><initials>C.</initials><afid>60012937</afid><afid>60025063</afid><afid>60012937</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23006562000</author-url><authid>23006562000</authid><authname>Vanroy C.</authname><surname>Vanroy</surname><given-name>Christel</given-name><initials>C.</initials><afid>60012937</afid><afid>60025063</afid><afid>60012937</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56641770700</author-url><authid>56641770700</authid><authname>Volckaerts T.</authname><surname>Volckaerts</surname><given-name>Tess</given-name><initials>T.</initials><afid>60012937</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35452176900</author-url><authid>35452176900</authid><authname>Vrints C.</authname><surname>Vrints</surname><given-name>Christiaan</given-name><initials>C.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35452176900</author-url><authid>35452176900</authid><authname>Vrints C.</authname><surname>Vrints</surname><given-name>Christiaan</given-name><initials>C.</initials><afid>60013703</afid><afid>60012937</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56577940700</author-url><authid>56577940700</authid><authname>Vissers D.</authname><surname>Vissers</surname><given-name>Dirk</given-name><initials>D.</initials><afid>60012937</afid></author><authkeywords>Assessment | Cardiopulmonary exercise | Definition | Humans | Oscillatory ventilation | Review</authkeywords><intid>535918512</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929190808"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929190808?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929190808&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929190808&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008220"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929190808</prism:url><dc:identifier>SCOPUS_ID:84929190808</dc:identifier><eid>2-s2.0-84929190808</eid><dc:title>Life expectancy after implantation of a first cardiac permanent pacemaker (1995-2008): A population-based study</dc:title><dc:creator>Bradshaw P.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>42-46</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.099</prism:doi><dc:description>Â© 2015 Published by Elsevier Ireland Ltd. Introduction: Research suggests that survival among the recipients of a cardiac permanent pacemaker (PPM) matches the age- and sex-matched general population in the absence of cardiovascular disease. We used linked administrative data to examine life expectancy-based outcomes for adults requiring a cardiac PPM. Methods: Population-level hospital admissions data were used to identify all recipients of an initial PPM during 1995-2008. Expected years of additional life remaining at the time of implantation were calculated for each patient from population life tables. Observed years were calculated using linked mortality data to end 2011. Cox regression was used to determine demographic and clinical predictors of survival. Results: In 8757 patients age-adjusted risk of death to 5 years was associated with male sex, higher Charlson Comorbidity Index score (excluding cardiac disease), a history of heart failure, cardiomyopathy or atrial fibrillation and emergency admission. Coronary revascularisation surgery reduced long-term risk. The observed/expected ratio of additional years of life was 0.80 for men and 0.84 for women overall, varying from 0.92 for women without significant comorbidity to 0.40 for patients with the highest Charlson score and cardiomyopathy. The oldest patients (80-99 years) did relatively well, probably reflecting patient selection. Heart disease was the most frequent cause of death. Conclusions: Life expectancy among PPMrecipientswithout significant comorbidity approached that of the general population. Greater non-cardiac comorbidity, heart failure, atrial fibrillation and, in particular, cardiomyopathy, contributedmost to the loss of expected years of life in all age groups. The oldest patients andwomen did relatively well.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031806</affiliation-url><afid>60031806</afid><affilname>University of Western Australia</affilname><name-variant>University of Western Australia</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025898</affiliation-url><afid>60025898</afid><affilname>Sir Charles Gairdner Hospital</affilname><name-variant>Sir Charles Gairdner Hospital</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102263052</author-url><authid>7102263052</authid><authname>Bradshaw P.</authname><surname>Bradshaw</surname><given-name>Pamela J.</given-name><initials>P.J.</initials><afid>60031806</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506644353</author-url><authid>6506644353</authid><authname>Stobie P.</authname><surname>Stobie</surname><given-name>Paul</given-name><initials>P.</initials><afid>60025898</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005404334</author-url><authid>7005404334</authid><authname>Knuiman M.</authname><surname>Knuiman</surname><given-name>Matthew W.</given-name><initials>M.W.</initials><afid>60031806</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507675518</author-url><authid>6507675518</authid><authname>Briffa T.</authname><surname>Briffa</surname><given-name>Thomas G.</given-name><initials>T.G.</initials><afid>60031806</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101710506</author-url><authid>7101710506</authid><authname>Hobbs M.</authname><surname>Hobbs</surname><given-name>Michael S T</given-name><initials>M.S.T.</initials><afid>60031806</afid></author><authkeywords>Cardiac pacemaker | Comorbidity | Life expectancy | Survival</authkeywords><intid>35918118</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377402"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377402?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377402&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377402&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167876015001695"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377402</prism:url><dc:identifier>SCOPUS_ID:84929377402</dc:identifier><eid>2-s2.0-84929377402</eid><dc:title>Smoking's effects on respiratory sinus arrhythmia in adolescent smokers</dc:title><dc:creator>Conrad M.</dc:creator><prism:publicationName>International Journal of Psychophysiology</prism:publicationName><prism:issn>01678760</prism:issn><prism:eIssn>18727697</prism:eIssn><prism:volume>97</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>8-13</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijpsycho.2015.05.002</prism:doi><pii>S0167876015001695</pii><dc:description>Â© 2015. Respiratory sinus arrhythmia (RSA) has emerged as an indicator of how well the body maintains homeostasis and flexibly responds to environmental demands. Previous research has shown that smoking has both acute and chronic effects on RSA in adults. More recent work has focused on adolescent smokers because the natural decrease in RSA over the lifespan might be hastened by smoking at an early age. The goal of the current study, then, was to examine the acute effects of smoking on RSA and mean heart rate (HR) in a group of adolescent smokers. Participants completed two experimental sessions separated by 6-10. weeks, during which resting electrocardiogram (EKG) data were collected before and after smoking or not smoking a single cigarette ad libitum. Results indicate that smoking significantly decreased resting RSA and increased mean HR. In addition, those who smoked their first cigarette earlier in life (i.e., before age 8 or 10) evidenced a greater decrease in RSA during their smoking session relative to those who tried smoking after age 10. Importantly, these findings are largely consistent with the adult literature and suggest that smoking has acute effects on both RSA and HR in adolescence.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027561</affiliation-url><afid>60027561</afid><affilname>University of Illinois at Chicago</affilname><name-variant>University of Illinois at Chicago</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34871522800</author-url><authid>34871522800</authid><authname>Conrad M.</authname><surname>Conrad</surname><given-name>Megan</given-name><initials>M.</initials><afid>60027561</afid><afid>60014232</afid><afid>60014232</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34871522800</author-url><authid>34871522800</authid><authname>Conrad M.</authname><surname>Conrad</surname><given-name>Megan</given-name><initials>M.</initials><afid>60027561</afid><afid>60014232</afid><afid>60014232</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34871522800</author-url><authid>34871522800</authid><authname>Conrad M.</authname><surname>Conrad</surname><given-name>Megan</given-name><initials>M.</initials><afid>60027561</afid><afid>60014232</afid><afid>60014232</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35332202100</author-url><authid>35332202100</authid><authname>Gorka S.</authname><surname>Gorka</surname><given-name>Stephanie M.</given-name><initials>S.M.</initials><afid>60027561</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56648367700</author-url><authid>56648367700</authid><authname>Kassel J.</authname><surname>Kassel</surname><given-name>Jon</given-name><initials>J.</initials><afid>60027561</afid></author><authkeywords>Adolescent | Heart rate | Nicotine dependence | Respiratory sinus arrhythmia (RSA) | Smoking | Smoking behavior</authkeywords><intid>1535943229</intid><source-id>14902</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930177360"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930177360?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930177360&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930177360&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1043466614006577"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930177360</prism:url><dc:identifier>SCOPUS_ID:84930177360</dc:identifier><eid>2-s2.0-84930177360</eid><dc:title>The varying faces of IL-6: From cardiac protection to cardiac failure</dc:title><dc:creator>Fontes J.</dc:creator><prism:publicationName>Cytokine</prism:publicationName><prism:issn>10434666</prism:issn><prism:eIssn>10960023</prism:eIssn><prism:volume>74</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>62-68</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cyto.2014.12.024</prism:doi><pii>S1043466614006577</pii><dc:description>Â© 2015 Elsevier Ltd. IL6 is a pleiotropic cytokine that is made in response to perturbations in homeostasis. IL6 becomes elevated in the acute response to host injury and can activate immune cells, direct immune cell trafficking, signal protective responses in local tissue, initial the acute phase response or initiate wound healing. In the short term this proinflammatory response is protective and limits host damage. It is when this acute response remains chronically activated that IL6 becomes pathogenic to the host. Chronically elevated IL6 levels lead to chronic inflammation and fibrotic disorders. The heart is a tissue where this temporal regulation of IL6 is very apparent. Studies from myocardial infarction show how short-term IL6 signaling can protect and preserve the heart tissue in response to acute damage, where long term IL6 signaling or an over-production of IL6R protein plays a causal role in cardiovascular disease. Thus, IL6 can be both protective and pathogenic, depending on the kinetics of the host response.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006183</affiliation-url><afid>60006183</afid><affilname>Johns Hopkins Bloomberg School of Public Health</affilname><name-variant>Johns Hopkins University</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><name-variant>Johns Hopkins School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55881500000</author-url><authid>55881500000</authid><authname>Fontes J.</authname><surname>Fontes</surname><given-name>Jillian A.</given-name><initials>J.A.</initials><afid>60006183</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56664714800</author-url><authid>56664714800</authid><authname>Rose N.</authname><surname>Rose</surname><given-name>Noel R.</given-name><initials>N.R.</initials><afid>60006183</afid><afid>60001117</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56664714800</author-url><authid>56664714800</authid><authname>Rose N.</authname><surname>Rose</surname><given-name>Noel R.</given-name><initials>N.R.</initials><afid>60006183</afid><afid>60001117</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56664649600</author-url><authid>56664649600</authid><authname>ÄihÃ¡kovÃ¡ D.</authname><surname>ÄihÃ¡kovÃ¡</surname><given-name>Daniela</given-name><initials>D.</initials><afid>60006183</afid><afid>60001117</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56664649600</author-url><authid>56664649600</authid><authname>ÄihÃ¡kovÃ¡ D.</authname><surname>ÄihÃ¡kovÃ¡</surname><given-name>Daniela</given-name><initials>D.</initials><afid>60006183</afid><afid>60001117</afid></author><authkeywords>Gp130 | Heart failure | IL6 | Myocarditis | Trans-signaling</authkeywords><intid>1036074429</intid><source-id>22083</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928885775"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928885775?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928885775&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928885775&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001273"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928885775</prism:url><dc:identifier>SCOPUS_ID:84928885775</dc:identifier><eid>2-s2.0-84928885775</eid><dc:title>Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2</dc:title><dc:creator>Wang H.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>143-153</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.012</prism:doi><pii>S0022282815001273</pii><dc:description>Â© 2015 Elsevier Ltd. Ubiquitin proteasome system (UPS) consists of ubiquitin, ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), ubiquitin ligases (E3s), proteasomes, and deubiquitinating enzymes (DUBs). Ubiquitin, E1s, several E2s, E3s, and proteasomes play an important role in the regulation of cardiac homeostasis and dysfunction; however, less is known about the role of DUBs in the heart. Here, we uncovered a crucial role of cyclindromatosis (CYLD), a DUB, in mediating cardiac maladaptive remodeling and dysfunction. CYLD expression was dramatically upregulated in the cardiomyocytes of hypertrophic and failing human and murine hearts. Knockout of CYLD improved survival rate and alleviated cardiac hypertrophy, fibrosis, apoptosis, oxidative stress, and dysfunction in mice that were subjected to sustained pressure overload induced by transverse aortic constriction. Deep sequencing and gene array analyses revealed that the most dramatically changed genes are those involving in the free radical scavenging pathway and cardiovascular disease, including fos, jun, myc, and nuclear factor erythroid-2 related factor 2 (Nrf2) in the heart. Moreover, knockdown of CYLD enhanced mitogen-activated protein kinase (MAPK) ERK- and p38-mediated expression of c-jun, c-fos, and c-myc, which govern Nrf2 expression in cardiomyocytes. The CYLD deficiency-induced suppression of reactive oxygen species (ROS) formation, death and hypertrophy in cardiomyocytes was blocked by additional knockdown of Nrf2. Taken together, our findings demonstrate for the first time that CYLD mediates cardiac maladaptive remodeling and dysfunction, most likely via enhancing myocardial oxidative stress in response to pressure overload. At the molecular level, CYLD interrupts the ERK- and p38-/AP-1 and c-Myc pathways to suppress Nrf2-operated antioxidative capacity, thereby enhancing oxidative stress in the heart.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60092862</affiliation-url><afid>60092862</afid><affilname>Qilu Hospital of Shandong University</affilname><name-variant>Shandong University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006281</affiliation-url><afid>60006281</afid><affilname>University of South Carolina School of Medicine</affilname><name-variant>University of South Carolina</name-variant><affiliation-city>Columbia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015023</affiliation-url><afid>60015023</afid><affilname>University of Texas M. D. Anderson Cancer Center</affilname><name-variant>University of Texas</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622463900</author-url><authid>56622463900</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hui</given-name><initials>H.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622463900</author-url><authid>56622463900</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Hui</given-name><initials>H.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56020445200</author-url><authid>56020445200</authid><authname>Lai Y.</authname><surname>Lai</surname><given-name>Yimu</given-name><initials>Y.</initials><afid>60006281</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622762800</author-url><authid>56622762800</authid><authname>Mathis B.</authname><surname>Mathis</surname><given-name>Bryan J.</given-name><initials>B.J.</initials><afid>60006281</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56621522000</author-url><authid>56621522000</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wenjuan</given-name><initials>W.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56621522000</author-url><authid>56621522000</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wenjuan</given-name><initials>W.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56621512100</author-url><authid>56621512100</authid><authname>Li S.</authname><surname>Li</surname><given-name>Siying</given-name><initials>S.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56621512100</author-url><authid>56621512100</authid><authname>Li S.</authname><surname>Li</surname><given-name>Siying</given-name><initials>S.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56606729400</author-url><authid>56606729400</authid><authname>Qu C.</authname><surname>Qu</surname><given-name>Chen</given-name><initials>C.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56606729400</author-url><authid>56606729400</authid><authname>Qu C.</authname><surname>Qu</surname><given-name>Chen</given-name><initials>C.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55859024200</author-url><authid>55859024200</authid><authname>Li B.</authname><surname>Li</surname><given-name>Bin</given-name><initials>B.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55859024200</author-url><authid>55859024200</authid><authname>Li B.</authname><surname>Li</surname><given-name>Bin</given-name><initials>B.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56622082300</author-url><authid>56622082300</authid><authname>Shao L.</authname><surname>Shao</surname><given-name>Lei</given-name><initials>L.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56622082300</author-url><authid>56622082300</authid><authname>Shao L.</authname><surname>Shao</surname><given-name>Lei</given-name><initials>L.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56621753100</author-url><authid>56621753100</authid><authname>Song H.</authname><surname>Song</surname><given-name>Haibo</given-name><initials>H.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56621753100</author-url><authid>56621753100</authid><authname>Song H.</authname><surname>Song</surname><given-name>Haibo</given-name><initials>H.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005910491</author-url><authid>7005910491</authid><authname>Janicki J.</authname><surname>Janicki</surname><given-name>Joseph S.</given-name><initials>J.S.</initials><afid>60006281</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56621757300</author-url><authid>56621757300</authid><authname>Sun S.</authname><surname>Sun</surname><given-name>Sao Cong</given-name><initials>S.C.</initials><afid>60015023</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35249532600</author-url><authid>35249532600</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xing Li</given-name><initials>X.L.</initials><afid>60092862</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7401987219</author-url><authid>7401987219</authid><authname>Tang D.</authname><surname>Tang</surname><given-name>Dongqi</given-name><initials>D.</initials><afid>60092862</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56637153200</author-url><authid>56637153200</authid><authname>Cui T.</authname><surname>Cui</surname><given-name>Taixing</given-name><initials>T.</initials><afid>60092862</afid><afid>60006281</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56637153200</author-url><authid>56637153200</authid><authname>Cui T.</authname><surname>Cui</surname><given-name>Taixing</given-name><initials>T.</initials><afid>60092862</afid><afid>60006281</afid></author><authkeywords>Cardiomyopathy | CYLD | Heart failure | Nrf2 | Oxidative stress</authkeywords><intid>2035855850</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929169096"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929169096?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929169096&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929169096&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001388"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929169096</prism:url><dc:identifier>SCOPUS_ID:84929169096</dc:identifier><eid>2-s2.0-84929169096</eid><dc:title>T-tubule disease: Relationship between t-tubule organization and regional contractile performance in human dilated cardiomyopathy</dc:title><dc:creator>Crossman D.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>170-178</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.022</prism:doi><pii>S0022282815001388</pii><dc:description>Â© 2015 Elsevier Ltd. Evidence from animal models suggest that t-tubule changes may play an important role in the contractile deficit associated with heart failure. However samples are usually taken at random with no regard as to regional variability present in failing hearts which leads to uncertainty in the relationship between contractile performance and possible t-tubule derangement. Regional contraction in human hearts was measured by tagged cine MRI and model fitting. At transplant, failing hearts were biopsy sampled in identified regions and immunocytochemistry was used to label t-tubules and sarcomeric z-lines. Computer image analysis was used to assess 5 different unbiased measures of t-tubule structure/organization. In regions of failing hearts that showed good contractile performance, t-tubule organization was similar to that seen in normal hearts, with worsening structure correlating with the loss of regional contractile performance. Statistical analysis showed that t-tubule direction was most highly correlated with local contractile performance, followed by the amplitude of the sarcomeric peak in the Fourier transform of the t-tubule image. Other area based measures were less well correlated. We conclude that regional contractile performance in failing human hearts is strongly correlated with the local t-tubule organization. Cluster tree analysis with a functional definition of failing contraction strength allowed a pathological definition of 't-tubule disease'. The regional variability in contractile performance and cellular structure is a confounding issue for analysis of samples taken from failing human hearts, although this may be overcome with regional analysis by using tagged cMRI and biopsy mapping.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011750</affiliation-url><afid>60011750</afid><affilname>Auckland City Hospital</affilname><name-variant>Auckland City Hospital</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005455</affiliation-url><afid>60005455</afid><affilname>Yale University</affilname><name-variant>Yale University</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026479</affiliation-url><afid>60026479</afid><affilname>University of Exeter</affilname><name-variant>University of Exeter</name-variant><affiliation-city>Exeter</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005689853</author-url><authid>7005689853</authid><authname>Crossman D.</authname><surname>Crossman</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60005686</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56611163500</author-url><authid>56611163500</authid><authname>Young A.</authname><surname>Young</surname><given-name>Alistair A.</given-name><initials>A.A.</initials><afid>60005686</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006787982</author-url><authid>7006787982</authid><authname>Ruygrok P.</authname><surname>Ruygrok</surname><given-name>Peter N.</given-name><initials>P.N.</initials><afid>60011750</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603840010</author-url><authid>6603840010</authid><authname>Nason G.</authname><surname>Nason</surname><given-name>Guy P.</given-name><initials>G.P.</initials><afid>60020650</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641698900</author-url><authid>56641698900</authid><authname>Baddelely D.</authname><surname>Baddelely</surname><given-name>David</given-name><initials>D.</initials><afid>60005686</afid><afid>60005455</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641698900</author-url><authid>56641698900</authid><authname>Baddelely D.</authname><surname>Baddelely</surname><given-name>David</given-name><initials>D.</initials><afid>60005686</afid><afid>60005455</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56028651000</author-url><authid>56028651000</authid><authname>Soeller C.</authname><surname>Soeller</surname><given-name>Christian</given-name><initials>C.</initials><afid>60005686</afid><afid>60026479</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56028651000</author-url><authid>56028651000</authid><authname>Soeller C.</authname><surname>Soeller</surname><given-name>Christian</given-name><initials>C.</initials><afid>60005686</afid><afid>60026479</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005088032</author-url><authid>7005088032</authid><authname>Cannell M.</authname><surname>Cannell</surname><given-name>Mark B.</given-name><initials>M.B.</initials><afid>60005686</afid><afid>60020650</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005088032</author-url><authid>7005088032</authid><authname>Cannell M.</authname><surname>Cannell</surname><given-name>Mark B.</given-name><initials>M.B.</initials><afid>60005686</afid><afid>60020650</afid></author><authkeywords>Contraction | Heart failure | Human | T-tubules</authkeywords><intid>35916129</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928990047"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928990047?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928990047&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928990047&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002228281500139X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928990047</prism:url><dc:identifier>SCOPUS_ID:84928990047</dc:identifier><eid>2-s2.0-84928990047</eid><dc:title>Obesity induced by high fat diet attenuates postinfarct myocardial remodeling and dysfunction in adult B6D2F1 mice</dc:title><dc:creator>Poncelas M.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>154-161</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.023</prism:doi><pii>S002228281500139X</pii><dc:description>Â© 2015 Elsevier Ltd. Obesity is a major risk factor for cardiovascular morbidity and mortality. However, some studies suggest that among patients with established cardiovascular disease, obesity is associated with better prognosis, a phenomenon described as the obesity paradox. In this study we tested the hypothesis that obesity with hyperinsulinemia and without hyperglycemia attenuates the impact of transient coronary occlusion on left ventricular remodeling and function. B6D2F1 mice from both genders fed with a high fat diet (HFD) or control diet for 6. months were subjected to 45. min of coronary occlusion and 28. days of reperfusion. Left ventricular dimensions and function were assessed by serial echocardiography, and infarct size was determined by Picrosirius red staining. HFD mice developed obesity with hypercholesterolemia and hyperinsulinemia in the absence of hyperglycemia or hypertension. During the period of feeding, no changes were observed in ventricular mass, volume or function, or in vascular reactivity. HFD attenuated the consequences of transient coronary occlusion as shown by a marked reduction in infarct size (51%, P. =. 0.021) and cardiac dilation, as well as improved left ventricular function as compared to control diet animals. These effects were associated with enhanced reperfusion injury salvage kinases (RISK) pathway function in HFD hearts shown as increased Akt and GSK3Î² phosphorylation. These results demonstrate that dietary obesity without hyperglycemia or hypertension attenuates the impact of ischemia/reperfusion injury in association with increased insulin signaling and RISK activation. This study provides experimental support to the controversial concept of the obesity paradox in humans.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018312</affiliation-url><afid>60018312</afid><affilname>Universidad Autonoma de Barcelona, Facultad de Medicina</affilname><name-variant>Universitat AutÃ²noma de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023020</affiliation-url><afid>60023020</afid><affilname>Universidad Autonoma de Barcelona</affilname><name-variant>Universitat Autonoma de Barcelona</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56596659100</author-url><authid>56596659100</authid><authname>Poncelas M.</authname><surname>Poncelas</surname><given-name>Marcos</given-name><initials>M.</initials><afid>60018312</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55988853000</author-url><authid>55988853000</authid><authname>Inserte J.</authname><surname>Inserte</surname><given-name>Javier</given-name><initials>J.</initials><afid>60018312</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54885269800</author-url><authid>54885269800</authid><authname>Vilardosa Ã.</authname><surname>Vilardosa</surname><given-name>Ãrsula</given-name><initials>Ã.</initials><afid>60018312</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603350843</author-url><authid>6603350843</authid><authname>Rodriguez-Sinovas A.</authname><surname>Rodriguez-Sinovas</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60018312</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56032997900</author-url><authid>56032997900</authid><authname>BaÃ±eras J.</authname><surname>BaÃ±eras</surname><given-name>Jordi</given-name><initials>J.</initials><afid>60018312</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55390685400</author-url><authid>55390685400</authid><authname>SimÃ³ R.</authname><surname>SimÃ³</surname><given-name>Rafael</given-name><initials>R.</initials><afid>60023020</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005652216</author-url><authid>7005652216</authid><authname>Garcia-Dorado D.</authname><surname>Garcia-Dorado</surname><given-name>David</given-name><initials>D.</initials><afid>60018312</afid></author><authkeywords>Insulin | Myocardial infarction | Obesity | Remodeling</authkeywords><intid>1785884681</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929152244"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929152244?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929152244&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929152244&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009195"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929152244</prism:url><dc:identifier>SCOPUS_ID:84929152244</dc:identifier><eid>2-s2.0-84929152244</eid><dc:title>Long-term outcomes of catheter ablation of atrial fibrillation in dilated cardiomyopathy</dc:title><dc:creator>Zhao L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>227-232</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.186</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Objective: The long-term outcomes, efficacy and safety of catheter ablation in atrial fibrillation (AF) patients with dilated cardiomyopathy (DCM) have not been reported previously. Methods and results: Forty nine patients with AF (59% longstanding persistent AF, LSP-AF) and DCM were enrolled. Circumferential pulmonary vein ablation (CPVA, paroxysmal AF), bidirectional block of lines and disappearance of complex fractionated atrial electrograms (CFAEs, persistent and LSP-AF) were the endpoints of the index and repeat procedures. Cumulative success rate reached 49% (mean, 1.4 procedures) during the first year, and dropped to 38% at median follow-up of 45 months (range, 36-64 months) for multiple procedures (mean, 1.9 Â± 0.8 [1-4]). Incidence of procedural complications was similar to that of conventional procedures. In multivariate analysis, LSP-AF (OR, 7.40 [95% CI, 1.42-38.34]; P = 0.017) and larger left ventricular end-diastolic diameter (OR, 1.24 [95% CI, 1.01-1.52]; P = 0.034) were significant independent predictors of recurrent atrial tachyarrhythmia (ATa). Compared with patients with ATa recurrence, those free from ATa had better New York Heart Association functional class, 6-minute walk distance and left ventricular ejection fraction during longterm follow-up compared with pre-ablation, but this improvement was not sustained beyond 3 years. Conclusion: Inpatients with DCM, current commonly used ablation strategies including CPVA, linear ablation and CFAE ablation are not associated with long-term AF treatment success up to five years. Freedom from ATa is associated with improved heart failure during but not beyond 3 years post ablation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56523606300</author-url><authid>56523606300</authid><authname>Zhao L.</authname><surname>Zhao</surname><given-name>Liang</given-name><initials>L.</initials><afid>60025084</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640326600</author-url><authid>56640326600</authid><authname>Xu K.</authname><surname>Xu</surname><given-name>Kai</given-name><initials>K.</initials><afid>60025084</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56443110500</author-url><authid>56443110500</authid><authname>Jiang W.</authname><surname>Jiang</surname><given-name>Weifeng</given-name><initials>W.</initials><afid>60025084</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56178172700</author-url><authid>56178172700</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Li</given-name><initials>L.</initials><afid>60025084</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56524699600</author-url><authid>56524699600</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yuanlong</given-name><initials>Y.</initials><afid>60025084</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55638222500</author-url><authid>55638222500</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xiaodong</given-name><initials>X.</initials><afid>60025084</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55637806800</author-url><authid>55637806800</authid><authname>Wu S.</authname><surname>Wu</surname><given-name>Shaohui</given-name><initials>S.</initials><afid>60025084</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24722751900</author-url><authid>24722751900</authid><authname>Liu X.</authname><surname>Liu</surname><given-name>Xu</given-name><initials>X.</initials><afid>60025084</afid></author><authkeywords>Atrial fibrillation | Catheter ablation | Dilated cardiomyopathy</authkeywords><intid>35918219</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929657204"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929657204?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929657204&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929657204&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S002191501501031X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929657204</prism:url><dc:identifier>SCOPUS_ID:84929657204</dc:identifier><eid>2-s2.0-84929657204</eid><dc:title>Subclinical atherosclerosis and subsequent cognitive function</dc:title><dc:creator>Rossetti H.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>36-41</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.813</prism:doi><pii>S002191501501031X</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Objective: To examine the relationship between measures of subclinical atherosclerosis and subsequent cognitive function. Method: Participants from the Dallas Heart Study (DHS), a population-based multiethnic study of cardiovascular disease pathogenesis, were re-examined 8 years later (DHS-2) with the Montreal Cognitive Assessment (MoCA); N=1904, mean age=42.9, range 8-65. Associations of baseline measures of subclinical atherosclerosis (coronary artery calcium, abdominal aortic plaque, and abdominal aortic wall thickness) with MoCA scores measured at follow-up were examined in the group as a whole and in relation to age and ApoE4 status. Results: A significant linear trend of successively lower MoCA scores with increasing numbers of atherosclerotic indicators was observed (F(3, 1150)=5.918, p=001). CAC was weakly correlated with MoCA scores (p=047) and MoCA scores were significantly different between participants with and without CAC (M=22.35 vs 23.69, p=0.038). With the exception of a small association between abdominal AWT and MoCA in subjects over age 50, abdominal AWT and abdominal aortic plaque did not correlate with MoCA total score (pâ¥.052). Cognitive scores and atherosclerosis measures were not impacted by ApoE4 status (pâ¥.455). Conclusion: In this ethnically diverse population-based sample, subclinical atherosclerosis was minimally associated with later cognitive function in middle-aged adults.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026695</affiliation-url><afid>60026695</afid><affilname>UT Southwestern Medical Center</affilname><name-variant>University of Texas Southwestern Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026695</affiliation-url><afid>60026695</afid><affilname>UT Southwestern Medical Center</affilname><name-variant>University of Texas Southwestern Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026695</affiliation-url><afid>60026695</afid><affilname>UT Southwestern Medical Center</affilname><name-variant>University of Texas Southwestern Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026695</affiliation-url><afid>60026695</afid><affilname>UT Southwestern Medical Center</affilname><name-variant>University of Texas Southwestern Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36103137700</author-url><authid>36103137700</authid><authname>Rossetti H.</authname><surname>Rossetti</surname><given-name>Heidi C.</given-name><initials>H.C.</initials><afid>60026695</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402253653</author-url><authid>7402253653</authid><authname>Weiner M.</authname><surname>Weiner</surname><given-name>Myron</given-name><initials>M.</initials><afid>60026695</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34975495400</author-url><authid>34975495400</authid><authname>Hynan L.</authname><surname>Hynan</surname><given-name>Linda S.</given-name><initials>L.S.</initials><afid>60026695</afid><afid>60026695</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34975495400</author-url><authid>34975495400</authid><authname>Hynan L.</authname><surname>Hynan</surname><given-name>Linda S.</given-name><initials>L.S.</initials><afid>60026695</afid><afid>60026695</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56605545800</author-url><authid>56605545800</authid><authname>Cullum C.</authname><surname>Cullum</surname><given-name>C. Munro</given-name><initials>C.M.</initials><afid>60026695</afid><afid>60026695</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56605545800</author-url><authid>56605545800</authid><authname>Cullum C.</authname><surname>Cullum</surname><given-name>C. Munro</given-name><initials>C.M.</initials><afid>60026695</afid><afid>60026695</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8240985600</author-url><authid>8240985600</authid><authname>Khera A.</authname><surname>Khera</surname><given-name>Amit</given-name><initials>A.</initials><afid>60026695</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603016427</author-url><authid>6603016427</authid><authname>Lacritz L.</authname><surname>Lacritz</surname><given-name>Laura H.</given-name><initials>L.H.</initials><afid>60026695</afid><afid>60026695</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603016427</author-url><authid>6603016427</authid><authname>Lacritz L.</authname><surname>Lacritz</surname><given-name>Laura H.</given-name><initials>L.H.</initials><afid>60026695</afid><afid>60026695</afid></author><authkeywords>Atherosclerosis | Cognition | Dallas heart study | MoCA | Montreal Cognitive Assessment</authkeywords><intid>1035986812</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925808679"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925808679?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925808679&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925808679&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915000629"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925808679</prism:url><dc:identifier>SCOPUS_ID:84925808679</dc:identifier><eid>2-s2.0-84925808679</eid><dc:title>Blockage of ROS and NF-ÎºB-mediated inflammation by a new chalcone L6H9 protects cardiomyocytes from hyperglycemia-induced injuries</dc:title><dc:creator>Zhong P.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1230-1241</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.02.011</prism:doi><pii>S0925443915000629</pii><dc:description>Â© 2015 Elsevier B.V. Increased oxidative stress and cardiac inflammation have been implicated in the pathogenesis of diabetic cardiomyopathy (DCM). We previously found that a novel chalcone derivative, L6H9, was able to reduce LPS-induced inflammatory response in macrophages. This study was designed to investigate its protective effects on DCM and the underlying mechanisms. H9C2 cells were cultured with DMEM containing 33. mmol/L of glucose in the presence or absence of L6H9. Pretreatment with L6H9 significantly reduced high glucose-induced inflammatory cytokine expression, ROS level increase, mitochondrial dysfunction, cell apoptosis, fibrosis, and hypertrophy in H9c2 cells, which may be mediated by NF-ÎºB inhibition and Nrf2 activation. In mice with STZ-induced diabetes, oral administration of L6H9 at 20. mg/kg/day for 8. weeks significantly decreased the cardiac cytokine and ROS level, accompanied by decreasing cardiac apoptosis and hypertrophy, and, finally, improved histological abnormalities and fibrosis, without affecting the hyperglycemia. L6H9 also attenuated the diabetes-induced NF-ÎºB activation and Nrf2 decrease in diabetic hearts. These results strongly suggest that L6H9 may have great therapeutic potential in the treatment of DCM via blockage of inflammation and oxidative stress. This study also provides a deeper understanding of the regulatory role of Nrf2 and NF-ÎºB in DCM, indicating that they may be important therapeutic targets for diabetic complications.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114853442</affiliation-url><afid>114853442</afid><affilname>The 5th Affiliated Hospital of Wenzhou Medical University</affilname><name-variant>The 5th Affiliated Hospital of Wenzhou Medical University</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008073</affiliation-url><afid>60008073</afid><affilname>Wenzhou Medical College</affilname><name-variant>Wenzhou Medical College</name-variant><affiliation-city>Wenzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56421544600</author-url><authid>56421544600</authid><authname>Zhong P.</authname><surname>Zhong</surname><given-name>Peng</given-name><initials>P.</initials><afid>60008073</afid><afid>114853442</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56421544600</author-url><authid>56421544600</authid><authname>Zhong P.</authname><surname>Zhong</surname><given-name>Peng</given-name><initials>P.</initials><afid>60008073</afid><afid>114853442</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55775072300</author-url><authid>55775072300</authid><authname>Wu L.</authname><surname>Wu</surname><given-name>Lianpin</given-name><initials>L.</initials><afid>60008073</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56549327100</author-url><authid>56549327100</authid><authname>Qian Y.</authname><surname>Qian</surname><given-name>Yuanyuan</given-name><initials>Y.</initials><afid>60008073</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55959285500</author-url><authid>55959285500</authid><authname>Fang Q.</authname><surname>Fang</surname><given-name>Qilu</given-name><initials>Q.</initials><afid>60008073</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56571963400</author-url><authid>56571963400</authid><authname>Liang D.</authname><surname>Liang</surname><given-name>Dandan</given-name><initials>D.</initials><afid>60008073</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56040100600</author-url><authid>56040100600</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jingying</given-name><initials>J.</initials><afid>60008073</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56421314000</author-url><authid>56421314000</authid><authname>Zeng C.</authname><surname>Zeng</surname><given-name>Chunlai</given-name><initials>C.</initials><afid>114853442</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56638782100</author-url><authid>56638782100</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60008073</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55728604600</author-url><authid>55728604600</authid><authname>Liang G.</authname><surname>Liang</surname><given-name>Guang</given-name><initials>G.</initials><afid>60008073</afid></author><authkeywords>Chalcone derivative | Diabetic cardiomyopathy | Inflammation | NF-ÎºB | Nrf2 | Oxidative stress</authkeywords><intid>35347274</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928883229"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928883229?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928883229&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928883229&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001340"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928883229</prism:url><dc:identifier>SCOPUS_ID:84928883229</dc:identifier><eid>2-s2.0-84928883229</eid><dc:title>Calcineurin B homologous protein 3 negatively regulates cardiomyocyte hypertrophy via inhibition of glycogen synthase kinase 3 phosphorylation</dc:title><dc:creator>Kobayashi S.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>133-142</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.018</prism:doi><pii>S0022282815001340</pii><dc:description>Â© 2015 Elsevier Ltd. Cardiac hypertrophy is a leading cause of serious heart diseases. Although many signaling molecules are involved in hypertrophy, the functions of some proteins in this process are still unknown. Calcineurin B homologous protein 3 (CHP3)/tescalcin is an EF-hand Ca&lt;sup&gt;2+&lt;/sup&gt;-binding protein that is abundantly expressed in the heart; however, the function of CHP3 is unclear. Here, we aimed to identify the cardiac functions of CHP3. CHP3 was expressed in hearts at a wide range of developmental stages and was specifically detected in neonatal rat ventricular myocytes (NRVMs) but not in cardiac fibroblasts in culture. Moreover, knockdown of CHP3 expression using adenoviral-based RNA interference in NRVMs resulted in enlargement of cardiomyocyte size, concomitant with increased expression of a pathological hypertrophy marker ANP. This same treatment elevated glycogen synthase kinase (GSK3Î±/Î²) phosphorylation, which is known to inhibit GSK3 function. In contrast, CHP3 overexpression blocked the insulin-induced phosphorylation of GSK3Î±/Î² without affecting the phosphorylation of Akt, which is an upstream kinase of GSK3Î±/Î², in HEK293 cells, and it inhibited both IGF-1-induced phosphorylation of GSK3Î² and cardiomyocyte hypertrophy in NRVMs. Co-immunoprecipitation experiments revealed that GSK3Î² interacted with CHP3. However, a Ca&lt;sup&gt;2+&lt;/sup&gt;-binding-defective mutation of CHP3 (CHP3-D123A) also interacted with GSK3Î² and had the same inhibitory effect on GSK3Î±/Î² phosphorylation, suggesting that the action of CHP3 was independent of Ca&lt;sup&gt;2+&lt;/sup&gt;. These findings suggest that CHP3 functions as a novel negative regulator of cardiomyocyte hypertrophy via inhibition of GSK3Î±/Î² phosphorylation and subsequent enzymatic activation of GSK3Î±/Î².</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112940478</affiliation-url><afid>112940478</afid><affilname>National Cerebral and Cardiovascular Center Research Institute</affilname><name-variant>National Cerebral and Cardiovascular Center</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56307203000</author-url><authid>56307203000</authid><authname>Kobayashi S.</authname><surname>Kobayashi</surname><given-name>Soushi</given-name><initials>S.</initials><afid>112940478</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56621658900</author-url><authid>56621658900</authid><authname>Nakamura T.</authname><surname>Nakamura</surname><given-name>Tomoe Y.</given-name><initials>T.Y.</initials><afid>112940478</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102828781</author-url><authid>7102828781</authid><authname>Wakabayashi S.</authname><surname>Wakabayashi</surname><given-name>Shigeo</given-name><initials>S.</initials><afid>112940478</afid></author><authkeywords>Calcineurin B homologous protein | Cardiac hypertrophy | Cardiomyocytes</authkeywords><intid>2035857531</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930203515"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930203515?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930203515&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930203515&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167876015001713"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930203515</prism:url><dc:identifier>SCOPUS_ID:84930203515</dc:identifier><eid>2-s2.0-84930203515</eid><dc:title>Night or darkness, which intensifies the feeling of fear?</dc:title><dc:creator>Li Y.</dc:creator><prism:publicationName>International Journal of Psychophysiology</prism:publicationName><prism:issn>01678760</prism:issn><prism:eIssn>18727697</prism:eIssn><prism:volume>97</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>46-57</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijpsycho.2015.04.021</prism:doi><pii>S0167876015001713</pii><dc:description>Â© 2015 Elsevier B.V. Nighttime fear is a phenomenon in which people feel more afraid of threats at night. Despite the vast amount of psychological research on nighttime fear, previous researchers have not accurately distinguished between "night" and "darkness", both of which play important roles in nighttime fear. We collected physiological (skin conductance response and heart rate) and psychological (self-report) data simultaneously to investigate the effects of "night" and "darkness" on fearful feelings and whether these effects were moderated by the mode of stimulus delivery (i.e., visual or auditory). Specifically, two tasks were employed in which time (day vs. night), illumination (light vs. darkness) and stimulus type (fearful vs. neutral) were manipulated. Participants (. n=. 128) were exposed to visual and auditory oddball tasks consisting of fearful and neutral stimuli. The results indicated that there were significant increases in fear responses at night, and the difference between day and night was significant for fear stimuli but not for neutral events. Furthermore, these effects were consistent over different sensory modalities (visual and auditory). The results of this study underscore the importance of the day-night cycle in fear-related information processing and suggest that further attention needs to be paid to the influence of the biological circadian rhythm on these processes. The current findings could inform a deeper understanding of anxiety and fear-related disorders, and thus, we invite future studies to illuminate the underlying neurobiological mechanisms therein.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001604</affiliation-url><afid>60001604</afid><affilname>Ministry of Education China</affilname><name-variant>Ministry of Education</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023863</affiliation-url><afid>60023863</afid><affilname>Southwest China Normal University</affilname><name-variant>Southwest University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115293742</affiliation-url><afid>115293742</afid><affilname>China Mobile Group Yunnan Company Limited</affilname><name-variant>China Mobile Group Yunnan Company Limited</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000937</affiliation-url><afid>60000937</afid><affilname>Shenzhen University</affilname><name-variant>Shenzhen University</name-variant><affiliation-city>Qingshuihe, Shenzhen</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55877259600</author-url><authid>55877259600</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yadan</given-name><initials>Y.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55877259600</author-url><authid>55877259600</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yadan</given-name><initials>Y.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662624500</author-url><authid>56662624500</authid><authname>Ma W.</authname><surname>Ma</surname><given-name>Wenjuan</given-name><initials>W.</initials><afid>115293742</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662780600</author-url><authid>56662780600</authid><authname>Kang Q.</authname><surname>Kang</surname><given-name>Qin</given-name><initials>Q.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662780600</author-url><authid>56662780600</authid><authname>Kang Q.</authname><surname>Kang</surname><given-name>Qin</given-name><initials>Q.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55914934600</author-url><authid>55914934600</authid><authname>Qiao L.</authname><surname>Qiao</surname><given-name>Lei</given-name><initials>L.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55914934600</author-url><authid>55914934600</authid><authname>Qiao L.</authname><surname>Qiao</surname><given-name>Lei</given-name><initials>L.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55613349500</author-url><authid>55613349500</authid><authname>Tang D.</authname><surname>Tang</surname><given-name>Dandan</given-name><initials>D.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55613349500</author-url><authid>55613349500</authid><authname>Tang D.</authname><surname>Tang</surname><given-name>Dandan</given-name><initials>D.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56602116500</author-url><authid>56602116500</authid><authname>Qiu J.</authname><surname>Qiu</surname><given-name>Jiang</given-name><initials>J.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56602116500</author-url><authid>56602116500</authid><authname>Qiu J.</authname><surname>Qiu</surname><given-name>Jiang</given-name><initials>J.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12345014000</author-url><authid>12345014000</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qinglin</given-name><initials>Q.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12345014000</author-url><authid>12345014000</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qinglin</given-name><initials>Q.</initials><afid>60001604</afid><afid>60023863</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56506656600</author-url><authid>56506656600</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hong</given-name><initials>H.</initials><afid>60000937</afid></author><authkeywords>Circadian rhythm | Dark | Heart rate | Nighttime fear | Sensory modality | Skin conductance</authkeywords><intid>1036082622</intid><source-id>14902</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929154635"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929154635?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929154635&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929154635&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1746809415000634"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929154635</prism:url><dc:identifier>SCOPUS_ID:84929154635</dc:identifier><eid>2-s2.0-84929154635</eid><dc:title>Recurrence quantification analysis across sleep stages</dc:title><dc:creator>Rolink J.</dc:creator><prism:publicationName>Biomedical Signal Processing and Control</prism:publicationName><prism:issn>17468094</prism:issn><prism:eIssn>17468108</prism:eIssn><prism:volume>20</prism:volume><prism:pageRange>107-116</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bspc.2015.04.006</prism:doi><pii>S1746809415000634</pii><dc:description>Â© 2015 Elsevier Ltd. In this work we employ a nonlinear data analysis method called recurrence quantification analysis (RQA) to analyze differences between sleep stages and wake using cardio-respiratory signals, only. The data were recorded during full-night polysomnographies of 313 healthy subjects in nine different sleep laboratories. The raw signals are first normalized to common time bases and ranges. Thirteen different RQA and cross-RQA features derived from ECG, respiratory effort, heart rate and their combinations are additionally reconditioned with windowed standard deviation filters and ZSCORE normalization procedures leading to a total feature count of 195. The discriminative power between Wake, NREM and REM of each feature is evaluated using the Cohen's kappa coefficient. Besides kappa performance, sensitivity, specificity, accuracy and inter-correlations of the best 20 features with high discriminative power is also analyzed. The best kappa values for each class versus the other classes are 0.24, 0.12 and 0.31 for NREM, REM and Wake, respectively. Significance is tested with ANOVA F-test (mostly p &lt; 0.001). The results are compared to known cardio-respiratory features for sleep analysis. We conclude that many RQA features are suited to discriminate between Wake and Sleep, whereas the differentiation between REM and the other classes remains in the midrange.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016653</affiliation-url><afid>60016653</afid><affilname>Rheinisch-Westfalische Technische Hochschule Aachen</affilname><name-variant>RWTH Aachen</name-variant><affiliation-city>Aachen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032882</affiliation-url><afid>60032882</afid><affilname>Technische Universiteit Eindhoven</affilname><name-variant>Eindhoven University of Technology</name-variant><affiliation-city>Eindhoven</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114685830</affiliation-url><afid>114685830</afid><affilname>Philips Group Innovation Research</affilname><name-variant>Philips Group Innovation Research</name-variant><affiliation-city/><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56592927200</author-url><authid>56592927200</authid><authname>Rolink J.</authname><surname>Rolink</surname><given-name>Jerome</given-name><initials>J.</initials><afid>60016653</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56641099400</author-url><authid>56641099400</authid><authname>Kutz M.</authname><surname>Kutz</surname><given-name>Martin</given-name><initials>M.</initials><afid>60016653</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8314466800</author-url><authid>8314466800</authid><authname>Fonseca P.</authname><surname>Fonseca</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60032882</afid><afid>114685830</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8314466800</author-url><authid>8314466800</authid><authname>Fonseca P.</authname><surname>Fonseca</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60032882</afid><afid>114685830</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35774383200</author-url><authid>35774383200</authid><authname>Long X.</authname><surname>Long</surname><given-name>Xi</given-name><initials>X.</initials><afid>60032882</afid><afid>114685830</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35774383200</author-url><authid>35774383200</authid><authname>Long X.</authname><surname>Long</surname><given-name>Xi</given-name><initials>X.</initials><afid>60032882</afid><afid>114685830</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6504592448</author-url><authid>6504592448</authid><authname>Misgeld B.</authname><surname>Misgeld</surname><given-name>Berno</given-name><initials>B.</initials><afid>60016653</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004971042</author-url><authid>7004971042</authid><authname>Leonhardt S.</authname><surname>Leonhardt</surname><given-name>Steffen</given-name><initials>S.</initials><afid>60016653</afid></author><authkeywords>Cardio-respiratory features | Feature extraction | Recurrence quantification analysis | Sleep stages</authkeywords><intid>1785918998</intid><source-id>4700152237</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928136639"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928136639?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928136639&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928136639&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001042"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928136639</prism:url><dc:identifier>SCOPUS_ID:84928136639</dc:identifier><eid>2-s2.0-84928136639</eid><dc:title>Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function</dc:title><dc:creator>Kain V.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>24-35</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.003</prism:doi><pii>S0022282815001042</pii><dc:description>Â© 2015 Elsevier Ltd. Unresolved inflammation is a major contributor to the development of heart failure following myocardial infarction (MI). Pro-resolving lipid mediators, such as resolvins (e.g. RvD1), are biosynthesized endogenously. The role of RvD1 in resolving post-MI inflammation has not been elucidated due to its unstable nature. Here, we have tested the role for two forms of RvD1, after incorporation into liposomes (Lipo-RvD1) and its free acid form (RvD1) in the left ventricle (LV) and splenic remodeling post-MI. 8 to 12-week old male, C57BL/6J-mice were subjected to coronary artery ligation and Lipo-RvD1 or RvD1 (3Î¼g/kg/day) was injected 3h post-MI for day (d)1 or until d5. No-MI mice and saline-injected MI mice served as controls. RvD1 injected groups showed improved fractional shortening post-MI; preserving transient changes in the splenic reservoir compared to MI-saline. RvD1-groups showed an early exit of neutrophils from LV and spleen at d5 post-MI with an increased expression of lipoxin A&lt;inf&gt;4&lt;/inf&gt; receptor (ALX; synonym formyl peptide receptor; FPR2) compared to the MI-saline group. The levels of pro-resolving mediators RvD1, RvD2, Maresin 1 (MaR1) and Lipoxin A&lt;inf&gt;4&lt;/inf&gt; (LXA&lt;inf&gt;4&lt;/inf&gt;) were increased in spleens from RvD1 injected mice at d5 post-MI. RvD1 administration reduced macrophage density, ccr5 and cxcl5 levels at d5 post-MI compared to saline injected mice (both, p&lt;0.05). Increased transcripts of mrc-1, arg-1 and Ym-1 (all, p&lt;0.05) suggest macrophage-mediated clearance of necrotic cells in RvD1-groups. RvD1 reduced the pro-fibrotic genes (colla1, coll2a1 and tnc (all; p&lt;0.05)) and decreased collagen deposition, thereby reducing post-MI fibrosis and thus stabilizing the extracellular matrix. In summary, RvD1 and Lipo-RvD1 promote the resolution of acute inflammation initiated by MI, thereby delaying the onset of heart failure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025371</affiliation-url><afid>60025371</afid><affilname>University of Alabama</affilname><name-variant>University of Alabama</name-variant><affiliation-city>Tuscaloosa</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008423</affiliation-url><afid>60008423</afid><affilname>Midwestern University</affilname><name-variant>Midwestern University</name-variant><affiliation-city>Downers Grove</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56421793900</author-url><authid>56421793900</authid><authname>Kain V.</authname><surname>Kain</surname><given-name>Vasundhara</given-name><initials>V.</initials><afid>60025371</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56518103700</author-url><authid>56518103700</authid><authname>Ingle K.</authname><surname>Ingle</surname><given-name>Kevin A.</given-name><initials>K.A.</initials><afid>60025371</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35975590200</author-url><authid>35975590200</authid><authname>Colas R.</authname><surname>Colas</surname><given-name>Romain A.</given-name><initials>R.A.</initials><afid>60016782</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16416651300</author-url><authid>16416651300</authid><authname>Dalli J.</authname><surname>Dalli</surname><given-name>Jesmond</given-name><initials>J.</initials><afid>60016782</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101753861</author-url><authid>7101753861</authid><authname>Prabhu S.</authname><surname>Prabhu</surname><given-name>Sumanth D.</given-name><initials>S.D.</initials><afid>60025371</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101709764</author-url><authid>7101709764</authid><authname>Serhan C.</authname><surname>Serhan</surname><given-name>Charles N.</given-name><initials>C.N.</initials><afid>60016782</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8988113800</author-url><authid>8988113800</authid><authname>Joshi M.</authname><surname>Joshi</surname><given-name>Medha</given-name><initials>M.</initials><afid>60008423</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:12787551500</author-url><authid>12787551500</authid><authname>Halade G.</authname><surname>Halade</surname><given-name>Ganesh V.</given-name><initials>G.V.</initials><afid>60025371</afid></author><authkeywords>Metabololipidomics | Myocardial infarction | Neutrophils | Resolution of inflammation | Resolvin D1 | Splenic remodeling</authkeywords><intid>535734358</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928724167"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928724167?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928724167&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928724167&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0141813015002536"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928724167</prism:url><dc:identifier>SCOPUS_ID:84928724167</dc:identifier><eid>2-s2.0-84928724167</eid><dc:title>Characterization and bioactivities of a novel purified polysaccharide from endothelium corneum gigeriae galli</dc:title><dc:creator>Xiong Q.</dc:creator><prism:publicationName>International Journal of Biological Macromolecules</prism:publicationName><prism:issn>01418130</prism:issn><prism:eIssn>18790003</prism:eIssn><prism:volume>78</prism:volume><prism:pageRange>324-332</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijbiomac.2015.04.015</prism:doi><pii>S0141813015002536</pii><dc:description>Â© 2015 Elsevier B.V. In the present study, characterization and cardioprotective activities in vivo of a novel purified polysaccharide (PECG&lt;inf&gt;p&lt;/inf&gt;) from Endothelium corneum gigeriae Galli were investigated. The results found that PECGp had a 96kDa molecular weight. The backbone chains were composed of Î±-d-Glc and Î±-l-Rha linked by (1â4) glycosidic bonds. (1â4, 6) linked Î±-d-Glc and (1â2, 4) linked Î±-l-Rha in backbone chains with branches consisting of (1â4) linked Î±-d-Glc and terminal Î±-d-Glc-6-COOH. The assay of cardioprotective activities demonstrated that PECGp could significantly reduce the ST-segment elevation, prevented abnormal changes of heart muscle morphology, reverse abnormal hemodynamic and hemorheological parameters, rectify disorganized superoxide dismutase, nitric oxide synthase, nitric oxide, malondialdehyde, creatine kinase, creatine kinase MB fraction and lactate dehydrogenase levels. The results suggested that PECGp could be considered as a potential candidate for developing novel cardioprotective agents.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082830</affiliation-url><afid>60082830</afid><affilname>Huaiyin Institute of Technology</affilname><name-variant>Huaiyin Institute of Technology</name-variant><affiliation-city>Huaian</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022050</affiliation-url><afid>60022050</afid><affilname>Xuzhou Medical College</affilname><name-variant>Affiliated Hospital of Xuzhou Medical College</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028009</affiliation-url><afid>60028009</afid><affilname>Yunnan University</affilname><name-variant>Yunnan University</name-variant><affiliation-city>Kunming</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082830</affiliation-url><afid>60082830</afid><affilname>Huaiyin Institute of Technology</affilname><name-variant>Huaiyin Institute of Technology</name-variant><affiliation-city>Huaian</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55348865700</author-url><authid>55348865700</authid><authname>Xiong Q.</authname><surname>Xiong</surname><given-name>Qingping</given-name><initials>Q.</initials><afid>60082830</afid><afid>60082830</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55348865700</author-url><authid>55348865700</authid><authname>Xiong Q.</authname><surname>Xiong</surname><given-name>Qingping</given-name><initials>Q.</initials><afid>60082830</afid><afid>60082830</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37053868500</author-url><authid>37053868500</authid><authname>Jing Y.</authname><surname>Jing</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60082830</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55775935800</author-url><authid>55775935800</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xia</given-name><initials>X.</initials><afid>60022050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56502736800</author-url><authid>56502736800</authid><authname>Zheng S.</authname><surname>Zheng</surname><given-name>Shangyong</given-name><initials>S.</initials><afid>60028009</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56503639600</author-url><authid>56503639600</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xiaoli</given-name><initials>X.</initials><afid>60082830</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55158713300</author-url><authid>55158713300</authid><authname>Li S.</authname><surname>Li</surname><given-name>Songlin</given-name><initials>S.</initials><afid>60082830</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56502480300</author-url><authid>56502480300</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qianghua</given-name><initials>Q.</initials><afid>60082830</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56610877100</author-url><authid>56610877100</authid><authname>Hu Y.</authname><surname>Hu</surname><given-name>Youdong</given-name><initials>Y.</initials><afid>60022050</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55972629700</author-url><authid>55972629700</authid><authname>Shi Y.</authname><surname>Shi</surname><given-name>Yingying</given-name><initials>Y.</initials><afid>60082830</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56612090900</author-url><authid>56612090900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yunpeng</given-name><initials>Y.</initials><afid>60082830</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56122826300</author-url><authid>56122826300</authid><authname>Jiang D.</authname><surname>Jiang</surname><given-name>Dingyun</given-name><initials>D.</initials><afid>60082830</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:37006711800</author-url><authid>37006711800</authid><authname>Jiang C.</authname><surname>Jiang</surname><given-name>Changxing</given-name><initials>C.</initials><afid>60082830</afid><afid>60028009</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:37006711800</author-url><authid>37006711800</authid><authname>Jiang C.</authname><surname>Jiang</surname><given-name>Changxing</given-name><initials>C.</initials><afid>60082830</afid><afid>60028009</afid></author><authkeywords>Characterization and cardioprotective activity | Endothelium corneum gigeriae galli | Polysaccharide</authkeywords><intid>1535839754</intid><source-id>17544</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929323612"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929323612?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929323612&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929323612&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1752928X15000773"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929323612</prism:url><dc:identifier>SCOPUS_ID:84929323612</dc:identifier><eid>2-s2.0-84929323612</eid><dc:title>Pathological changes in anabolic androgenic steroid users</dc:title><dc:creator>Lusetti M.</dc:creator><prism:publicationName>Journal of Forensic and Legal Medicine</prism:publicationName><prism:issn>1752928X</prism:issn><prism:eIssn>18787487</prism:eIssn><prism:volume>33</prism:volume><prism:pageRange>101-104</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jflm.2015.04.014</prism:doi><pii>S1752928X15000773</pii><dc:description>Â© 2015 Elsevier Ltd and Faculty of Forensic and Legal Medicine All rights reserved. Several classes of recreational and prescription drugs have additional effects on the heart and vasculature, which may significantly contribute to morbidity and mortality in chronic users. The study presented herein focuses on pathological changes involving the heart possibly due to anabolic androgenic steroid use. The role these hormones may play in their occurrence of sudden cardiac death is also investigated. 98 medico-legal cases including 6 anabolic androgenic steroid users were retrospectively reviewed. Autopsies, histology, immunohistochemistry, biochemistry and toxicology were performed in all cases. Pathological changes consisted of various degrees of interstitial and perivascular fibrosis as well as fibroadipous metaplasia and perineural fibrosis within the myocardium of the left ventricle. Within the limits of the small number of investigated cases, our results appear to confirm former observations on this topic and suggest anabolic androgenic steroid's potential causative role in the pathogenesis of sudden cardiac deaths in chronic users.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004591</affiliation-url><afid>60004591</afid><affilname>Universita degli Studi di Modena e Reggio Emilia</affilname><name-variant>University of Modena</name-variant><affiliation-city>Modena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004591</affiliation-url><afid>60004591</afid><affilname>Universita degli Studi di Modena e Reggio Emilia</affilname><name-variant>University of Modena</name-variant><affiliation-city>Modena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023561</affiliation-url><afid>60023561</afid><affilname>Centre Hospitalier Universitaire Vaudois</affilname><name-variant>CHUV</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644891600</author-url><authid>56644891600</authid><authname>Lusetti M.</authname><surname>Lusetti</surname><given-name>Monia</given-name><initials>M.</initials><afid>60004591</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603579771</author-url><authid>6603579771</authid><authname>Licata M.</authname><surname>Licata</surname><given-name>Manuela</given-name><initials>M.</initials><afid>60004591</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602446607</author-url><authid>6602446607</authid><authname>Silingardi E.</authname><surname>Silingardi</surname><given-name>Enrico</given-name><initials>E.</initials><afid>60004591</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24179428400</author-url><authid>24179428400</authid><authname>Reggiani Bonetti L.</authname><surname>Reggiani Bonetti</surname><given-name>Luca</given-name><initials>L.</initials><afid>60004591</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12778839400</author-url><authid>12778839400</authid><authname>Palmiere C.</authname><surname>Palmiere</surname><given-name>Cristian</given-name><initials>C.</initials><afid>60023561</afid></author><authkeywords>Anabolic androgenic steroids | Autopsy | Histopathology | Sudden death | Toxicology</authkeywords><intid>1035939038</intid><source-id>5100154502</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928152361"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928152361?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928152361&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928152361&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001145"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928152361</prism:url><dc:identifier>SCOPUS_ID:84928152361</dc:identifier><eid>2-s2.0-84928152361</eid><dc:title>Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly</dc:title><dc:creator>Dupuis L.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>70-80</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.007</prism:doi><pii>S0022282815001145</pii><dc:description>Â© 2015 Elsevier Ltd. The ability of the heart to adapt to increased stress is dependent on the modification of its extracellular matrix (ECM) architecture that is established during postnatal development as cardiomyocytes differentiate, a process that is poorly understood. We hypothesized that the small leucine-rich proteoglycan (SLRP) lumican (LUM), which binds collagen and facilitates collagen assembly in other tissues, may play a critical role in establishing the postnatal murine myocardial ECM. Although previous studies suggest that LUM deficient mice (lum&lt;sup&gt;-/-&lt;/sup&gt;) exhibit skin anomalies consistent with Ehlers-Danlos syndrome, lum&lt;sup&gt;-/-&lt;/sup&gt; hearts have not been evaluated. These studies show that LUM was immunolocalized to non-cardiomyocytes of the cardiac ventricles and its expression increased throughout development. Lumican deficiency resulted in significant (50%) perinatal death and further examination of the lum&lt;sup&gt;-/-&lt;/sup&gt; neonatal hearts revealed an increase in myocardial tissue without a significant increase in cell proliferation. However cardiomyocytes from surviving postnatal day 0 (P0), 1. month (1. mo) and adult (4. mo) lum&lt;sup&gt;-/-&lt;/sup&gt; hearts were significantly larger than their wild type (WT) littermates. Immunohistochemistry revealed that the increased cardiomyocyte size in the lum&lt;sup&gt;-/-&lt;/sup&gt; hearts correlated with alteration of the cardiomyocyte pericellular ECM components collagenÎ±1(I) and the class I SLRP decorin (DCN). Western blot analysis demonstrated that the ratio of glycosaminoglycan (GAG) decorated DCN to core DCN was reduced in P0 and 1. mo lum&lt;sup&gt;-/-&lt;/sup&gt; hearts. There was also a reduction in the Î² and Î³ forms of collagenÎ±1(I) in lum&lt;sup&gt;-/-&lt;/sup&gt; hearts. While the total insoluble collagen content was significantly reduced, the fibril size was increased in lum&lt;sup&gt;-/-&lt;/sup&gt; hearts, indicating that LUM may play a role in collagen fiber stability and lateral fibril assembly. These results suggest that LUM controls cardiomyocyte growth by regulating the pericellular ECM and also indicates that LUM may coordinate multiple factors of collagen assembly in the murine heart. Further investigation into the role of LUM may yield novel therapeutic targets and/or biomarkers for patients with cardiovascular disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023222</affiliation-url><afid>60023222</afid><affilname>Medical University of South Carolina</affilname><name-variant>Medical University of South Carolina</name-variant><affiliation-city>Charleston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013340</affiliation-url><afid>60013340</afid><affilname>College of Charleston</affilname><name-variant>College of Charleston</name-variant><affiliation-city>Charleston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><name-variant>Johns Hopkins School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023222</affiliation-url><afid>60023222</afid><affilname>Medical University of South Carolina</affilname><name-variant>Medical University of South Carolina</name-variant><affiliation-city>Charleston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54388780900</author-url><authid>54388780900</authid><authname>Dupuis L.</authname><surname>Dupuis</surname><given-name>Loren E.</given-name><initials>L.E.</initials><afid>60023222</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56599636100</author-url><authid>56599636100</authid><authname>Berger M.</authname><surname>Berger</surname><given-name>Matthew G.</given-name><initials>M.G.</initials><afid>60013340</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56497484200</author-url><authid>56497484200</authid><authname>Feldman S.</authname><surname>Feldman</surname><given-name>Samuel</given-name><initials>S.</initials><afid>60013340</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56600452300</author-url><authid>56600452300</authid><authname>Doucette L.</authname><surname>Doucette</surname><given-name>Lorna</given-name><initials>L.</initials><afid>60013340</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23567634600</author-url><authid>23567634600</authid><authname>Fowlkes V.</authname><surname>Fowlkes</surname><given-name>Vennece</given-name><initials>V.</initials><afid>60023222</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004398632</author-url><authid>7004398632</authid><authname>Chakravarti S.</authname><surname>Chakravarti</surname><given-name>Shukti</given-name><initials>S.</initials><afid>60001117</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56600384200</author-url><authid>56600384200</authid><authname>Thibaudeau S.</authname><surname>Thibaudeau</surname><given-name>Sarah</given-name><initials>S.</initials><afid>60023222</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56618768700</author-url><authid>56618768700</authid><authname>Alcala N.</authname><surname>Alcala</surname><given-name>Nicolas E.</given-name><initials>N.E.</initials><afid>60013340</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7101793074</author-url><authid>7101793074</authid><authname>Bradshaw A.</authname><surname>Bradshaw</surname><given-name>Amy D.</given-name><initials>A.D.</initials><afid>60023222</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005220168</author-url><authid>7005220168</authid><authname>Kern C.</authname><surname>Kern</surname><given-name>Christine B.</given-name><initials>C.B.</initials><afid>60023222</afid></author><authkeywords>Cardiomyocyte | Collagen | Decorin | Lumican | Myocardium | SLRP</authkeywords><intid>1785733465</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928677420"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928677420?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928677420&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928677420&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0003347215001426"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928677420</prism:url><dc:identifier>SCOPUS_ID:84928677420</dc:identifier><eid>2-s2.0-84928677420</eid><dc:title>Effect of reward downshift on the behaviour and physiology of chickens</dc:title><dc:creator>Davies A.</dc:creator><prism:publicationName>Animal Behaviour</prism:publicationName><prism:issn>00033472</prism:issn><prism:volume>105</prism:volume><prism:pageRange>21-28</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.anbehav.2015.04.005</prism:doi><pii>S0003347215001426</pii><dc:description>Â© 2015 The Authors. When a reward is downgraded in quantity or quality from that which is expected, one of two possible outcomes can result. Acquisition responses may decline gradually, owing to a strong stimulus-response reinforcement history, and thus follow the Thorndikian law of effect. Alternatively, there may be an exaggerated reaction to a downgraded reward when it is initially altered, compared to the behaviour of individuals that have always been trained to receive the lower magnitude reward; this is known as successive negative contrast (SNC). While behavioural SNC effects have been commonly demonstrated in mammals, evidence that they occur in other taxa is more equivocal. Additionally, studies demonstrating immediate physiological reactions during reward downshifts are limited. We investigated the reaction of chickens, Gallus gallus domesticus, to a downshift in the quality of a food reward that they had been trained to expect in a runway apparatus. During a preshift phase, 16 chickens (control) were given food that was flavoured to make it less preferred, while the other 16 (contrast) were fed the same food but without flavouring. During trial 7, unflavoured food was substituted by flavoured food for contrast hens and all birds were fed the flavoured food during a postshift phase. In the contrast group, food consumption immediately decreased and heart rate increased when the reward was downshifted from unflavoured to flavoured food, but there was no evidence of SNC effects, which could stem from methodological or taxonomic differences from previous studies. The latency to reach the food appeared to follow the Thorndikian law of effect, gradually increasing following the downshift. We suggest that the disparity between the pattern shown by the latency results and other measures could relate to the time period in which measures were taken, as acquisition responses are more likely to follow the law of effect.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55915401200</author-url><authid>55915401200</authid><authname>Davies A.</authname><surname>Davies</surname><given-name>Anna C.</given-name><initials>A.C.</initials><afid>60020650</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35448885300</author-url><authid>35448885300</authid><authname>Nicol C.</authname><surname>Nicol</surname><given-name>Christine J.</given-name><initials>C.J.</initials><afid>60020650</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102332799</author-url><authid>7102332799</authid><authname>Radford A.</authname><surname>Radford</surname><given-name>Andrew N.</given-name><initials>A.N.</initials><afid>60020650</afid></author><authkeywords>Bird | Chicken | Contrast | Expectation | Heart rate | Latency to reach food | Reward | Temperature</authkeywords><intid>1785825001</intid><source-id>24580</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929320357"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929320357?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929320357&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929320357&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1567724915000471"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929320357</prism:url><dc:identifier>SCOPUS_ID:84929320357</dc:identifier><eid>2-s2.0-84929320357</eid><dc:title>Mitochondrial Lon protease controls ROS-dependent apoptosis in cardiomyocyte under hypoxia</dc:title><dc:creator>Kuo C.</dc:creator><prism:publicationName>Mitochondrion</prism:publicationName><prism:issn>15677249</prism:issn><prism:eIssn>18728278</prism:eIssn><prism:volume>23</prism:volume><prism:pageRange>7-16</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mito.2015.04.004</prism:doi><pii>S1567724915000471</pii><dc:description>Â© 2015 Elsevier B.V. Apoptosis of cardiomyocytes, under ischemic conditions, has been identified as an essential process in the progression of heart failure. Under hypoxic conditions, mitochondria can become a threat to the cell because of their capacity to generate reactive oxygen species (ROS). As ROS appear to have a critical role in heart failure, there has been considerable interest in identifying the candidate proteins involved and in developing strategies to reduce oxidative stress. Lon protease (Lon) is a multifunctional protein that mediates protein quality control and stress response in mitochondria. However, comprehensive and detailed studies, on the role of Lon in hypoxia-induced cardiomyocyte apoptosis, have yet to be carried out. In the present study, we demonstrated that hypoxia induced ROS-dependent cardiomyocyte apoptosis. Lon was upregulated in hypoxia-induced cardiomyocytes. Lon downregulation attenuated hypoxia-induced cardiomyocyte apoptosis through a reduction of ROS level. Moreover, overexpression of Lon stimulated ROS production and induced apoptosis under normoxic conditions in cardiomyocytes. Our results identify Lon as a novel regulator of cardiomyocyte fate and offers exciting new insights into the therapeutic potential of hypoxia-induced cardiomyocyte apoptosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020351</affiliation-url><afid>60020351</afid><affilname>Chang Gung University</affilname><name-variant>Chang Gung University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010037</affiliation-url><afid>60010037</afid><affilname>National Health Research Institutes Taiwan</affilname><name-variant>National Health Research Institutes</name-variant><affiliation-city>Zhunan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60090105</affiliation-url><afid>60090105</afid><affilname>Chang Gung University of Science and Technology</affilname><name-variant>Chang-Gung Institute of Technology</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031913</affiliation-url><afid>60031913</afid><affilname>Chang Gung Memorial Hospital</affilname><name-variant>Chang Gung Memorial Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56591129900</author-url><authid>56591129900</authid><authname>Kuo C.</authname><surname>Kuo</surname><given-name>Chan Yen</given-name><initials>C.Y.</initials><afid>60020351</afid><afid>60010037</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56591129900</author-url><authid>56591129900</authid><authname>Kuo C.</authname><surname>Kuo</surname><given-name>Chan Yen</given-name><initials>C.Y.</initials><afid>60020351</afid><afid>60010037</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591442100</author-url><authid>56591442100</authid><authname>Chiu Y.</authname><surname>Chiu</surname><given-name>Yi Chieh</given-name><initials>Y.C.</initials><afid>60010037</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55308512000</author-url><authid>55308512000</authid><authname>Lee A.</authname><surname>Lee</surname><given-name>Alan Yueh Luen</given-name><initials>A.Y.L.</initials><afid>60010037</afid><afid>60006988</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55308512000</author-url><authid>55308512000</authid><authname>Lee A.</authname><surname>Lee</surname><given-name>Alan Yueh Luen</given-name><initials>A.Y.L.</initials><afid>60010037</afid><afid>60006988</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202848949</author-url><authid>7202848949</authid><authname>Hwang T.</authname><surname>Hwang</surname><given-name>Tsong Long</given-name><initials>T.L.</initials><afid>60020351</afid><afid>60090105</afid><afid>60031913</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202848949</author-url><authid>7202848949</authid><authname>Hwang T.</authname><surname>Hwang</surname><given-name>Tsong Long</given-name><initials>T.L.</initials><afid>60020351</afid><afid>60090105</afid><afid>60031913</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202848949</author-url><authid>7202848949</authid><authname>Hwang T.</authname><surname>Hwang</surname><given-name>Tsong Long</given-name><initials>T.L.</initials><afid>60020351</afid><afid>60090105</afid><afid>60031913</afid></author><authkeywords>Apoptosis | Cardiomyocyte | Hypoxia | Mitochondrial lon protease | Reactive oxygen species</authkeywords><intid>535946048</intid><source-id>20296</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929660193"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929660193?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929660193&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929660193&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010308"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929660193</prism:url><dc:identifier>SCOPUS_ID:84929660193</dc:identifier><eid>2-s2.0-84929660193</eid><dc:title>Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk</dc:title><dc:creator>Gustafson B.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>27-35</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.812</prism:doi><pii>S0021915015010308</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. The subcutaneous adipose tissue (SAT) is the largest and least harmful adipose depot to store excess lipids. However, SAT has a limited ability to expand and recruit new cells. When the SAT adipose cells become expanded (hypertrophic obesity), this leads to a dysregulated and dysfunctional SAT and the accumulation of ectopic fat in many depots. Increased hepatic and visceral fat are well-known ectopic fat depots and reflect the inability of SAT to accommodate excess fat. Ectopic fat also leads to paracrine and endocrine effects and promotes the metabolic profile of the Metabolic Syndrome. In addition, ectopic fat accumulation in and around the heart and vessels are considered to be active and cross talk with the tissues, thereby enhancing several aspects associated with the risk of developing cardiovascular disease and atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027675</affiliation-url><afid>60027675</afid><affilname>Sahlgrenska Academy</affilname><name-variant>GÃ¶teborg University</name-variant><affiliation-city>Gothenburg</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006747704</author-url><authid>7006747704</authid><authname>Gustafson B.</authname><surname>Gustafson</surname><given-name>Birgit</given-name><initials>B.</initials><afid>60027675</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7103181011</author-url><authid>7103181011</authid><authname>Smith U.</authname><surname>Smith</surname><given-name>Ulf</given-name><initials>U.</initials><afid>60027675</afid></author><authkeywords>Adipose tissue | Cardiovascular disease | Ectopic fat | Insulin resistance | Obesity</authkeywords><intid>1785992271</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926386874"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926386874?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926386874&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926386874&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167488915000786"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926386874</prism:url><dc:identifier>SCOPUS_ID:84926386874</dc:identifier><eid>2-s2.0-84926386874</eid><dc:title>The non-glycosylated isoform of MIC26 is a constituent of the mammalian MICOS complex and promotes formation of crista junctions</dc:title><dc:creator>Koob S.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Cell Research</prism:publicationName><prism:issn>01674889</prism:issn><prism:eIssn>18792596</prism:eIssn><prism:volume>1853</prism:volume><prism:issueIdentifier>7</prism:issueIdentifier><prism:pageRange>1551-1563</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbamcr.2015.03.004</prism:doi><pii>S0167488915000786</pii><dc:description>Â© 2015 Elsevier B.V. Mitochondrial membrane architecture is important for organelle function. Alterations thereof are linked to a number of human disorders including diabetes and cardiomyopathy. The MICOS complex was recently reported to be a central player determining cristae structure and formation of crista junctions. Here we investigated the functional role of MIC26, a lipoprotein formerly termed APOO. Its levels are increased in diabetic heart tissue and in blood plasma of patients suffering from acute coronary syndrome. We demonstrate that human MIC26 exists in three distinct forms: (1) a glycosylated and secreted 55. kDa protein, (2) an ER/Golgi-resident form thereof, and (3) a non-glycosylated 22. kDa mitochondrial protein. The latter isoform spans the mitochondrial inner membrane and physically interacts with several MICOS complex subunits such as MIC60, MIC27, and MIC10. We further demonstrate that MIC26 and MIC27, a homologous protein formerly termed APOOL, regulate their levels in an antagonistic manner. Both proteins are positively correlated with the levels of MIC10 as well as tafazzin, an enzyme required for cardiolipin remodeling. Overexpression of MIC26 induced fragmentation of mitochondria, promoted ROS formation and resulted in impaired mitochondrial respiration. Downregulation of MIC26 induced a decrease in mitochondrial oxygen consumption, whereas mitochondrial network morphology and ROS levels remained unaffected. MIC26 depletion led to alterations in mitochondrial ultrastructure and caused a significant reduction in the number of crista junctions. In summary, we show that the human apolipoprotein MIC26 is a bona fide subunit of the MICOS complex and that MIC26 is linked to cardiolipin metabolism and promotes crista junction formation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007762</affiliation-url><afid>60007762</afid><affilname>Johann Wolfgang Goethe Universitat Frankfurt am Main</affilname><affiliation-city>Frankfurt am Main</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025310</affiliation-url><afid>60025310</afid><affilname>Heinrich Heine Universitat</affilname><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36984097500</author-url><authid>36984097500</authid><authname>Koob S.</authname><surname>Koob</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60007762</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26643841200</author-url><authid>26643841200</authid><authname>Barrera M.</authname><surname>Barrera</surname><given-name>Miguel</given-name><initials>M.</initials><afid>60007762</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55303700300</author-url><authid>55303700300</authid><authname>Anand R.</authname><surname>Anand</surname><given-name>Ruchika</given-name><initials>R.</initials><afid>60025310</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35557757100</author-url><authid>35557757100</authid><authname>Reichert A.</authname><surname>Reichert</surname><given-name>Andreas S.</given-name><initials>A.S.</initials><afid>60007762</afid><afid>60025310</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35557757100</author-url><authid>35557757100</authid><authname>Reichert A.</authname><surname>Reichert</surname><given-name>Andreas S.</given-name><initials>A.S.</initials><afid>60007762</afid><afid>60025310</afid></author><authkeywords>Apolipoproteins | Arteriosclerosis | Cardiolipin metabolism | Crista junctions | MICOS complex | Mitochondria</authkeywords><intid>1535429328</intid><source-id>18408</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929193071"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929193071?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929193071&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929193071&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008426"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929193071</prism:url><dc:identifier>SCOPUS_ID:84929193071</dc:identifier><eid>2-s2.0-84929193071</eid><dc:title>Vascular response to 1 week of sleep restriction in healthy subjects. A metabolic response?</dc:title><dc:creator>Sauvet F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>246-255</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.119</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Sleep loss may induce endothelial dysfunction, a key factor in cardiovascular risk. We examined the endothelial function during one week of sleep restriction and a recovery period (from 3-to-13 days) in healthy subjects, and its link to autonomic, inflammatory and/or endocrine responses. Methods: 12 men were followed at baseline (B1, 8-h sleep), after 2 (SR2) and 6 (SR6) days of SR (4-h sleep: 02:00-06:00) and after 1 (R1) and 12 (R12) recovery nights (8 h sleep). At 10:00, we assessed changes in: arm cutaneous vascular conductance (CVC) induced by local application of methacholine (MCh), cathodal current (CIV) and heat (44 Â°C), finger CVC and skin temperature (Tfi) during local cold exposure (5 Â°C, 20-min) and passive recovery (22 Â°C, 20-min). Blood samples were collected at 08:00. Results: Compared with baseline (B1), MCh and heat-induced maximal CVC values (CVC&lt;inf&gt;peak&lt;/inf&gt;) were decreased at SR6 and R1.No effect of SRwas observed for Tfi and CVC during immersionwhereas these valueswere lower during passive recovery on SR6 and R1. FromSR2 to R12, plasma concentrations of insulin, IGF-1 (total and free) and MCP-1 were significantly increased while those of testosterone and prolactin were decreased. Whole-blood blood mRNA concentrations of TNF-Ã¡ and IL-1Ã¢ were higher than B1. No changes in noradrenaline concentrations, heart rate and blood pressure were observed. Conclusions: These results demonstrate that SR reduces endothelial-dependent vasodilatation and local tolerance to cold. This endothelial dysfunction is independent of blood pressure and sympathetic activity but associated with inflammatory and metabolic pathway responses (ClinicalTrials-NCT01989741).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114686313</affiliation-url><afid>114686313</afid><affilname>Institut de Recherche BiomÃ©dicale des ArmÃ©es (IRBA)</affilname><name-variant>Institut de Recherche BiomÃ©dicale des ArmÃ©es (IRBA)</name-variant><affiliation-city/><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028950</affiliation-url><afid>60028950</afid><affilname>Universite Paris Descartes</affilname><name-variant>UniversitÃ© Paris Descartes</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102126</affiliation-url><afid>60102126</afid><affilname>Universite de Lyon</affilname><name-variant>UniversitÃ© de Lyon</name-variant><affiliation-city>Lyon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021567</affiliation-url><afid>60021567</afid><affilname>AP-HP Assistance Publique - Hopitaux de Paris</affilname><name-variant>Assistance Publique-HÃ´pitaux de Paris</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">23</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:33667829100</author-url><authid>33667829100</authid><authname>Sauvet F.</authname><surname>Sauvet</surname><given-name>Fabien</given-name><initials>F.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:33667829100</author-url><authid>33667829100</authid><authname>Sauvet F.</authname><surname>Sauvet</surname><given-name>Fabien</given-name><initials>F.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603656630</author-url><authid>6603656630</authid><authname>Drogou C.</authname><surname>Drogou</surname><given-name>Catherine</given-name><initials>C.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603656630</author-url><authid>6603656630</authid><authname>Drogou C.</authname><surname>Drogou</surname><given-name>Catherine</given-name><initials>C.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23768015500</author-url><authid>23768015500</authid><authname>Bougard C.</authname><surname>Bougard</surname><given-name>ClÃ©ment</given-name><initials>C.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23768015500</author-url><authid>23768015500</authid><authname>Bougard C.</authname><surname>Bougard</surname><given-name>ClÃ©ment</given-name><initials>C.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55330448800</author-url><authid>55330448800</authid><authname>Arnal P.</authname><surname>Arnal</surname><given-name>Pierrick J.</given-name><initials>P.J.</initials><afid>114686313</afid><afid>60028950</afid><afid>60102126</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55330448800</author-url><authid>55330448800</authid><authname>Arnal P.</authname><surname>Arnal</surname><given-name>Pierrick J.</given-name><initials>P.J.</initials><afid>114686313</afid><afid>60028950</afid><afid>60102126</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55330448800</author-url><authid>55330448800</authid><authname>Arnal P.</authname><surname>Arnal</surname><given-name>Pierrick J.</given-name><initials>P.J.</initials><afid>114686313</afid><afid>60028950</afid><afid>60102126</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26430832700</author-url><authid>26430832700</authid><authname>Dispersyn G.</authname><surname>Dispersyn</surname><given-name>Garance</given-name><initials>G.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26430832700</author-url><authid>26430832700</authid><authname>Dispersyn G.</authname><surname>Dispersyn</surname><given-name>Garance</given-name><initials>G.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507037228</author-url><authid>6507037228</authid><authname>Bourrilhon C.</authname><surname>Bourrilhon</surname><given-name>Cyprien</given-name><initials>C.</initials><afid>114686313</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8915796000</author-url><authid>8915796000</authid><authname>Rabat A.</authname><surname>Rabat</surname><given-name>Arnaud</given-name><initials>A.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8915796000</author-url><authid>8915796000</authid><authname>Rabat A.</authname><surname>Rabat</surname><given-name>Arnaud</given-name><initials>A.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603466229</author-url><authid>6603466229</authid><authname>Van Beers P.</authname><surname>Van Beers</surname><given-name>Pascal</given-name><initials>P.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603466229</author-url><authid>6603466229</authid><authname>Van Beers P.</authname><surname>Van Beers</surname><given-name>Pascal</given-name><initials>P.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602671564</author-url><authid>6602671564</authid><authname>Gomez-Merino D.</authname><surname>Gomez-Merino</surname><given-name>Danielle</given-name><initials>D.</initials><afid>60028950</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7801345138</author-url><authid>7801345138</authid><authname>Faraut B.</authname><surname>Faraut</surname><given-name>Brice</given-name><initials>B.</initials><afid>60028950</afid><afid>60021567</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7801345138</author-url><authid>7801345138</authid><authname>Faraut B.</authname><surname>Faraut</surname><given-name>Brice</given-name><initials>B.</initials><afid>60028950</afid><afid>60021567</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004781855</author-url><authid>7004781855</authid><authname>Leger D.</authname><surname>Leger</surname><given-name>Damien</given-name><initials>D.</initials><afid>60028950</afid><afid>60021567</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004781855</author-url><authid>7004781855</authid><authname>Leger D.</authname><surname>Leger</surname><given-name>Damien</given-name><initials>D.</initials><afid>60028950</afid><afid>60021567</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55928057700</author-url><authid>55928057700</authid><authname>Chennaoui M.</authname><surname>Chennaoui</surname><given-name>Mounir</given-name><initials>M.</initials><afid>114686313</afid><afid>60028950</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55928057700</author-url><authid>55928057700</authid><authname>Chennaoui M.</authname><surname>Chennaoui</surname><given-name>Mounir</given-name><initials>M.</initials><afid>114686313</afid><afid>60028950</afid></author><authkeywords>Endothelial function | Inflammation | Iontophoresis | Laser doppler | Sleep | Sleep restriction</authkeywords><intid>1035912676</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928802497"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928802497?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928802497&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928802497&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001094"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928802497</prism:url><dc:identifier>SCOPUS_ID:84928802497</dc:identifier><eid>2-s2.0-84928802497</eid><dc:title>A rapid in vivo zebrafish model to elucidate oxidative stress-mediated PCB126-induced apoptosis and developmental toxicity</dc:title><dc:creator>Liu H.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>91-102</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.03.002</prism:doi><pii>S0891584915001094</pii><dc:description>Â© 2015 Elsevier Inc. All rights resereved. Abstract Dioxin-like 3,3â²,4,4â²,5-pentachlorobiphenyl (PCB126) is one of the most potent and widespread environmental pollutants. Although PCB126-induced toxicity is related to the aryl hydrocarbon receptor pathway, there is still no study that has constructed an in vivo visual model to clarify the role of the Nrf2/ARE signaling pathway in the oxidative stress mechanism of PCB126-induced toxicity. In the present study, an in vivo zebrafish model of nrf2a fused to enhanced green fluorescent protein (nrf2a-eGFP) was constructed. The zebrafish embryos microinjected with nrf2a-eGFP (72 h postfertilization) were exposed to various concentrations of PCB126 (0, 25, 50, 100, 200 Î¼g/L) or 30 mM N-acetylcysteine (NAC)+200 Î¼g/L PCB126. After 72 h exposure, PCB126 significantly increased the malformation rates and induced eGFP expression in a dose-dependent manner in several zebrafish tissue types. The distribution of eGFP fluorescence coincided with developmental deformity sites. NAC pretreatment effectively counteracted PCB126-induced developmental toxicity including heart rate, pericardial edema, and body length. The highest PCB126 dose, 200 Î¼g/L, produced marked apoptosis in the eye, gill, and trunk detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay. At 48 and 72 h exposure, 200 Î¼g/L PCB126 affected glutathione metabolism as evidenced by decreased glutathione and increased glutathione disulfide concentrations, indicative of oxidative stress. These effects were also counteracted by NAC pretreatment. Furthermore, the Nrf2-regulated genes gclc, gpx, gstp1, and hmox1 were significantly induced at 24, 48, and 72 h at the highest PCB126 exposures but not in the NAC-pretreated group. In addition, a significant increase in ROS generation was detected in zebrafish larvae at 72 h PCB126 exposure, which might offer a link for future mechanistic studies. Collectively, these data suggest that PCB126-induced developmental toxicity and apoptosis in the nrf2a-eGFP-injected zebrafish model are due to oxidative stress mediated by disruption to glutathione metabolism and changes in Nrf2-regulated gene expression.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032955</affiliation-url><afid>60032955</afid><affilname>Huazhong Agricultural University</affilname><name-variant>Huazhong Agricultural University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006625</affiliation-url><afid>60006625</afid><affilname>Lincoln University, New Zealand</affilname><name-variant>Lincoln University</name-variant><affiliation-city>Christchurch</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56420664800</author-url><authid>56420664800</authid><authname>Liu H.</authname><surname>Liu</surname><given-name>Han</given-name><initials>H.</initials><afid>60032955</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602517006</author-url><authid>6602517006</authid><authname>Gooneratne R.</authname><surname>Gooneratne</surname><given-name>Ravi</given-name><initials>R.</initials><afid>60006625</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55531549700</author-url><authid>55531549700</authid><authname>Huang X.</authname><surname>Huang</surname><given-name>Xin</given-name><initials>X.</initials><afid>60032955</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56612826700</author-url><authid>56612826700</authid><authname>Lai R.</authname><surname>Lai</surname><given-name>Ruifang</given-name><initials>R.</initials><afid>60032955</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56612583000</author-url><authid>56612583000</authid><authname>Wei J.</authname><surname>Wei</surname><given-name>Jin</given-name><initials>J.</initials><afid>60032955</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35086878600</author-url><authid>35086878600</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Weimin</given-name><initials>W.</initials><afid>60032955</afid></author><authkeywords>Apoptosis | Developmental toxicity | Free radicals | Glutathione metabolism | Nrf2a | PCB126 | Zebrafish</authkeywords><intid>35850554</intid><article-number>12337</article-number><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929458759"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929458759?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929458759&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929458759&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166445X1500137X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929458759</prism:url><dc:identifier>SCOPUS_ID:84929458759</dc:identifier><eid>2-s2.0-84929458759</eid><dc:title>Toxicity of naphthenic acid fraction components extracted from fresh and aged oil sands process-affected waters, and commercial naphthenic acid mixtures, to fathead minnow (Pimephales promelas) embryos</dc:title><dc:creator>Marentette J.</dc:creator><prism:publicationName>Aquatic Toxicology</prism:publicationName><prism:issn>0166445X</prism:issn><prism:eIssn>18791514</prism:eIssn><prism:volume>164</prism:volume><prism:pageRange>108-117</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.aquatox.2015.04.024</prism:doi><pii>S0166445X1500137X</pii><dc:description>Â© 2015 Published by Elsevier B.V. Naphthenic acids (NAs) are constituents of oil sands process-affected water (OSPW). These compounds can be both toxic and persistent and thus are a primary concern for the ultimate remediation of tailings ponds in northern Alberta's oil sands regions. Recent research has focused on the toxicity of NAs to the highly vulnerable early life-stages of fish. Here we examined fathead minnow embryonic survival, growth and deformities after exposure to extracted NA fraction components (NAFCs), from fresh and aged oil sands process-affected water (OSPW), as well as commercially available NA mixtures. Commercial NA mixtures were dominated by acyclic O&lt;inf&gt;2&lt;/inf&gt; species, while NAFCs from OSPW were dominated by bi- and tricyclic O&lt;inf&gt;2&lt;/inf&gt; species. Fathead minnow embryos less than 24h old were reared in tissue culture plates terminating at hatch. Both NAFC and commercial NA mixtures reduced hatch success, although NAFCs from OSPW were less toxic (EC50=5-12mg/L, nominal concentrations) than commercial NAs (2mg/L, nominal concentrations). The toxicities of NAFCs from aged and fresh OSPW were similar. Embryonic heart rates at 2 days post-fertilization (dpf) declined with increasing NAFC exposure, paralleling patterns of hatch success and rates of cardiovascular abnormalities (e.g., pericardial edemas) at hatch. Finfold deformities increased in exposures to commercial NA mixtures, not NAFCs. Thus, commercial NA mixtures are not appropriate surrogates for NAFC toxicity. Further work clarifying the mechanisms of action of NAFCs in OSPW, as well as comparisons with additional aged sources of OSPW, is merited.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000673</affiliation-url><afid>60000673</afid><affilname>Environment Canada</affilname><name-variant>Environment Canada</name-variant><affiliation-city>Gatineau</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000673</affiliation-url><afid>60000673</afid><affilname>Environment Canada</affilname><name-variant>Environment Canada</name-variant><affiliation-city>Gatineau</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000673</affiliation-url><afid>60000673</afid><affilname>Environment Canada</affilname><name-variant>Environment Canada</name-variant><affiliation-city>Gatineau</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23667803500</author-url><authid>23667803500</authid><authname>Marentette J.</authname><surname>Marentette</surname><given-name>Julie R.</given-name><initials>J.R.</initials><afid>60000673</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15129425700</author-url><authid>15129425700</authid><authname>Frank R.</authname><surname>Frank</surname><given-name>Richard A.</given-name><initials>R.A.</initials><afid>60000673</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647732900</author-url><authid>56647732900</authid><authname>Bartlett A.</authname><surname>Bartlett</surname><given-name>Adrienne J.</given-name><initials>A.J.</initials><afid>60000673</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8083341300</author-url><authid>8083341300</authid><authname>Gillis P.</authname><surname>Gillis</surname><given-name>Patricia L.</given-name><initials>P.L.</initials><afid>60000673</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006937818</author-url><authid>7006937818</authid><authname>Hewitt L.</authname><surname>Hewitt</surname><given-name>L. Mark</given-name><initials>L.M.</initials><afid>60000673</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6601985564</author-url><authid>6601985564</authid><authname>Peru K.</authname><surname>Peru</surname><given-name>Kerry M.</given-name><initials>K.M.</initials><afid>60000673</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005733957</author-url><authid>7005733957</authid><authname>Headley J.</authname><surname>Headley</surname><given-name>John V.</given-name><initials>J.V.</initials><afid>60000673</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56647988600</author-url><authid>56647988600</authid><authname>Brunswick P.</authname><surname>Brunswick</surname><given-name>Pamela</given-name><initials>P.</initials><afid>60000673</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56647699500</author-url><authid>56647699500</authid><authname>Shang D.</authname><surname>Shang</surname><given-name>Dayue</given-name><initials>D.</initials><afid>60000673</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005783210</author-url><authid>7005783210</authid><authname>Parrott J.</authname><surname>Parrott</surname><given-name>Joanne L.</given-name><initials>J.L.</initials><afid>60000673</afid></author><authkeywords>Acid-extractable organics (AEO) | Deformities | Fish | Hatch success | Larval survival | NAFC | Naphthenic acid | Oil sands | OSPW | Time to hatch</authkeywords><intid>535965720</intid><source-id>24602</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927743187"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927743187?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927743187&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927743187&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715001755"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927743187</prism:url><dc:identifier>SCOPUS_ID:84927743187</dc:identifier><eid>2-s2.0-84927743187</eid><dc:title>Depressive symptoms and changes in physiological and social factors 1 week to 4 months postpartum in Japan</dc:title><dc:creator>Shimizu A.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>179</prism:volume><prism:pageRange>175-182</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.03.036</prism:doi><pii>S0165032715001755</pii><dc:description>Background Postpartum depression (PPD) is a common condition and may be exacerbated unless treated. There is, however, a lack of longitudinal studies about the relationship between PPD and changes in physiological status and social role postpartum. Methods We enrolled longitudinally 65 Japanese mothers (36 primiparas) and measured their psychological responses at 1 week, 1 month, and 4 months postpartum. The physiological indicators were three urine catecholamine fraction levels, cortisol levels, and heart-rate variability. We used the Edinburgh Postnatal Depression Scale (EPDS) and 28-item General Health Questionnaire (GHQ) for psychological evaluation. Results Eleven participants had an EPDS score &amp;yen.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011418</affiliation-url><afid>60011418</afid><affilname>Kobe University</affilname><name-variant>Kobe University</name-variant><affiliation-city>Kobe</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100310364</affiliation-url><afid>100310364</afid><affilname>Japanese Red Cross Hiroshima College of Nursing</affilname><name-variant>J. Red Cross Hiroshima Coll. Nursing</name-variant><affiliation-city>Hiroshima</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007144</affiliation-url><afid>60007144</afid><affilname>University of Shiga Prefecture</affilname><name-variant>The University of Shiga Prefecture</name-variant><affiliation-city>Hikone</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56594257800</author-url><authid>56594257800</authid><authname>Shimizu A.</authname><surname>Shimizu</surname><given-name>Aya</given-name><initials>A.</initials><afid>60011418</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56594813600</author-url><authid>56594813600</authid><authname>Nishiumi H.</authname><surname>Nishiumi</surname><given-name>Hitomi</given-name><initials>H.</initials><afid>60011418</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56594348400</author-url><authid>56594348400</authid><authname>Okumura Y.</authname><surname>Okumura</surname><given-name>Yukari</given-name><initials>Y.</initials><afid>100310364</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56593925000</author-url><authid>56593925000</authid><authname>Watanabe K.</authname><surname>Watanabe</surname><given-name>Kaori</given-name><initials>K.</initials><afid>60007144</afid></author><authkeywords>Cortisol | Depression | Longitudinal study | Parity | Postpartum | Stress</authkeywords><intid>1535665823</intid><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929468972"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929468972?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929468972&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929468972&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010482515001365"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929468972</prism:url><dc:identifier>SCOPUS_ID:84929468972</dc:identifier><eid>2-s2.0-84929468972</eid><dc:title>Thoracic cavity definition for 3D PET/CT analysis and visualization</dc:title><dc:creator>Cheirsilp R.</dc:creator><prism:publicationName>Computers in Biology and Medicine</prism:publicationName><prism:issn>00104825</prism:issn><prism:eIssn>18790534</prism:eIssn><prism:volume>62</prism:volume><prism:pageRange>222-238</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiomed.2015.04.018</prism:doi><pii>S0010482515001365</pii><dc:description>Â© 2015 Elsevier Ltd. X-ray computed tomography (CT) and positron emission tomography (PET) serve as the standard imaging modalities for lung-cancer management. CT gives anatomical details on diagnostic regions of interest (ROIs), while PET gives highly specific functional information. During the lung-cancer management process, a patient receives a co-registered whole-body PET/CT scan pair and a dedicated high-resolution chest CT scan. With these data, multimodal PET/CT ROI information can be gleaned to facilitate disease management. Effective image segmentation of the thoracic cavity, however, is needed to focus attention on the central chest. We present an automatic method for thoracic cavity segmentation from 3D CT scans. We then demonstrate how the method facilitates 3D ROI localization and visualization in patient multimodal imaging studies. Our segmentation method draws upon digital topological and morphological operations, active-contour analysis, and key organ landmarks. Using a large patient database, the method showed high agreement to ground-truth regions, with a mean coverage=99.2% and leakage=0.52%. Furthermore, it enabled extremely fast computation. For PET/CT lesion analysis, the segmentation method reduced ROI search space by 97.7% for a whole-body scan, or nearly 3 times greater than that achieved by a lung mask. Despite this reduction, we achieved 100% true-positive ROI detection, while also reducing the false-positive (FP) detection rate by &gt;5 times over that achieved with a lung mask. Finally, the method greatly improved PET/CT visualization by eliminating false PET-avid obscurations arising from the heart, bones, and liver. In particular, PET MIP views and fused PET/CT renderings depicted unprecedented clarity of the lesions and neighboring anatomical structures truly relevant to lung-cancer assessment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001439</affiliation-url><afid>60001439</afid><affilname>Pennsylvania State University</affilname><name-variant>Pennsylvania State University</name-variant><affiliation-city>State College</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013671</affiliation-url><afid>60013671</afid><affilname>Milton S. Hershey Medical Center</affilname><name-variant>Penn State Milton S. Hershey Medical Center</name-variant><affiliation-city>Hershey</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027671</affiliation-url><afid>60027671</afid><affilname>Penn State College of Medicine</affilname><name-variant>Pennsylvania State University College of Medicine</name-variant><affiliation-city>Hershey</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55752678700</author-url><authid>55752678700</authid><authname>Cheirsilp R.</authname><surname>Cheirsilp</surname><given-name>Ronnarit</given-name><initials>R.</initials><afid>60001439</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006714543</author-url><authid>7006714543</authid><authname>Bascom R.</authname><surname>Bascom</surname><given-name>Rebecca</given-name><initials>R.</initials><afid>60013671</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56375719600</author-url><authid>56375719600</authid><authname>Allen T.</authname><surname>Allen</surname><given-name>Thomas W.</given-name><initials>T.W.</initials><afid>60027671</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004840013</author-url><authid>7004840013</authid><authname>Higgins W.</authname><surname>Higgins</surname><given-name>William E.</given-name><initials>W.E.</initials><afid>60001439</afid></author><authkeywords>Chest | CT imaging | Image segmentation | Lung cancer | Multimodal imaging | PET/CT | Pulmonary imaging | Thoracic region segmentation | Visualization</authkeywords><intid>1035958873</intid><source-id>17957</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927923518"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927923518?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927923518&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927923518&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0166445X15001204"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927923518</prism:url><dc:identifier>SCOPUS_ID:84927923518</dc:identifier><eid>2-s2.0-84927923518</eid><dc:title>Microcystin-RR exposure results in growth impairment by disrupting thyroid endocrine in zebrafish larvae</dc:title><dc:creator>Xie L.</dc:creator><prism:publicationName>Aquatic Toxicology</prism:publicationName><prism:issn>0166445X</prism:issn><prism:eIssn>18791514</prism:eIssn><prism:volume>164</prism:volume><prism:pageRange>16-22</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.aquatox.2015.04.014</prism:doi><pii>S0166445X15001204</pii><dc:description>Â© 2015 Elsevier B.V.. Recent studies have shown that cyanobacteria-derived microcystins (MCs) have the potential to disrupt endocrine systems. However, the effects of microcystin-RR (MC-RR) and their underlying mechanisms are poorly resolved in fish. In this study, MC-RR exposure through submersion caused serious developmental toxicity, such as growth delay and depressed heart rates in zebrafish larvae. We also detected decreased levels of thyroid hormones (THs), suggesting that MC-RR-triggered thyroid endocrine disruption might contribute to the growth impairment observed in developing zebrafish. To further our understanding of mechanisms of MC-RR-induced endocrine toxicity, quantitative real-time PCR (QPCR) analysis was performed on hypothalamic-pituitary-thyroid (HPT) axis related genes, i.e., corticotropin-releasing factor (CRF), thyroid-stimulating hormone (TSH), sodium/iodide symporter (NIS), thyroglobulin (TG), thyroid receptors (TRÎ± and TRÎ²) and iodothyronine deiodinases (Dio1 and Dio2), of developing zebrafish embryos exposed to 0, 0.3, 1.0 or 3.0mgL&lt;sup&gt;-1&lt;/sup&gt; MC-RR until 96h post-fertilization. Our results showed that transcription pattern of HPT axis related genes were greatly changed by MC-RR exposure, except TG gene. Furthermore, western blot was used to validate the results of gene expression. The results showed protein synthesis of TG was not affected, while that of NIS was significantly up-regulated, which are in accordance with gene expression. The overall results indicated that exposure to MC-RR can induce developmental toxicity, which might be associated with thyroid endocrine disruption in developing zebrafish larvae.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027277</affiliation-url><afid>60027277</afid><affilname>Nanjing Institute of Geography and Limnology Chinese Academy of Sciences</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107025275</affiliation-url><afid>107025275</afid><affilname>Hubei Academy of Agricultural Sciences</affilname><name-variant>Hubei Agriculture Academy of Science</name-variant><affiliation-city>Enshi</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032955</affiliation-url><afid>60032955</afid><affilname>Huazhong Agricultural University</affilname><name-variant>Huazhong Agricultural University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114983215</affiliation-url><afid>114983215</afid><affilname>Freshwater Aquaculture Collaborative Innovation Center of Hubei Province</affilname><name-variant>Freshwater Aquaculture Collaborative Innovative Center of Hubei Province</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025659</affiliation-url><afid>60025659</afid><affilname>Grand Valley State University</affilname><name-variant>Grand Valley State University</name-variant><affiliation-city>Allendale</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56595953700</author-url><authid>56595953700</authid><authname>Xie L.</authname><surname>Xie</surname><given-name>Liqiang</given-name><initials>L.</initials><afid>60027277</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56595977100</author-url><authid>56595977100</authid><authname>Yan W.</authname><surname>Yan</surname><given-name>Wei</given-name><initials>W.</initials><afid>107025275</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56199159700</author-url><authid>56199159700</authid><authname>Li J.</authname><surname>Li</surname><given-name>Jing</given-name><initials>J.</initials><afid>60032955</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56528627200</author-url><authid>56528627200</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Liqin</given-name><initials>L.</initials><afid>60032955</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56596873000</author-url><authid>56596873000</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jianghua</given-name><initials>J.</initials><afid>60032955</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55521336400</author-url><authid>55521336400</authid><authname>Li G.</authname><surname>Li</surname><given-name>Guangyu</given-name><initials>G.</initials><afid>60032955</afid><afid>114983215</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55521336400</author-url><authid>55521336400</authid><authname>Li G.</authname><surname>Li</surname><given-name>Guangyu</given-name><initials>G.</initials><afid>60032955</afid><afid>114983215</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56562254300</author-url><authid>56562254300</authid><authname>Chen N.</authname><surname>Chen</surname><given-name>Nan</given-name><initials>N.</initials><afid>60032955</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005277653</author-url><authid>7005277653</authid><authname>Steinman A.</authname><surname>Steinman</surname><given-name>Alan D.</given-name><initials>A.D.</initials><afid>60025659</afid></author><authkeywords>Developing zebrafish | Growth impairment | Hypothalamic-pituitary-thyroid axis | MC-RR</authkeywords><intid>535701704</intid><source-id>24602</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929159766"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929159766?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929159766&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929159766&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008943"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929159766</prism:url><dc:identifier>SCOPUS_ID:84929159766</dc:identifier><eid>2-s2.0-84929159766</eid><dc:title>Ectopic adiposopathy and association with cardiovascular disease risk factors: The UberlÃ¢ndia Heart Study</dc:title><dc:creator>Roever L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>140-142</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.170</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015104</affiliation-url><afid>60015104</afid><affilname>Universidade Federal de Uberlandia</affilname><name-variant>Federal University of UberlÃ¢ndia</name-variant><affiliation-city>Uberlandia</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013877</affiliation-url><afid>60013877</afid><affilname>Hospital das Clinicas da FMUSP</affilname><name-variant>Universidade de SÃ£o Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100392090</affiliation-url><afid>100392090</afid><affilname>Faculty of Medicine ABC</affilname><name-variant>ABC Faculty of Medicine</name-variant><affiliation-city>Santo Andre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641632800</author-url><authid>56641632800</authid><authname>Roever L.</authname><surname>Roever</surname><given-name>L.</given-name><initials>L.</initials><afid>60015104</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602606517</author-url><authid>6602606517</authid><authname>Resende E.</authname><surname>Resende</surname><given-name>E. S.</given-name><initials>E.S.</initials><afid>60015104</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640929500</author-url><authid>56640929500</authid><authname>Diniz A.</authname><surname>Diniz</surname><given-name>A. L D</given-name><initials>A.L.D.</initials><afid>60015104</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55924553100</author-url><authid>55924553100</authid><authname>Penha-Silva N.</authname><surname>Penha-Silva</surname><given-name>N.</given-name><initials>N.</initials><afid>60015104</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641043000</author-url><authid>56641043000</authid><authname>Veloso F.</authname><surname>Veloso</surname><given-name>F. C.</given-name><initials>F.C.</initials><afid>60015104</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:16027659600</author-url><authid>16027659600</authid><authname>Casella-Filho A.</authname><surname>Casella-Filho</surname><given-name>A.</given-name><initials>A.</initials><afid>60013877</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:12791613200</author-url><authid>12791613200</authid><authname>Dourado P.</authname><surname>Dourado</surname><given-name>P. M M</given-name><initials>P.M.M.</initials><afid>60013877</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003516265</author-url><authid>7003516265</authid><authname>Chagas A.</authname><surname>Chagas</surname><given-name>A. C P</given-name><initials>A.C.P.</initials><afid>60013877</afid><afid>100392090</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003516265</author-url><authid>7003516265</authid><authname>Chagas A.</authname><surname>Chagas</surname><given-name>A. C P</given-name><initials>A.C.P.</initials><afid>60013877</afid><afid>100392090</afid></author><intid>1535917497</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929163036"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929163036?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929163036&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929163036&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008074"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929163036</prism:url><dc:identifier>SCOPUS_ID:84929163036</dc:identifier><eid>2-s2.0-84929163036</eid><dc:title>Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes</dc:title><dc:creator>Tan N.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>34-39</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.085</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Purpose: To examine the prognostic significance of low QRS voltage in a large contemporary cohort of patients with a broad spectrum of acute coronary syndromes (ACS). Methods: 12409 patients with STEMI or NSTE-ACS from the Global Registry of Acute Coronary Events (GRACE) and Canadian ACS I registries were stratified based on the presence of low QRS voltage (b0.5 mV in all limb leads and b1.0 mV in all precordial leads) on the admission ECG. We performed multivariable logistic regression to assess the independent association between lowvoltage and in-hospital and 6-monthmortality, and tested for its interaction with ST-segment deviation for these outcomes. Results: Patients with low voltage (3.2%) had higher GRACE risk scores, rates of prior myocardial infarction, and pathological Q waves, with less prevalent ST-segment deviation and ST-segment depression. They hadworse left ventricular function and higher unadjusted rates of in-hospital and 6-month mortality. After adjustment for established prognosticators in the GRACE risk models in multivariable analysis, low voltage was independently associated with higher in-hospital mortality (adjusted OR 1.77, 95% CI 1.13-2.78, P = 0.013) and mortality/reinfarction (adjusted OR 1.42, 95% CI 1.05-1.93, P = 0.023), but not 6-month mortality (adjusted OR 1.25, 95% CI 0.85-1.84, P = 0.27). There was no significant interaction between low voltage and ST-segment deviation for any endpoint (interaction P N 0.10 for all endpoints). Conclusions: Low QRS voltage was associated with previous myocardial infarction and adverse hemodynamic variables at presentation. After adjusting for other prognosticators, low voltage independently predicted higher in-hospital mortality. This increased risk was not modulated by concomitant ST-segment deviation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017018</affiliation-url><afid>60017018</afid><affilname>Saint Michael's Hospital University of Toronto</affilname><name-variant>St. Michael's Hospital</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100329985</affiliation-url><afid>100329985</afid><affilname>Canadian Heart Research Centre</affilname><name-variant>Canadian Heart Research Centre</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027272</affiliation-url><afid>60027272</afid><affilname>University of Edinburgh</affilname><name-variant>University of Edinburgh</name-variant><affiliation-city>Edinburgh</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000986</affiliation-url><afid>60000986</afid><affilname>University of Massachusetts Medical School</affilname><name-variant>Univ. of Massachusetts Med. School</name-variant><affiliation-city>Worcester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029482</affiliation-url><afid>60029482</afid><affilname>Concord Repatriation General Hospital</affilname><name-variant>Concord Hospital</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005711</affiliation-url><afid>60005711</afid><affilname>Universite Paris 7- Denis Diderot</affilname><name-variant>UniversitÃ© Paris 7</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56008768200</author-url><authid>56008768200</authid><authname>Tan N.</authname><surname>Tan</surname><given-name>Nigel S.</given-name><initials>N.S.</initials><afid>60017018</afid><afid>60016849</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56008768200</author-url><authid>56008768200</authid><authname>Tan N.</authname><surname>Tan</surname><given-name>Nigel S.</given-name><initials>N.S.</initials><afid>60017018</afid><afid>60016849</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402115222</author-url><authid>7402115222</authid><authname>Goodman S.</authname><surname>Goodman</surname><given-name>Shaun G.</given-name><initials>S.G.</initials><afid>60017018</afid><afid>60016849</afid><afid>100329985</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402115222</author-url><authid>7402115222</authid><authname>Goodman S.</authname><surname>Goodman</surname><given-name>Shaun G.</given-name><initials>S.G.</initials><afid>60017018</afid><afid>60016849</afid><afid>100329985</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402115222</author-url><authid>7402115222</authid><authname>Goodman S.</authname><surname>Goodman</surname><given-name>Shaun G.</given-name><initials>S.G.</initials><afid>60017018</afid><afid>60016849</afid><afid>100329985</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56446264000</author-url><authid>56446264000</authid><authname>Yan R.</authname><surname>Yan</surname><given-name>Raymond T.</given-name><initials>R.T.</initials><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56459427900</author-url><authid>56459427900</authid><authname>Tan M.</authname><surname>Tan</surname><given-name>Mary K.</given-name><initials>M.K.</initials><afid>100329985</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56479914500</author-url><authid>56479914500</authid><authname>Fox K.</authname><surname>Fox</surname><given-name>Keith A A</given-name><initials>K.A.A.</initials><afid>60027272</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7202240980</author-url><authid>7202240980</authid><authname>Gore J.</authname><surname>Gore</surname><given-name>Joel M.</given-name><initials>J.M.</initials><afid>60000986</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004107910</author-url><authid>7004107910</authid><authname>Brieger D.</authname><surname>Brieger</surname><given-name>David</given-name><initials>D.</initials><afid>60029482</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35373935400</author-url><authid>35373935400</authid><authname>Steg P.</authname><surname>Steg</surname><given-name>Ph Gabriel</given-name><initials>P.G.</initials><afid>60005711</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102782974</author-url><authid>7102782974</authid><authname>Langer A.</authname><surname>Langer</surname><given-name>Anatoly</given-name><initials>A.</initials><afid>60016849</afid><afid>100329985</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7102782974</author-url><authid>7102782974</authid><authname>Langer A.</authname><surname>Langer</surname><given-name>Anatoly</given-name><initials>A.</initials><afid>60016849</afid><afid>100329985</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7103203041</author-url><authid>7103203041</authid><authname>Yan A.</authname><surname>Yan</surname><given-name>Andrew T.</given-name><initials>A.T.</initials><afid>60017018</afid><afid>60016849</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7103203041</author-url><authid>7103203041</authid><authname>Yan A.</authname><surname>Yan</surname><given-name>Andrew T.</given-name><initials>A.T.</initials><afid>60017018</afid><afid>60016849</afid></author><authkeywords>Acute coronary syndrome | Electrocardiogram | Low QRS voltage | Prognosis</authkeywords><intid>1785916950</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929149904"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929149904?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929149904&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929149904&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009237"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929149904</prism:url><dc:identifier>SCOPUS_ID:84929149904</dc:identifier><eid>2-s2.0-84929149904</eid><dc:title>Influence of baseline ejection fraction on the prognostic value of paravalvular leak after transcatheter aortic valve implantation</dc:title><dc:creator>Miyazaki S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>277-281</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.190</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Moderate or severe paravalvular leak (PVL â¥ moderate) after transcatheter aortic valve implantation (TAVI) is associated with poor outcomes. The aim of this study was to assess whether the baseline ejection fraction (EF) affects the impact of PVL on mortality after TAVI. Methods: Weanalyzed 514 consecutive patients with native severe aortic stenosis who underwent TAVI. Patients were divided into two groups: EF b40% group (n = 84) and EF â¥40% group (n = 430) according to baseline EF. Results: The mean age was 79.5 years and 49% were male. Patients in the EF b40% group were younger and with higher logistic EuroSCORE compared to patients in the EF â¥40% group. Diabetes, coronary artery disease, atrial fibrillation and renal insufficiency were more prevalent in the EF b40% group. Patients in the EF b40% group had more mitral regurgitation. In-hospital mortality was significantly higher in the EF b40% group (8.3% vs. 0.9%, p b 0.0001). PVL â¥ moderate was significantly associated with increased 2-year estimated mortality only in the EF b40% group (65% vs. 20%, log-rank p b 0.0001) whereas no difference was seen in the EF â¥40% group (24% vs. 19%, log-rank p = 0.509). Interaction between PVL â¥ moderate and EF b40% was statistically significant. Conclusions: The impact of PVL â¥moderateonmortality after TAVI was significantin the EF b40% group but not in the EF â¥40% group in our study. Even though operators should aim to minimize PVL in all TAVI patients, special attention is required for patients with reduced baseline EF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082964</affiliation-url><afid>60082964</afid><affilname>Fondazione San Raffaele del Monte Tabor</affilname><name-variant>Fondazione San Raffaele del Monte Tabor</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009740</affiliation-url><afid>60009740</afid><affilname>Juntendo University School of Medicine</affilname><name-variant>Juntendo University School of Medicine</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082964</affiliation-url><afid>60082964</afid><affilname>Fondazione San Raffaele del Monte Tabor</affilname><name-variant>Fondazione San Raffaele del Monte Tabor</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082964</affiliation-url><afid>60082964</afid><affilname>Fondazione San Raffaele del Monte Tabor</affilname><name-variant>Fondazione San Raffaele del Monte Tabor</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640518100</author-url><authid>56640518100</authid><authname>Miyazaki S.</authname><surname>Miyazaki</surname><given-name>Sakiko</given-name><initials>S.</initials><afid>60082964</afid><afid>60009740</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640518100</author-url><authid>56640518100</authid><authname>Miyazaki S.</authname><surname>Miyazaki</surname><given-name>Sakiko</given-name><initials>S.</initials><afid>60082964</afid><afid>60009740</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004352036</author-url><authid>7004352036</authid><authname>Agricola E.</authname><surname>Agricola</surname><given-name>Eustachio</given-name><initials>E.</initials><afid>60082964</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23012962500</author-url><authid>23012962500</authid><authname>Panoulas V.</authname><surname>Panoulas</surname><given-name>Vasileios F.</given-name><initials>V.F.</initials><afid>60082964</afid><afid>60010719</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23012962500</author-url><authid>23012962500</authid><authname>Panoulas V.</authname><surname>Panoulas</surname><given-name>Vasileios F.</given-name><initials>V.F.</initials><afid>60082964</afid><afid>60010719</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15137580700</author-url><authid>15137580700</authid><authname>Slavich M.</authname><surname>Slavich</surname><given-name>Massimo</given-name><initials>M.</initials><afid>60082964</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55964550000</author-url><authid>55964550000</authid><authname>Giustino G.</authname><surname>Giustino</surname><given-name>Gennaro</given-name><initials>G.</initials><afid>60082964</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55453208800</author-url><authid>55453208800</authid><authname>Miyazaki T.</authname><surname>Miyazaki</surname><given-name>Tadashi</given-name><initials>T.</initials><afid>60009740</afid><afid>60082964</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55453208800</author-url><authid>55453208800</authid><authname>Miyazaki T.</authname><surname>Miyazaki</surname><given-name>Tadashi</given-name><initials>T.</initials><afid>60009740</afid><afid>60082964</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26635086800</author-url><authid>26635086800</authid><authname>Figini F.</authname><surname>Figini</surname><given-name>Filippo</given-name><initials>F.</initials><afid>60082964</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24401460900</author-url><authid>24401460900</authid><authname>Latib A.</authname><surname>Latib</surname><given-name>Azeem</given-name><initials>A.</initials><afid>60082964</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603921260</author-url><authid>6603921260</authid><authname>Chieffo A.</authname><surname>Chieffo</surname><given-name>Alaide</given-name><initials>A.</initials><afid>60082964</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003659232</author-url><authid>7003659232</authid><authname>Montorfano M.</authname><surname>Montorfano</surname><given-name>Matteo</given-name><initials>M.</initials><afid>60082964</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003544168</author-url><authid>7003544168</authid><authname>Margonato A.</authname><surname>Margonato</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60082964</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7004629354</author-url><authid>7004629354</authid><authname>Maisano F.</authname><surname>Maisano</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60019619</afid><afid>60082964</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7004629354</author-url><authid>7004629354</authid><authname>Maisano F.</authname><surname>Maisano</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60019619</afid><afid>60082964</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7006850825</author-url><authid>7006850825</authid><authname>Alfieri O.</authname><surname>Alfieri</surname><given-name>Ottavio</given-name><initials>O.</initials><afid>60082964</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56542547000</author-url><authid>56542547000</authid><authname>Colombo A.</authname><surname>Colombo</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60082964</afid></author><authkeywords>2-Year mortality | Aortic stenosis | Left ventricular ejection fraction | Paravalvular leak | Transcatheter aortic valve implantation</authkeywords><intid>35917245</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929207331"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929207331?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929207331&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929207331&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008803"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929207331</prism:url><dc:identifier>SCOPUS_ID:84929207331</dc:identifier><eid>2-s2.0-84929207331</eid><dc:title>Successful repair ofmitral valve with acute infective endocarditis located in anterior mitral leaflet: The evidence of Three-dimensional echocardiography</dc:title><dc:creator>Gan S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>294-295</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.156</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018205</affiliation-url><afid>60018205</afid><affilname>Xiamen University</affilname><name-variant>Xiamen University</name-variant><affiliation-city>Xiamen</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018205</affiliation-url><afid>60018205</afid><affilname>Xiamen University</affilname><name-variant>Xiamen University</name-variant><affiliation-city>Xiamen</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640722400</author-url><authid>56640722400</authid><authname>Gan S.</authname><surname>Gan</surname><given-name>Shu Fen</given-name><initials>S.F.</initials><afid>60018205</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55624484990</author-url><authid>55624484990</authid><authname>Fang F.</authname><surname>Fang</surname><given-name>Fang</given-name><initials>F.</initials><afid>60002798</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640189600</author-url><authid>56640189600</authid><authname>Yang Q.</authname><surname>Yang</surname><given-name>Qian</given-name><initials>Q.</initials><afid>60018205</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7404976646</author-url><authid>7404976646</authid><authname>Yu C.</authname><surname>Yu</surname><given-name>Cheuk Man</given-name><initials>C.M.</initials><afid>60002798</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640917800</author-url><authid>56640917800</authid><authname>Chen J.</authname><surname>Chen</surname><given-name>Jiang Hua</given-name><initials>J.H.</initials><afid>60018205</afid></author><authkeywords>Infective endocarditis | Mitral valve repair | Real-time three-dimensional tranesophageal echocardiography</authkeywords><intid>1535917819</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930178044"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930178044?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930178044&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930178044&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1043466615001428"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930178044</prism:url><dc:identifier>SCOPUS_ID:84930178044</dc:identifier><eid>2-s2.0-84930178044</eid><dc:title>Prospective assessment of cytokine IL-15 activity in patients with refractory atrial fibrillation episodes</dc:title><dc:creator>Borowiec A.</dc:creator><prism:publicationName>Cytokine</prism:publicationName><prism:issn>10434666</prism:issn><prism:eIssn>10960023</prism:eIssn><prism:volume>74</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>164-170</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cyto.2015.04.002</prism:doi><pii>S1043466615001428</pii><dc:description>Â© 2015 Elsevier Ltd. Aims: Inflammatory state is considered a risk factor of atrial fibrillation (AF) occurrence. The aim of this study was a prospective evaluation of the inflammation parameters in patients with different forms of AF without structural heart disease. Methods and results: One hundred fifty-eight patients with paroxysmal/persistent AF (87; 55.1% men, mean age 65.8. Â±. 9.6. years) without structural heart disease were enrolled in the study. Inflammatory parameters: WBC, ESR, hs-CRP, IL-6, IL-15 and TNF-alpha were measured at baseline and after one year follow-up. Despite frequent AF episodes median values of WBC, ESR and C-reactive protein at baseline and after follow up were within normal ranges. There were no significant differences between WBC, ESR and hs-CRP regarding AF types. In patients who developed permanent AF form (. n=. 14) hs-CRP concentrations were higher at baseline: 0.35 (IQR1: 0.09 IQR: 0.61) vs 0.15 (IQR1: 0.07 IQR: 0.29), p&lt;. 0.01. Nevertheless, after one year's observation these differences were not significant. Among all cytokines were studied only IL-15 was significantly correlated with the number of AF episodes (. r=. 0.26), mean (IQ1-IQ3): 10 (3-30) vs 60 (50-100), p=. 0.00681. Conclusion: Basic inflammatory markers were not changed in patients with refractory atrial fibrillation episodes in prospective one year's observation. Only cytokine IL-15 was correlated to numbers of AF episodes. It's potential role as a marker of arrhythmia deserves further evaluation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106588141</affiliation-url><afid>106588141</afid><affilname>National Institute of Cardiology</affilname><name-variant>National Institute of Cardiology</name-variant><affiliation-city/><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115184237</affiliation-url><afid>115184237</afid><affilname>National Institute of Rheumatology</affilname><name-variant>National Institute of Rheumatology</name-variant><affiliation-city/><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36862941000</author-url><authid>36862941000</authid><authname>Borowiec A.</authname><surname>Borowiec</surname><given-name>Anna</given-name><initials>A.</initials><afid>106588141</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003897203</author-url><authid>7003897203</authid><authname>Kontny E.</authname><surname>Kontny</surname><given-name>Ewa</given-name><initials>E.</initials><afid>115184237</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15046110700</author-url><authid>15046110700</authid><authname>Smolis-Bak E.</authname><surname>Smolis-Bak</surname><given-name>Edyta</given-name><initials>E.</initials><afid>106588141</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003636620</author-url><authid>7003636620</authid><authname>Kowalik I.</authname><surname>Kowalik</surname><given-name>Ilona</given-name><initials>I.</initials><afid>106588141</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:40261795700</author-url><authid>40261795700</authid><authname>Majos E.</authname><surname>Majos</surname><given-name>Ewa</given-name><initials>E.</initials><afid>106588141</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55978722500</author-url><authid>55978722500</authid><authname>ZaÅucka L.</authname><surname>ZaÅucka</surname><given-name>Laura</given-name><initials>L.</initials><afid>106588141</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56146370700</author-url><authid>56146370700</authid><authname>PlaziÅski K.</authname><surname>PlaziÅski</surname><given-name>Krzysztof</given-name><initials>K.</initials><afid>106588141</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56115993200</author-url><authid>56115993200</authid><authname>MaÅliÅski W.</authname><surname>MaÅliÅski</surname><given-name>WÅodzimierz</given-name><initials>W.</initials><afid>115184237</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7007183538</author-url><authid>7007183538</authid><authname>Szwed H.</authname><surname>Szwed</surname><given-name>Hanna</given-name><initials>H.</initials><afid>106588141</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102754191</author-url><authid>7102754191</authid><authname>Dabrowski R.</authname><surname>Dabrowski</surname><given-name>Rafal</given-name><initials>R.</initials><afid>106588141</afid></author><authkeywords>Atrial fibrillation | Inflammation | Inflammatory markers | Interleukins</authkeywords><intid>1786079943</intid><source-id>22083</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929144263"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929144263?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929144263&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929144263&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008360"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929144263</prism:url><dc:identifier>SCOPUS_ID:84929144263</dc:identifier><eid>2-s2.0-84929144263</eid><dc:title>Right ventricular lead perforation complicating late pacemaker infection</dc:title><dc:creator>Gurunathan S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>47-48</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.113</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009009</affiliation-url><afid>60009009</afid><affilname>Royal Brompton Hospital</affilname><name-variant>Brompton Hospital</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56446562100</author-url><authid>56446562100</authid><authname>Gurunathan S.</authname><surname>Gurunathan</surname><given-name>Sothinathan</given-name><initials>S.</initials><afid>60009009</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56113405200</author-url><authid>56113405200</authid><authname>Senior R.</authname><surname>Senior</surname><given-name>Roxy</given-name><initials>R.</initials><afid>60009009</afid><afid>60010719</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56113405200</author-url><authid>56113405200</authid><authname>Senior R.</authname><surname>Senior</surname><given-name>Roxy</given-name><initials>R.</initials><afid>60009009</afid><afid>60010719</afid></author><authkeywords>Cardiac perforation | Echocardiography | Pacemaker infection</authkeywords><intid>1535916568</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929156277"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929156277?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929156277&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929156277&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008645"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929156277</prism:url><dc:identifier>SCOPUS_ID:84929156277</dc:identifier><eid>2-s2.0-84929156277</eid><dc:title>Recurrent ventricular tachycardia in a patient with continuous flow left ventricle assist device: Successful management with radiofrequency ablation and medical treatment</dc:title><dc:creator>Romano G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>98-200</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.141</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101003394</affiliation-url><afid>101003394</afid><affilname>Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)</affilname><name-variant>Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IsMeTT)</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101003394</affiliation-url><afid>101003394</afid><affilname>Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)</affilname><name-variant>Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IsMeTT)</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106283742</affiliation-url><afid>106283742</afid><affilname>University Hospital P. Giaccone</affilname><name-variant>University Hospital P. Giaccone</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112586920</affiliation-url><afid>112586920</afid><affilname>ARNAS Civico Hospital</affilname><name-variant>Civico-A.R.N.A.S. Hospital</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56440931300</author-url><authid>56440931300</authid><authname>Romano G.</authname><surname>Romano</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>101003394</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25632752900</author-url><authid>25632752900</authid><authname>Raffa G.</authname><surname>Raffa</surname><given-name>Giuseppe Maria</given-name><initials>G.M.</initials><afid>101003394</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:50162322600</author-url><authid>50162322600</authid><authname>Ruggieri A.</authname><surname>Ruggieri</surname><given-name>Aldo</given-name><initials>A.</initials><afid>106283742</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12445117000</author-url><authid>12445117000</authid><authname>Sgarito G.</authname><surname>Sgarito</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>112586920</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6506872862</author-url><authid>6506872862</authid><authname>Falletta C.</authname><surname>Falletta</surname><given-name>Calogero</given-name><initials>C.</initials><afid>101003394</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:17135974100</author-url><authid>17135974100</authid><authname>Sciacca S.</authname><surname>Sciacca</surname><given-name>Sergio</given-name><initials>S.</initials><afid>101003394</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:17135553000</author-url><authid>17135553000</authid><authname>Pilato M.</authname><surname>Pilato</surname><given-name>Michele</given-name><initials>M.</initials><afid>101003394</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6507364936</author-url><authid>6507364936</authid><authname>Clemenza F.</authname><surname>Clemenza</surname><given-name>Francesco</given-name><initials>F.</initials><afid>101003394</afid></author><authkeywords>Catheter ablation | Ventricular assist device | Ventricular tachyarrhythmia</authkeywords><intid>35917330</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929587540"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929587540?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929587540&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929587540&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015013076"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929587540</prism:url><dc:identifier>SCOPUS_ID:84929587540</dc:identifier><eid>2-s2.0-84929587540</eid><dc:title>Lipoprotein-associated phospholipase A&lt;inf&gt;2&lt;/inf&gt; and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis</dc:title><dc:creator>Garg P.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>176-182</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.05.006</prism:doi><pii>S0021915015013076</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Objective: Prospective studies reporting a positive association of lipoprotein-associated phospholipase A&lt;inf&gt;2&lt;/inf&gt; (Lp-PLA&lt;inf&gt;2&lt;/inf&gt;) mass and activity with incident cardiovascular disease (CVD) have included primarily white individuals. We evaluated associations of Lp-PLA&lt;inf&gt;2&lt;/inf&gt; and first-time cardiovascular events in a healthy multi-ethnic cohort characterized by presence or absence of baseline subclinical atherosclerosis. Methods: Lp-PLA&lt;inf&gt;2&lt;/inf&gt; mass and activity were measured at baseline in 5456 participants in the Multi-Ethnic Study of Atherosclerosis. Individuals were characterized for presence of baseline subclinical disease (coronary artery calcium score &gt; 0 or carotid intima-media thickness value &gt; 80th percentile) and followed prospectively for development of CVD events (coronary heart disease, ischemic stroke, and cardiovascular death). Results: 516 incident CVD events occurred over median follow-up of 10.2 years. In adjusted Cox proportional hazards models, each higher standard deviation of both Lp-PLA&lt;inf&gt;2&lt;/inf&gt; activity and mass was associated with an increased risk of cardiovascular events; hazard ratios (HR; 95% confidence intervals (CI)) 1.12 (1.01-1.26) for Lp-PLA&lt;inf&gt;2&lt;/inf&gt; activity and 1.10 (1.01-1.21) for mass. Associations did not differ by subclinical disease status (p-value for interaction 0.99 for Lp-PLA&lt;inf&gt;2&lt;/inf&gt; activity and 0.32 for Lp-PLA&lt;inf&gt;2&lt;/inf&gt; mass) and there was no confounding by subclinical atherosclerosis measures. Associations of Lp-PLA&lt;inf&gt;2&lt;/inf&gt; activity but not mass were weaker in Chinese participants but there were relatively few events among Chinese in race-stratified analysis. Conclusion: In this multi-ethnic cohort, Lp-PLA&lt;inf&gt;2&lt;/inf&gt; was positively associated with CVD risk, regardless of the presence of coronary artery calcium or a thickened carotid-intimal media.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015183</affiliation-url><afid>60015183</afid><affilname>Keck School of Medicine of USC</affilname><name-variant>University of Southern California School of Medicine</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031576</affiliation-url><afid>60031576</afid><affilname>University of Vermont College of Medicine</affilname><name-variant>Univ. of Vermont College of Medicine</name-variant><affiliation-city>Burlington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012981</affiliation-url><afid>60012981</afid><affilname>Icahn School of Medicine at Mount Sinai</affilname><name-variant>Mount Sinai School of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010040</affiliation-url><afid>60010040</afid><affilname>New York Academy of Medicine</affilname><name-variant>New York Academy of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031576</affiliation-url><afid>60031576</afid><affilname>University of Vermont College of Medicine</affilname><name-variant>Univ. of Vermont College of Medicine</name-variant><affiliation-city>Burlington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16301668700</author-url><authid>16301668700</authid><authname>Garg P.</authname><surname>Garg</surname><given-name>Parveen K.</given-name><initials>P.K.</initials><afid>60015183</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35403567600</author-url><authid>35403567600</authid><authname>McClelland R.</authname><surname>McClelland</surname><given-name>Robyn L.</given-name><initials>R.L.</initials><afid>60015481</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506446610</author-url><authid>6506446610</authid><authname>Jenny N.</authname><surname>Jenny</surname><given-name>Nancy S.</given-name><initials>N.S.</initials><afid>60031576</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55628588951</author-url><authid>55628588951</authid><authname>Criqui M.</authname><surname>Criqui</surname><given-name>Michael H.</given-name><initials>M.H.</initials><afid>60030612</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103188831</author-url><authid>7103188831</authid><authname>Greenland P.</authname><surname>Greenland</surname><given-name>Philip</given-name><initials>P.</initials><afid>60007363</afid><afid>60013227</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103188831</author-url><authid>7103188831</authid><authname>Greenland P.</authname><surname>Greenland</surname><given-name>Philip</given-name><initials>P.</initials><afid>60007363</afid><afid>60013227</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006279584</author-url><authid>7006279584</authid><authname>Rosenson R.</authname><surname>Rosenson</surname><given-name>Robert S.</given-name><initials>R.S.</initials><afid>60012981</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005419833</author-url><authid>7005419833</authid><authname>Siscovick D.</authname><surname>Siscovick</surname><given-name>David S.</given-name><initials>D.S.</initials><afid>60010040</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102768408</author-url><authid>7102768408</authid><authname>Jorgensen N.</authname><surname>Jorgensen</surname><given-name>Neal</given-name><initials>N.</initials><afid>60015481</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103113524</author-url><authid>7103113524</authid><authname>Cushman M.</authname><surname>Cushman</surname><given-name>Mary</given-name><initials>M.</initials><afid>60031576</afid><afid>60031576</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103113524</author-url><authid>7103113524</authid><authname>Cushman M.</authname><surname>Cushman</surname><given-name>Mary</given-name><initials>M.</initials><afid>60031576</afid><afid>60031576</afid></author><authkeywords>Biomarker | Cardiovascular disease | Ethnicity | Inflammation | Lipoprotein-associated phospholipase A&lt;inf&gt;2&lt;/inf&gt;</authkeywords><intid>2035976440</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929176493"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929176493?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929176493&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929176493&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500889X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929176493</prism:url><dc:identifier>SCOPUS_ID:84929176493</dc:identifier><eid>2-s2.0-84929176493</eid><dc:title>Cardiac manifestations of Sneddon's syndrome</dc:title><dc:creator>Dominguez F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>275-276</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.165</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025844</affiliation-url><afid>60025844</afid><affilname>Hospital Universitario Puerta de Hierro</affilname><name-variant>Hospital Universitario Puerta de Hierro</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009113</affiliation-url><afid>60009113</afid><affilname>Deutsches Herzzentrum Berlin</affilname><name-variant>German Heart Institute</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56008538500</author-url><authid>56008538500</authid><authname>Dominguez F.</authname><surname>Dominguez</surname><given-name>Fernando</given-name><initials>F.</initials><afid>60025844</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35499467500</author-url><authid>35499467500</authid><authname>Pieske B.</authname><surname>Pieske</surname><given-name>Burkert</given-name><initials>B.</initials><afid>60009113</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:11141332300</author-url><authid>11141332300</authid><authname>Kelle S.</authname><surname>Kelle</surname><given-name>Sebastian</given-name><initials>S.</initials><afid>60009113</afid></author><authkeywords>Cardiac magnetic resonance | Cardiac manifestations of systemic disease | Echocardiography | Sneddon's syndrome</authkeywords><intid>1035914265</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929191112"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929191112?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929191112&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929191112&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016752731500933X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929191112</prism:url><dc:identifier>SCOPUS_ID:84929191112</dc:identifier><eid>2-s2.0-84929191112</eid><dc:title>Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy</dc:title><dc:creator>Inciardi R.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>329-331</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.200</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032256</affiliation-url><afid>60032256</afid><affilname>Universita degli Studi di Verona</affilname><name-variant>University of Verona</name-variant><affiliation-city>Verona</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113720921</affiliation-url><afid>113720921</afid><affilname>ISMETT</affilname><name-variant>ISMETT</name-variant><affiliation-city>Palermo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56015777500</author-url><authid>56015777500</authid><authname>Inciardi R.</authname><surname>Inciardi</surname><given-name>Riccardo M.</given-name><initials>R.M.</initials><afid>60032256</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55335640200</author-url><authid>55335640200</authid><authname>Rossi A.</authname><surname>Rossi</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60032256</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12759501800</author-url><authid>12759501800</authid><authname>Pesarini G.</authname><surname>Pesarini</surname><given-name>Gabriele</given-name><initials>G.</initials><afid>60032256</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507364936</author-url><authid>6507364936</authid><authname>Clemenza F.</authname><surname>Clemenza</surname><given-name>Francesco</given-name><initials>F.</initials><afid>113720921</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006445005</author-url><authid>7006445005</authid><authname>Vassanelli C.</authname><surname>Vassanelli</surname><given-name>Corrado</given-name><initials>C.</initials><afid>60032256</afid></author><authkeywords>ARVD/C | Cardiac MRI | Cardiovascular imaging | RV angiography | Task force criteria | Transthoracic echocardiography</authkeywords><intid>2035912309</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929191109"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929191109?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929191109&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929191109&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009146"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929191109</prism:url><dc:identifier>SCOPUS_ID:84929191109</dc:identifier><eid>2-s2.0-84929191109</eid><dc:title>Repetitive, incessant supraventricular tachycardia: Noninvasive determination of the electrophysiologic mechanism</dc:title><dc:creator>Littmann L.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>256-259</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.181</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030824</affiliation-url><afid>60030824</afid><affilname>Carolinas Medical Center</affilname><name-variant>Carolinas Medical Center</name-variant><affiliation-city>Charlotte</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030824</affiliation-url><afid>60030824</afid><affilname>Carolinas Medical Center</affilname><name-variant>Carolinas Medical Center</name-variant><affiliation-city>Charlotte</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35571507900</author-url><authid>35571507900</authid><authname>Littmann L.</authname><surname>Littmann</surname><given-name>Laszlo</given-name><initials>L.</initials><afid>60030824</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507549225</author-url><authid>6507549225</authid><authname>Saxonhouse S.</authname><surname>Saxonhouse</surname><given-name>Sherry J.</given-name><initials>S.J.</initials><afid>60030824</afid></author><authkeywords>Activation mapping | Bundle branch block | Concealed accessory pathway | Incessant tachycardia | Retrograde preexcitation | Supraventricular tachycardia</authkeywords><intid>2035913329</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928118417"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928118417?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928118417&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928118417&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001078"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928118417</prism:url><dc:identifier>SCOPUS_ID:84928118417</dc:identifier><eid>2-s2.0-84928118417</eid><dc:title>Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction</dc:title><dc:creator>Chang K.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>36-44</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.03.016</prism:doi><pii>S0022282815001078</pii><dc:description>Â© 2015 Elsevier Ltd. Chronic kidney disease (CKD), an independent risk factor for cardiovascular disease, is associated with abnormal lipoprotein metabolism. We examined whether electronegative low-density lipoprotein (LDL) is mechanistically linked to cardiac dysfunction in patients with early CKD. We compared echocardiographic parameters between patients with stage 2 CKD (n=88) and normal controls (n=89) and found that impaired relaxation was more common in CKD patients. Reduction in estimated glomerular filtration rate was an independent predictor of left ventricular relaxation dysfunction. We then examined cardiac function in a rat model of early CKD induced by unilateral nephrectomy (UNx) by analyzing pressure-volume loop data. The time constant of isovolumic pressure decay was longer and the maximal velocity of pressure fall was slower in UNx rats than in controls. When we investigated the mechanisms underlying relaxation dysfunction, we found that LDL from CKD patients and UNx rats was more electronegative than LDL from their respective controls and that LDL from UNx rats induced intracellular calcium overload in H9c2 cardiomyocytes in vitro. Furthermore, chronic administration of electronegative LDL, which signals through lectin-like oxidized LDL receptor-1 (LOX-1), induced relaxation dysfunction in wild-type but not LOX-1&lt;sup&gt;-/-&lt;/sup&gt; mice. In in vitro and in vivo experiments, impaired cardiac relaxation was associated with increased calcium transient resulting from nitric oxide (NO)-dependent nitrosylation of SERCA2a due to increases in inducible NO synthase expression and endothelial NO synthase uncoupling. In conclusion, LDL becomes more electronegative in early CKD. This change disrupts SERCA2a-regulated calcium homeostasis, which may be the mechanism underlying cardiorenal syndrome.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104437</affiliation-url><afid>60104437</afid><affilname>Mackay Medical College</affilname><name-variant>Mackay Medical College</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002106</affiliation-url><afid>60002106</afid><affilname>Shinshu University Faculty of Medicine</affilname><name-variant>Shinshu University</name-variant><affiliation-city>Matsumoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006988</affiliation-url><afid>60006988</afid><affilname>China Medical University Taichung</affilname><name-variant>China Medical University</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005429</affiliation-url><afid>60005429</afid><affilname>National Taiwan University</affilname><name-variant>National Taiwan University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023304</affiliation-url><afid>60023304</afid><affilname>Texas Heart Institute</affilname><name-variant>Texas Heart Institute</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002441</affiliation-url><afid>60002441</afid><affilname>Baylor College of Medicine</affilname><name-variant>Baylor College of Medicine</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100787691</affiliation-url><afid>100787691</afid><affilname>K.M.U Hospital</affilname><name-variant>KMU Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56599523400</author-url><authid>56599523400</authid><authname>Chang K.</authname><surname>Chang</surname><given-name>Kuan Cheng</given-name><initials>K.C.</initials><afid>60006988</afid><afid>60006988</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56599523400</author-url><authid>56599523400</authid><authname>Chang K.</authname><surname>Chang</surname><given-name>Kuan Cheng</given-name><initials>K.C.</initials><afid>60006988</afid><afid>60006988</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55258055100</author-url><authid>55258055100</authid><authname>Lee A.</authname><surname>Lee</surname><given-name>An Sheng</given-name><initials>A.S.</initials><afid>60104437</afid><afid>60006988</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55258055100</author-url><authid>55258055100</authid><authname>Lee A.</authname><surname>Lee</surname><given-name>An Sheng</given-name><initials>A.S.</initials><afid>60104437</afid><afid>60006988</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56094873400</author-url><authid>56094873400</authid><authname>Chen W.</authname><surname>Chen</surname><given-name>Wei Yu</given-name><initials>W.Y.</initials><afid>60006988</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56366088900</author-url><authid>56366088900</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yen Nien</given-name><initials>Y.N.</initials><afid>60006988</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56533002900</author-url><authid>56533002900</authid><authname>Hsu J.</authname><surname>Hsu</surname><given-name>Jing Fang</given-name><initials>J.F.</initials><afid>60006988</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:50061100300</author-url><authid>50061100300</authid><authname>Chan H.</authname><surname>Chan</surname><given-name>Hua Chen</given-name><initials>H.C.</initials><afid>60006988</afid><afid>60012256</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:50061100300</author-url><authid>50061100300</authid><authname>Chan H.</authname><surname>Chan</surname><given-name>Hua Chen</given-name><initials>H.C.</initials><afid>60006988</afid><afid>60012256</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56532611800</author-url><authid>56532611800</authid><authname>Chang C.</authname><surname>Chang</surname><given-name>Chia Ming</given-name><initials>C.M.</initials><afid>60006988</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56599342400</author-url><authid>56599342400</authid><authname>Chang S.</authname><surname>Chang</surname><given-name>Shih Sheng</given-name><initials>S.S.</initials><afid>60006988</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56599594800</author-url><authid>56599594800</authid><authname>Pan C.</authname><surname>Pan</surname><given-name>Chia Chi</given-name><initials>C.C.</initials><afid>60006988</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56600046800</author-url><authid>56600046800</authid><authname>Sawamura T.</authname><surname>Sawamura</surname><given-name>Tatsuya</given-name><initials>T.</initials><afid>60002106</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56599216100</author-url><authid>56599216100</authid><authname>Chang C.</authname><surname>Chang</surname><given-name>Chi Tzong</given-name><initials>C.T.</initials><afid>60006988</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7403166866</author-url><authid>7403166866</authid><authname>Su M.</authname><surname>Su</surname><given-name>Ming Jai</given-name><initials>M.J.</initials><afid>60005429</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:26643329300</author-url><authid>26643329300</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chu Huang</given-name><initials>C.H.</initials><afid>60006988</afid><afid>60023304</afid><afid>60002441</afid><afid>100787691</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:26643329300</author-url><authid>26643329300</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chu Huang</given-name><initials>C.H.</initials><afid>60006988</afid><afid>60023304</afid><afid>60002441</afid><afid>100787691</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:26643329300</author-url><authid>26643329300</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chu Huang</given-name><initials>C.H.</initials><afid>60006988</afid><afid>60023304</afid><afid>60002441</afid><afid>100787691</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:26643329300</author-url><authid>26643329300</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chu Huang</given-name><initials>C.H.</initials><afid>60006988</afid><afid>60023304</afid><afid>60002441</afid><afid>100787691</afid></author><authkeywords>Cardiorenal syndrome | Lipoproteins | SERCA2a | Unilateral nephrectomy</authkeywords><intid>1535732252</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928410322"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928410322?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928410322&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928410322&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010482515001171"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928410322</prism:url><dc:identifier>SCOPUS_ID:84928410322</dc:identifier><eid>2-s2.0-84928410322</eid><dc:title>Computer-aided diagnosis of Myocardial Infarction using ultrasound images with DWT, GLCM and HOS methods: A comparative study</dc:title><dc:creator>Vidya K.</dc:creator><prism:publicationName>Computers in Biology and Medicine</prism:publicationName><prism:issn>00104825</prism:issn><prism:eIssn>18790534</prism:eIssn><prism:volume>62</prism:volume><prism:pageRange>86-93</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiomed.2015.03.033</prism:doi><pii>S0010482515001171</pii><dc:description>Â© 2015 Elsevier Ltd. Myocardial Infarction (MI) or acute MI (AMI) is one of the leading causes of death worldwide. Precise and timely identification of MI and extent of muscle damage helps in early treatment and reduction in the time taken for further tests. MI diagnosis using 2D echocardiography is prone to inter-/intra-observer variability in the assessment. Therefore, a computerised scheme based on image processing and artificial intelligent techniques can reduce the workload of clinicians and improve the diagnosis accuracy. A Computer-Aided Diagnosis (CAD) of infarcted and normal ultrasound images will be useful for clinicians. In this study, the performance of CAD approach using Discrete Wavelet Transform (DWT), second order statistics calculated from Gray-Level Co-Occurrence Matrix (GLCM) and Higher-Order Spectra (HOS) texture descriptors are compared. The proposed system is validated using 400 MI and 400 normal ultrasound images, obtained from 80 patients with MI and 80 normal subjects. The extracted features are ranked based on t-value and fed to the Support Vector Machine (SVM) classifier to obtain the best performance using minimum number of features. The features extracted from DWT coefficients obtained an accuracy of 99.5%, sensitivity of 99.75% and specificity of 99.25%; GLCM have achieved an accuracy of 85.75%, sensitivity of 90.25% and specificity of 81.25%; and HOS obtained an accuracy of 93.0%, sensitivity of 94.75% and specificity of 91.25%. Among the three techniques presented DWT yielded the highest classification accuracy. Thus, the proposed CAD approach may be used as a complementary tool to assist cardiologists in making a more accurate diagnosis for the presence of MI.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005510</affiliation-url><afid>60005510</afid><affilname>Nanyang Technological University</affilname><name-variant>Nanyang Technological University</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012607</affiliation-url><afid>60012607</afid><affilname>Ngee Ann Polytechnic</affilname><name-variant>Ngee Ann Polytechnic</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029157</affiliation-url><afid>60029157</afid><affilname>University of Malaya</affilname><name-variant>University of Malaya</name-variant><affiliation-city>Kuala Lumpur</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004409</affiliation-url><afid>60004409</afid><affilname>National Heart Centre, Singapore</affilname><name-variant>National Heart Centre Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115033685</affiliation-url><afid>115033685</afid><affilname>University 2020 Foundation</affilname><name-variant>University 2020 Foundation</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56538323900</author-url><authid>56538323900</authid><authname>Vidya K.</authname><surname>Vidya</surname><given-name>K. Sudarshan</given-name><initials>K.S.</initials><afid>60005510</afid><afid>60012607</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56538323900</author-url><authid>56538323900</authid><authname>Vidya K.</authname><surname>Vidya</surname><given-name>K. Sudarshan</given-name><initials>K.S.</initials><afid>60005510</afid><afid>60012607</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7201647536</author-url><authid>7201647536</authid><authname>Ng E.</authname><surname>Ng</surname><given-name>E. Y K</given-name><initials>E.Y.K.</initials><afid>60005510</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004510847</author-url><authid>7004510847</authid><authname>Acharya U.</authname><surname>Acharya</surname><given-name>U. Rajendra</given-name><initials>U.R.</initials><afid>60012607</afid><afid>60029157</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004510847</author-url><authid>7004510847</authid><authname>Acharya U.</authname><surname>Acharya</surname><given-name>U. Rajendra</given-name><initials>U.R.</initials><afid>60012607</afid><afid>60029157</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7401538783</author-url><authid>7401538783</authid><authname>Chou S.</authname><surname>Chou</surname><given-name>Siaw Meng</given-name><initials>S.M.</initials><afid>60005510</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201984906</author-url><authid>7201984906</authid><authname>Tan R.</authname><surname>Tan</surname><given-name>Ru San</given-name><initials>R.S.</initials><afid>60004409</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7007177778</author-url><authid>7007177778</authid><authname>Ghista D.</authname><surname>Ghista</surname><given-name>Dhanjoo N.</given-name><initials>D.N.</initials><afid>115033685</afid></author><authkeywords>DWT | GLCM | HOS | Myocardial Infarction | Texture | Ultrasound image</authkeywords><intid>1785779020</intid><source-id>17957</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929501457"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929501457?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929501457&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929501457&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001376"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929501457</prism:url><dc:identifier>SCOPUS_ID:84929501457</dc:identifier><eid>2-s2.0-84929501457</eid><dc:title>The changing landscape of cardiac metabolism</dc:title><dc:creator>Davogustto G.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.021</prism:doi><pii>S0022282815001376</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027512</affiliation-url><afid>60027512</afid><affilname>University of Texas Health Science Center at Houston</affilname><name-variant>University of Texas Health Science Center at Houston</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55070861300</author-url><authid>55070861300</authid><authname>Davogustto G.</authname><surname>Davogustto</surname><given-name>Giovanni</given-name><initials>G.</initials><afid>60027512</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56651201700</author-url><authid>56651201700</authid><authname>Taegtmeyer H.</authname><surname>Taegtmeyer</surname><given-name>Heinrich</given-name><initials>H.</initials><afid>60027512</afid></author><intid>535964272</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928688943"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928688943?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928688943&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928688943&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515001085"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928688943</prism:url><dc:identifier>SCOPUS_ID:84928688943</dc:identifier><eid>2-s2.0-84928688943</eid><dc:title>Early origins of ethnic disparities in cardiovascular risk factors</dc:title><dc:creator>Gishti O.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>76</prism:volume><prism:pageRange>84-91</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.027</prism:doi><pii>S0091743515001085</pii><dc:description>Â© 2015 Elsevier Inc. Background: Not much is known about the ethnic differences in cardiovascular risk factors during childhood in European countries. We examined the ethnic differences in childhood cardiovascular risk factors in the Netherlands. Methods: In a multi-ethnic population-based prospective cohort study, we measured blood pressure, left ventricular mass, and levels of cholesterol, triglyceride and insulin at the median age of 6.2. years. Results: As compared to Dutch children, Cape Verdean and Turkish children had a higher blood pressure, whereas Cape Verdean, Surinamese-Creole and Turkish children had higher total-cholesterol levels (p-values. &lt;. 0.05). Turkish children had higher triglyceride levels, but lower insulin levels than Dutch children (p-values. &lt;. 0.05). As compared to Dutch children, only Turkish children had an increased risk of clustering of cardiovascular risk factors (odds ratio: 2.45 (95% confidence interval 1.18, 3.37)). Parental pre-pregnancy factors explained up to 50% of the ethnic differences in childhood risk factors. In addition to these factors, pregnancy and childhood factors and childhood BMI explained up to 50%, 12.5% and 61.1%, respectively. Conclusions: Our results suggest that compared to Dutch children, Cape Verdean, Surinamese-Creole and Turkish children have an adverse cardiovascular profile. These differences are largely explained by parental pre-pregnancy factors, pregnancy factors and childhood BMI.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032114</affiliation-url><afid>60032114</afid><affilname>Erasmus University Medical Center</affilname><name-variant>Erasmus Medical Center</name-variant><affiliation-city>Rotterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56118317500</author-url><authid>56118317500</authid><authname>Gishti O.</authname><surname>Gishti</surname><given-name>Olta</given-name><initials>O.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56118317500</author-url><authid>56118317500</authid><authname>Gishti O.</authname><surname>Gishti</surname><given-name>Olta</given-name><initials>O.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56118317500</author-url><authid>56118317500</authid><authname>Gishti O.</authname><surname>Gishti</surname><given-name>Olta</given-name><initials>O.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37121709000</author-url><authid>37121709000</authid><authname>Gaillard R.</authname><surname>Gaillard</surname><given-name>Romy</given-name><initials>R.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37121709000</author-url><authid>37121709000</authid><authname>Gaillard R.</authname><surname>Gaillard</surname><given-name>Romy</given-name><initials>R.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37121709000</author-url><authid>37121709000</authid><authname>Gaillard R.</authname><surname>Gaillard</surname><given-name>Romy</given-name><initials>R.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56513418000</author-url><authid>56513418000</authid><authname>Felix J.</authname><surname>Felix</surname><given-name>Janine F.</given-name><initials>J.F.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56513418000</author-url><authid>56513418000</authid><authname>Felix J.</authname><surname>Felix</surname><given-name>Janine F.</given-name><initials>J.F.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56513418000</author-url><authid>56513418000</authid><authname>Felix J.</authname><surname>Felix</surname><given-name>Janine F.</given-name><initials>J.F.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36458075500</author-url><authid>36458075500</authid><authname>Bouthoorn S.</authname><surname>Bouthoorn</surname><given-name>Selma</given-name><initials>S.</initials><afid>60032114</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006208502</author-url><authid>7006208502</authid><authname>Steegers E.</authname><surname>Steegers</surname><given-name>Eric</given-name><initials>E.</initials><afid>60032114</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56400503100</author-url><authid>56400503100</authid><authname>Raat H.</authname><surname>Raat</surname><given-name>Hein</given-name><initials>H.</initials><afid>60032114</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36048731400</author-url><authid>36048731400</authid><authname>Hofman A.</authname><surname>Hofman</surname><given-name>Albert</given-name><initials>A.</initials><afid>60032114</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23667086000</author-url><authid>23667086000</authid><authname>Duijts L.</authname><surname>Duijts</surname><given-name>Liesbeth</given-name><initials>L.</initials><afid>60032114</afid><afid>60032114</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23667086000</author-url><authid>23667086000</authid><authname>Duijts L.</authname><surname>Duijts</surname><given-name>Liesbeth</given-name><initials>L.</initials><afid>60032114</afid><afid>60032114</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:24553920400</author-url><authid>24553920400</authid><authname>Franco O.</authname><surname>Franco</surname><given-name>Oscar H.</given-name><initials>O.H.</initials><afid>60032114</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6506585188</author-url><authid>6506585188</authid><authname>Jaddoe V.</authname><surname>Jaddoe</surname><given-name>Vincent W V</given-name><initials>V.W.V.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6506585188</author-url><authid>6506585188</authid><authname>Jaddoe V.</authname><surname>Jaddoe</surname><given-name>Vincent W V</given-name><initials>V.W.V.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6506585188</author-url><authid>6506585188</authid><authname>Jaddoe V.</authname><surname>Jaddoe</surname><given-name>Vincent W V</given-name><initials>V.W.V.</initials><afid>60032114</afid><afid>60032114</afid><afid>60032114</afid></author><authkeywords>Ethnicity | Hypertension | Insulin | Lipids | Pediatrics</authkeywords><intid>1535823200</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929173275"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929173275?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929173275&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929173275&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008633"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929173275</prism:url><dc:identifier>SCOPUS_ID:84929173275</dc:identifier><eid>2-s2.0-84929173275</eid><dc:title>Left ventricular non-compaction and hypertrabeculation in the athlete: Distinguishing between pathology and physiology</dc:title><dc:creator>D'Ascenzi F.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>122-123</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.140</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002838</affiliation-url><afid>60002838</afid><affilname>Universita degli Studi di Siena</affilname><name-variant>UniversitÃ  di Siena</name-variant><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101022022</affiliation-url><afid>101022022</afid><affilname>Institute of Sports Medicine and Science</affilname><name-variant>Institute of Sport Medicine and Science</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002838</affiliation-url><afid>60002838</afid><affilname>Universita degli Studi di Siena</affilname><name-variant>UniversitÃ  di Siena</name-variant><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36185204600</author-url><authid>36185204600</authid><authname>D'Ascenzi F.</authname><surname>D'Ascenzi</surname><given-name>Flavio</given-name><initials>F.</initials><afid>60002838</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006756673</author-url><authid>7006756673</authid><authname>Pelliccia A.</authname><surname>Pelliccia</surname><given-name>Antonio</given-name><initials>A.</initials><afid>101022022</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602847660</author-url><authid>6602847660</authid><authname>Bonifazi M.</authname><surname>Bonifazi</surname><given-name>Marco</given-name><initials>M.</initials><afid>60002838</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003927718</author-url><authid>7003927718</authid><authname>Mondillo S.</authname><surname>Mondillo</surname><given-name>Sergio</given-name><initials>S.</initials><afid>60002838</afid></author><authkeywords>Cardiomyopathy | Echocardiography | Exercise | Noncompaction cardiomyopathy | Training</authkeywords><intid>2035910970</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929153054"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929153054?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929153054&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929153054&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010370"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929153054</prism:url><dc:identifier>SCOPUS_ID:84929153054</dc:identifier><eid>2-s2.0-84929153054</eid><dc:title>Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study</dc:title><dc:creator>Sun Y.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>138-142</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.818</prism:doi><pii>S0021915015010370</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Background: Neopterin is a pteridine derivative secreted by activated macrophages. Previous studies have shown that neopterin plays a pivotal role in coronary artery disease (CAD); however, the relationship between circulating neopterin and non-culprit plaque vulnerability in patients with CAD remains unclear. In this study, we investigated the correlation of neopterin and vulnerable plaque features in patients with CAD. Methods: One hundred and thirty non-culprit plaques from 81 patients with CAD were assessed by angiogram and optical coherence tomography (OCT) as well as intravascular ultrasound (IVUS) imaging. According to the median value of serum neopterin (10.61nmol/L), patients were divided into a low neopterin group (n=40, &lt;median) and a high neopterin group (n=41, â¥median). Plaque characteristics were compared between the two groups. Results: Compared with the low neopterin group, OCT findings showed that patients in the high neopterin group had thinner fibrous cap thickness (FCT) (90.02Â±52.96Î¼m vs. 124.69Â±65.23Î¼m, P=0.004) and more thin-cap fibroatheroma (TCFA) (38.0% vs. 13.6%, P=0.002). Microvessel and plaque rupture were more frequently observed in the high neopterin group (P=0.004 and P=0.005, respectively). IVUS findings showed that plaque burden was greater in the high neopterin group than that in the low neopterin group (P=0.005). Conclusions: Neopterin was positively associated with vulnerable plaque features including TCFA, thinner fibrous cap, plaque rupture, greater plaque burden and frequent microvessel occurrence in CAD patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073546</affiliation-url><afid>60073546</afid><affilname>Second Affiliated Hospital of Harbin Medical University</affilname><name-variant>The Second Affiliated Hospital of Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108363835</affiliation-url><afid>108363835</afid><affilname>Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment</affilname><name-variant>Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7406433227</author-url><authid>7406433227</authid><authname>Sun Y.</authname><surname>Sun</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7406433227</author-url><authid>7406433227</authid><authname>Sun Y.</authname><surname>Sun</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56156881500</author-url><authid>56156881500</authid><authname>He J.</authname><surname>He</surname><given-name>Jieqiong</given-name><initials>J.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56156881500</author-url><authid>56156881500</authid><authname>He J.</authname><surname>He</surname><given-name>Jieqiong</given-name><initials>J.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56424551300</author-url><authid>56424551300</authid><authname>Tian J.</authname><surname>Tian</surname><given-name>Jinwei</given-name><initials>J.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56424551300</author-url><authid>56424551300</authid><authname>Tian J.</authname><surname>Tian</surname><given-name>Jinwei</given-name><initials>J.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56310367100</author-url><authid>56310367100</authid><authname>Xie Z.</authname><surname>Xie</surname><given-name>Zulong</given-name><initials>Z.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56310367100</author-url><authid>56310367100</authid><authname>Xie Z.</authname><surname>Xie</surname><given-name>Zulong</given-name><initials>Z.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55684075600</author-url><authid>55684075600</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chao</given-name><initials>C.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55684075600</author-url><authid>55684075600</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chao</given-name><initials>C.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402092979</author-url><authid>7402092979</authid><authname>Yu B.</authname><surname>Yu</surname><given-name>Bo</given-name><initials>B.</initials><afid>60073546</afid><afid>108363835</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7402092979</author-url><authid>7402092979</authid><authname>Yu B.</authname><surname>Yu</surname><given-name>Bo</given-name><initials>B.</initials><afid>60073546</afid><afid>108363835</afid></author><authkeywords>Atherosclerosis | Intravascular ultrasound | Neopterin | Optimal coherence tomography | Plaque vulnerability</authkeywords><intid>1035914001</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928879518"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928879518?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928879518&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928879518&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015010266"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928879518</prism:url><dc:identifier>SCOPUS_ID:84928879518</dc:identifier><eid>2-s2.0-84928879518</eid><dc:title>Timing of invasive strategy in NSTE-ACS patients and effect on clinical outcomes: A systematic review and meta-analysis of randomized controlled trials</dc:title><dc:creator>Milasinovic D.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>241</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>48-54</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.808</prism:doi><pii>S0021915015010266</pii><dc:description>Â© 2015 Elsevier Ireland Ltd. Background: Previous randomized controlled trials (RCTs) have produced conflicting results on the effects of early versus delayed invasive strategy in NSTE-ACS patients. Objectives: To perform up to date meta-analysis on the pooled data sample comparing early versus delayed invasive strategy, and to explore potential causes for the observed high statistical heterogeneity. Methods: MEDLINE via Pubmed, Central, Google Scholar, Clinical Trials Registry, Current controlled study and ClinicalTrials.gov registry and relevant conference proceedings were searched. RCTs were included that directly compared early versus delayed invasive strategy and reported rates of death, new myocardial infarction (MI) and/or recurrent ischemia. Results: 10 RCTs with 6089 patients were included. Time to coronary angiography varied from 0.5 to 24h in the early and from 20.5 to 86h in the delayed group. Meta-analysis showed no significant difference in mortality (OR=0.83, 95%CI 0.64-1.08, P=0.16), and similar new MI rates (OR=1.02, 95%CI 0.63-1.64, P=0.94). The rate of recurrent ischemia was reduced in patients undergoing early coronary angiography (OR=0.56, 95%CI 0.40-0.79, P=0.001). Subgroup analysis indicated that the rate of new MI tended to depend on the study-specific endpoint definition (p for difference between subgroups 0.11), while a meta-regression revealed association of new MI rates with the within-study delay to coronary angiography (p=0.05). Conclusion: Early invasive strategy appears to reduce the occurrence of recurrent ischemia, but confers no mortality benefit. The true effect on the occurrence of new MI is obscured by the high between-study heterogeneity that stems mainly from non-uniform timing of early intervention and new MI definitions across the trials.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113026188</affiliation-url><afid>113026188</afid><affilname>Clinical Center of Serbia</affilname><name-variant>Clinical Center of Serbia</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068815</affiliation-url><afid>60068815</afid><affilname>University of Belgrade</affilname><name-variant>University of Belgrade</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112573719</affiliation-url><afid>112573719</afid><affilname>Institute for Medical Statistics and Informatics</affilname><name-variant>Institute for Medical Statistics and Informatics</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113026188</affiliation-url><afid>113026188</afid><affilname>Clinical Center of Serbia</affilname><name-variant>Clinical Center of Serbia</name-variant><affiliation-city>Belgrade</affiliation-city><affiliation-country>Serbia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24823024500</author-url><authid>24823024500</authid><authname>Milasinovic D.</authname><surname>Milasinovic</surname><given-name>Dejan</given-name><initials>D.</initials><afid>113026188</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56622640900</author-url><authid>56622640900</authid><authname>Milosevic A.</authname><surname>Milosevic</surname><given-name>Aleksandra</given-name><initials>A.</initials><afid>113026188</afid><afid>113026188</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56622640900</author-url><authid>56622640900</authid><authname>Milosevic A.</authname><surname>Milosevic</surname><given-name>Aleksandra</given-name><initials>A.</initials><afid>113026188</afid><afid>113026188</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622507300</author-url><authid>56622507300</authid><authname>Marinkovic J.</authname><surname>Marinkovic</surname><given-name>Jelena</given-name><initials>J.</initials><afid>60068815</afid><afid>112573719</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622507300</author-url><authid>56622507300</authid><authname>Marinkovic J.</authname><surname>Marinkovic</surname><given-name>Jelena</given-name><initials>J.</initials><afid>60068815</afid><afid>112573719</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15741934700</author-url><authid>15741934700</authid><authname>Vukcevic V.</authname><surname>Vukcevic</surname><given-name>Vladan</given-name><initials>V.</initials><afid>113026188</afid><afid>60068815</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15741934700</author-url><authid>15741934700</authid><authname>Vukcevic V.</authname><surname>Vukcevic</surname><given-name>Vladan</given-name><initials>V.</initials><afid>113026188</afid><afid>60068815</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56622595100</author-url><authid>56622595100</authid><authname>Ristic A.</authname><surname>Ristic</surname><given-name>Arsen</given-name><initials>A.</initials><afid>113026188</afid><afid>60068815</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56622595100</author-url><authid>56622595100</authid><authname>Ristic A.</authname><surname>Ristic</surname><given-name>Arsen</given-name><initials>A.</initials><afid>113026188</afid><afid>60068815</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8603366900</author-url><authid>8603366900</authid><authname>Asanin M.</authname><surname>Asanin</surname><given-name>Milika</given-name><initials>M.</initials><afid>113026188</afid><afid>60068815</afid><afid>113026188</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8603366900</author-url><authid>8603366900</authid><authname>Asanin M.</authname><surname>Asanin</surname><given-name>Milika</given-name><initials>M.</initials><afid>113026188</afid><afid>60068815</afid><afid>113026188</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8603366900</author-url><authid>8603366900</authid><authname>Asanin M.</authname><surname>Asanin</surname><given-name>Milika</given-name><initials>M.</initials><afid>113026188</afid><afid>60068815</afid><afid>113026188</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55866616800</author-url><authid>55866616800</authid><authname>Stankovic G.</authname><surname>Stankovic</surname><given-name>Goran</given-name><initials>G.</initials><afid>113026188</afid><afid>60068815</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55866616800</author-url><authid>55866616800</authid><authname>Stankovic G.</authname><surname>Stankovic</surname><given-name>Goran</given-name><initials>G.</initials><afid>113026188</afid><afid>60068815</afid></author><authkeywords>Early invasive strategy | Meta-analysis | NSTE-ACS | Randomized controlled trial</authkeywords><intid>1535861439</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929149112"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929149112?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929149112&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929149112&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007639"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929149112</prism:url><dc:identifier>SCOPUS_ID:84929149112</dc:identifier><eid>2-s2.0-84929149112</eid><dc:title>Exclude pregnancy, vigorous exercise and myopathy before diagnosing noncompaction in healthy subjects</dc:title><dc:creator>StÃ¶llberger C.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>32-33</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.044</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030339</affiliation-url><afid>60030339</afid><affilname>Rudolfstifung Hospital</affilname><name-variant>Krankenanstalt Rudolfstiftung</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030339</affiliation-url><afid>60030339</afid><affilname>Rudolfstifung Hospital</affilname><name-variant>Krankenanstalt Rudolfstiftung</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname/><affiliation-city>Wien, Ãsterreich</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55071525800</author-url><authid>55071525800</authid><authname>StÃ¶llberger C.</authname><surname>StÃ¶llberger</surname><given-name>Claudia</given-name><initials>C.</initials><afid>60030339</afid><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55071525800</author-url><authid>55071525800</authid><authname>StÃ¶llberger C.</authname><surname>StÃ¶llberger</surname><given-name>Claudia</given-name><initials>C.</initials><afid>60030339</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55181651300</author-url><authid>55181651300</authid><authname>Finsterer J.</authname><surname>Finsterer</surname><given-name>Josef</given-name><initials>J.</initials><afid>60030339</afid></author><authkeywords>Cardiomyopathy | Echocardiography | Left ventricle | Magnetic resonance imaging</authkeywords><intid>535917635</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928104278"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928104278?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928104278&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928104278&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001133"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928104278</prism:url><dc:identifier>SCOPUS_ID:84928104278</dc:identifier><eid>2-s2.0-84928104278</eid><dc:title>NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium</dc:title><dc:creator>White M.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>13-23</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.006</prism:doi><pii>S0022282815001133</pii><dc:description>Â© 2015. Valvular and vascular calcification are common causes of cardiovascular morbidity and mortality. Developing effective treatments requires understanding the molecular underpinnings of these processes. Shear stress is thought to play a role in inhibiting calcification. Furthermore, NOTCH1 regulates vascular and valvular endothelium, and human mutations in NOTCH1 can cause calcific aortic valve disease. Here, we determined the genome-wide impact of altering shear stress and NOTCH signaling on human aortic valve endothelium. mRNA-sequencing of primary human aortic valve endothelial cells (HAVECs) with or without knockdown of NOTCH1, in the presence or absence of shear stress, revealed NOTCH1-dependency of the atherosclerosis-related gene connexin 40 (GJA5), and numerous repressors of endochondral ossification. Among these, matrix gla protein (MGP) is highly expressed in aortic valve and vasculature, and inhibits soft tissue calcification by sequestering bone morphogenetic proteins (BMPs). Altering NOTCH1 levels affected MGP mRNA and protein in HAVECs. Furthermore, shear stress activated NOTCH signaling and MGP in a NOTCH1-dependent manner. NOTCH1 positively regulated endothelial MGP in vivo through specific binding motifs upstream of MGP. Our studies suggest that shear stress activates NOTCH1 in primary human aortic valve endothelial cells leading to downregulation of osteoblast-like gene networks that play a role in tissue calcification.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028421</affiliation-url><afid>60028421</afid><affilname>University of Colorado School of Medicine</affilname><name-variant>University of Colorado</name-variant><affiliation-city>Denver</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032838</affiliation-url><afid>60032838</afid><affilname>Stanford University School of Medicine</affilname><name-variant>Stanford University School of Medicine</name-variant><affiliation-city>Stanford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14326223900</author-url><authid>14326223900</authid><authname>White M.</authname><surname>White</surname><given-name>Mark P.</given-name><initials>M.P.</initials><afid>60023691</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23135823900</author-url><authid>23135823900</authid><authname>Theodoris C.</authname><surname>Theodoris</surname><given-name>Christina V.</given-name><initials>C.V.</initials><afid>60023691</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56544801500</author-url><authid>56544801500</authid><authname>Liu L.</authname><surname>Liu</surname><given-name>Lei</given-name><initials>L.</initials><afid>60023691</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54683665900</author-url><authid>54683665900</authid><authname>Collins W.</authname><surname>Collins</surname><given-name>William J.</given-name><initials>W.J.</initials><afid>60023691</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56600567700</author-url><authid>56600567700</authid><authname>Blue K.</authname><surname>Blue</surname><given-name>Kathleen W.</given-name><initials>K.W.</initials><afid>60023691</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56599930200</author-url><authid>56599930200</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>Joon Ho</given-name><initials>J.H.</initials><afid>60028421</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56599492300</author-url><authid>56599492300</authid><authname>Meng X.</authname><surname>Meng</surname><given-name>Xianzhong</given-name><initials>X.</initials><afid>60028421</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56473311300</author-url><authid>56473311300</authid><authname>Robbins R.</authname><surname>Robbins</surname><given-name>Robert C.</given-name><initials>R.C.</initials><afid>60032838</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:14028450400</author-url><authid>14028450400</authid><authname>Ivey K.</authname><surname>Ivey</surname><given-name>Kathryn N.</given-name><initials>K.N.</initials><afid>60023691</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7203029247</author-url><authid>7203029247</authid><authname>Srivastava D.</authname><surname>Srivastava</surname><given-name>Deepak</given-name><initials>D.</initials><afid>60023691</afid></author><authkeywords>Matrix gla protein | NOTCH signaling | NOTCH1 | Valve calcification | Valve endothelium</authkeywords><intid>1535732760</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929471373"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929471373?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929471373&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929471373&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1361841515000638"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929471373</prism:url><dc:identifier>SCOPUS_ID:84929471373</dc:identifier><eid>2-s2.0-84929471373</eid><dc:title>Multiscale properties of weighted total variation flow with applications to denoising and registration</dc:title><dc:creator>Athavale P.</dc:creator><prism:publicationName>Medical Image Analysis</prism:publicationName><prism:issn>13618415</prism:issn><prism:eIssn>13618423</prism:eIssn><prism:volume>23</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>28-42</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.media.2015.04.013</prism:doi><pii>S1361841515000638</pii><dc:description>Â© 2015 Elsevier B.V. Images consist of structures of varying scales: large scale structures such as flat regions, and small scale structures such as noise, textures, and rapidly oscillatory patterns. In the hierarchical (BV, L&lt;sup&gt;2&lt;/sup&gt;) image decomposition, Tadmor, etal. (2004) start with extracting coarse scale structures from a given image, and successively extract finer structures from the residuals in each step of the iterative decomposition. We propose to begin instead by extracting the finest structures from the given image and then proceed to extract increasingly coarser structures. In most images, noise could be considered as a fine scale structure. Thus, starting the image decomposition with finer scales, rather than large scales, leads to fast denoising. We note that our approach turns out to be equivalent to the nonstationary regularization in Scherzer and Weickert (2000). The continuous limit of this procedure leads to a time-scaled version of total variation flow.Motivated by specific clinical applications, we introduce an image depending weight in the regularization functional, and study the corresponding weighted TV flow. We show that the edge-preserving property of the multiscale representation of an input image obtained with the weighted TV flow can be enhanced and localized by appropriate choice of the weight. We use this in developing an efficient and edge-preserving denoising algorithm with control on speed and localization properties. We examine analytical properties of the weighted TV flow that give precise information about the denoising speed and the rate of change of energy of the images.An additional contribution of the paper is to use the images obtained at different scales for robust multiscale registration. We show that the inherently multiscale nature of the weighted TV flow improved performance for registration of noisy cardiac MRI images, compared to other methods such as bilateral or Gaussian filtering. A clinical application of the multiscale registration algorithm is also demonstrated for aligning viability assessment magnetic resonance (MR) images from 8 patients with previous myocardial infarctions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014528</affiliation-url><afid>60014528</afid><affilname>Fields Institute</affilname><name-variant>Fields Institute for Research in Mathematical Sciences</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100368611</affiliation-url><afid>100368611</afid><affilname>Sunnybrook Research Institute</affilname><name-variant>Sunnybrook Research Institute</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100608285</affiliation-url><afid>100608285</afid><affilname>The Edward S. Rogers Sr. Department of Electrical and Computer Engineering</affilname><name-variant>The Edward S. Rogers Sr. Department of Electrical and Computer Engineering</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35279409200</author-url><authid>35279409200</authid><authname>Athavale P.</authname><surname>Athavale</surname><given-name>Prashant</given-name><initials>P.</initials><afid>60016849</afid><afid>60014528</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35279409200</author-url><authid>35279409200</authid><authname>Athavale P.</authname><surname>Athavale</surname><given-name>Prashant</given-name><initials>P.</initials><afid>60016849</afid><afid>60014528</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36444660900</author-url><authid>36444660900</authid><authname>Xu R.</authname><surname>Xu</surname><given-name>Robert</given-name><initials>R.</initials><afid>100368611</afid><afid>60016849</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36444660900</author-url><authid>36444660900</authid><authname>Xu R.</authname><surname>Xu</surname><given-name>Robert</given-name><initials>R.</initials><afid>100368611</afid><afid>60016849</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603454561</author-url><authid>6603454561</authid><authname>Radau P.</authname><surname>Radau</surname><given-name>Perry</given-name><initials>P.</initials><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003618933</author-url><authid>7003618933</authid><authname>Nachman A.</authname><surname>Nachman</surname><given-name>Adrian</given-name><initials>A.</initials><afid>60016849</afid><afid>100608285</afid><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003618933</author-url><authid>7003618933</authid><authname>Nachman A.</authname><surname>Nachman</surname><given-name>Adrian</given-name><initials>A.</initials><afid>60016849</afid><afid>100608285</afid><afid>60016849</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003618933</author-url><authid>7003618933</authid><authname>Nachman A.</authname><surname>Nachman</surname><given-name>Adrian</given-name><initials>A.</initials><afid>60016849</afid><afid>100608285</afid><afid>60016849</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7402848725</author-url><authid>7402848725</authid><authname>Wright G.</authname><surname>Wright</surname><given-name>Graham A.</given-name><initials>G.A.</initials><afid>100368611</afid><afid>60016849</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7402848725</author-url><authid>7402848725</authid><authname>Wright G.</authname><surname>Wright</surname><given-name>Graham A.</given-name><initials>G.A.</initials><afid>100368611</afid><afid>60016849</afid></author><authkeywords>Fast denoising | Multiscale registration | Mutual information | Normalized gradient field | Total variation flow</authkeywords><intid>1035960202</intid><source-id>17271</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930201353"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930201353?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930201353&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930201353&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001467"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930201353</prism:url><dc:identifier>SCOPUS_ID:84930201353</dc:identifier><eid>2-s2.0-84930201353</eid><dc:title>Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy</dc:title><dc:creator>Thoonen R.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>202-211</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.002</prism:doi><pii>S0022282815001467</pii><dc:description>Â© 2015 Elsevier Ltd. Brown adipose tissue (BAT) has well recognized thermogenic properties mediated by uncoupling protein 1 (UCP1); more recently, BAT has been demonstrated to modulate cardiovascular risk factors. To investigate whether BAT also affects myocardial injury and remodeling, UCP1-deficient (UCP1&lt;sup&gt;-/-&lt;/sup&gt;) mice, which have dysfunctional BAT, were subjected to catecholamine-induced cardiomyopathy. At baseline, there were no differences in echocardiographic parameters, plasma cardiac troponin I (cTnI) or myocardial fibrosis between wild-type (WT) and UCP1&lt;sup&gt;-/-&lt;/sup&gt; mice. Isoproterenol infusion increased cTnI and myocardial fibrosis and induced left ventricular (LV) hypertrophy in both WT and UCP1&lt;sup&gt;-/-&lt;/sup&gt; mice. UCP1&lt;sup&gt;-/-&lt;/sup&gt; mice also demonstrated exaggerated myocardial injury, fibrosis, and adverse remodeling, as well as decreased survival. Transplantation of WT BAT to UCP1&lt;sup&gt;-/-&lt;/sup&gt; mice prevented the isoproterenol-induced cTnI increase and improved survival, whereas UCP1&lt;sup&gt;-/-&lt;/sup&gt; BAT transplanted to either UCP1&lt;sup&gt;-/-&lt;/sup&gt; or WT mice had no effect on cTnI release. After 3days of isoproterenol treatment, phosphorylated AKT and ERK were lower in the LV's of UCP1&lt;sup&gt;-/-&lt;/sup&gt; mice than in those of WT mice. Activation of BAT was also noted in a model of chronic ischemic cardiomyopathy, and was correlated to LV dysfunction. Deficiency in UCP1, and accompanying BAT dysfunction, increases cardiomyocyte injury and adverse LV remodeling, and decreases survival in a mouse model of catecholamine-induced cardiomyopathy. Myocardial injury and decreased survival are rescued by transplantation of functional BAT to UCP1&lt;sup&gt;-/-&lt;/sup&gt; mice, suggesting a systemic cardioprotective role of functional BAT. BAT is also activated in chronic ischemic cardiomyopathy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029929</affiliation-url><afid>60029929</afid><affilname>Massachusetts General Hospital</affilname><name-variant>Massachusetts General Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023970</affiliation-url><afid>60023970</afid><affilname>Hopital Henri Mondor</affilname><name-variant>HÃ´pital Henri Mondor</name-variant><affiliation-city>Creteil</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082819</affiliation-url><afid>60082819</afid><affilname>Shanghai Jiao Tong University School of Medicine</affilname><name-variant>Shanghai Jiao Tong University School of Medicine</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029929</affiliation-url><afid>60029929</afid><affilname>Massachusetts General Hospital</affilname><name-variant>Massachusetts General Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:30067969400</author-url><authid>30067969400</authid><authname>Thoonen R.</authname><surname>Thoonen</surname><given-name>Robrecht</given-name><initials>R.</initials><afid>60029929</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26635065000</author-url><authid>26635065000</authid><authname>Ernande L.</authname><surname>Ernande</surname><given-name>Laura</given-name><initials>L.</initials><afid>60029929</afid><afid>60023970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26635065000</author-url><authid>26635065000</authid><authname>Ernande L.</authname><surname>Ernande</surname><given-name>Laura</given-name><initials>L.</initials><afid>60029929</afid><afid>60023970</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662590500</author-url><authid>56662590500</authid><authname>Cheng J.</authname><surname>Cheng</surname><given-name>Juan</given-name><initials>J.</initials><afid>60029929</afid><afid>60082819</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56662590500</author-url><authid>56662590500</authid><authname>Cheng J.</authname><surname>Cheng</surname><given-name>Juan</given-name><initials>J.</initials><afid>60029929</afid><afid>60082819</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25624854600</author-url><authid>25624854600</authid><authname>Nagasaka Y.</authname><surname>Nagasaka</surname><given-name>Yasuko</given-name><initials>Y.</initials><afid>60029929</afid><afid>60029929</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25624854600</author-url><authid>25624854600</authid><authname>Nagasaka Y.</authname><surname>Nagasaka</surname><given-name>Yasuko</given-name><initials>Y.</initials><afid>60029929</afid><afid>60029929</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56662996700</author-url><authid>56662996700</authid><authname>Yao V.</authname><surname>Yao</surname><given-name>Vincent</given-name><initials>V.</initials><afid>60029929</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56663216000</author-url><authid>56663216000</authid><authname>Miranda-Bezerra A.</authname><surname>Miranda-Bezerra</surname><given-name>Alexandre</given-name><initials>A.</initials><afid>60029929</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55649501300</author-url><authid>55649501300</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chan</given-name><initials>C.</initials><afid>60029929</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56662760600</author-url><authid>56662760600</authid><authname>Chao W.</authname><surname>Chao</surname><given-name>Wei</given-name><initials>W.</initials><afid>60029929</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8574195900</author-url><authid>8574195900</authid><authname>Panagia M.</authname><surname>Panagia</surname><given-name>Marcello</given-name><initials>M.</initials><afid>60029929</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603003904</author-url><authid>6603003904</authid><authname>Sosnovik D.</authname><surname>Sosnovik</surname><given-name>David E.</given-name><initials>D.E.</initials><afid>60029929</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55861775900</author-url><authid>55861775900</authid><authname>Puppala D.</authname><surname>Puppala</surname><given-name>Dheeraj</given-name><initials>D.</initials><afid>60029929</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:6701320722</author-url><authid>6701320722</authid><authname>Armoundas A.</authname><surname>Armoundas</surname><given-name>Antonis A.</given-name><initials>A.A.</initials><afid>60029929</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7004648091</author-url><authid>7004648091</authid><authname>Hindle A.</authname><surname>Hindle</surname><given-name>Allyson</given-name><initials>A.</initials><afid>60029929</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:35407182500</author-url><authid>35407182500</authid><authname>Bloch K.</authname><surname>Bloch</surname><given-name>Kenneth D.</given-name><initials>K.D.</initials><afid>60029929</afid><afid>60029929</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:35407182500</author-url><authid>35407182500</authid><authname>Bloch K.</authname><surname>Bloch</surname><given-name>Kenneth D.</given-name><initials>K.D.</initials><afid>60029929</afid><afid>60029929</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:14031196700</author-url><authid>14031196700</authid><authname>Buys E.</authname><surname>Buys</surname><given-name>Emmanuel S.</given-name><initials>E.S.</initials><afid>60029929</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:6603723843</author-url><authid>6603723843</authid><authname>Scherrer-Crosbie M.</authname><surname>Scherrer-Crosbie</surname><given-name>Marielle</given-name><initials>M.</initials><afid>60029929</afid></author><authkeywords>Brown adipose tissue | Cardioprotection | Heart failure | Isoproterenol | Uncoupling protein 1</authkeywords><intid>1786087700</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928745519"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928745519?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928745519&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928745519&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001339"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928745519</prism:url><dc:identifier>SCOPUS_ID:84928745519</dc:identifier><eid>2-s2.0-84928745519</eid><dc:title>Regulation of L-type calcium channel by phospholemman in cardiac myocytes</dc:title><dc:creator>Zhang X.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>104-111</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.017</prism:doi><pii>S0022282815001339</pii><dc:description>Â© 2015 Elsevier Ltd. We evaluated whether phospholemman (PLM) regulates L-type Ca&lt;sup&gt;2+&lt;/sup&gt; current (I&lt;inf&gt;Ca&lt;/inf&gt;) in mouse ventricular myocytes. Expression of Î±&lt;inf&gt;1&lt;/inf&gt;-subunit of L-type Ca&lt;sup&gt;2+&lt;/sup&gt; channels between wild-type (WT) and PLM knockout (KO) hearts was similar. Compared to WT myocytes, peak I&lt;inf&gt;Ca&lt;/inf&gt; (at -10mV) from KO myocytes was ~41% larger, the inactivation time constant (Ï&lt;inf&gt;inact&lt;/inf&gt;) of I&lt;inf&gt;Ca&lt;/inf&gt; was ~39% longer, but deactivation time constant (Ï&lt;inf&gt;deact&lt;/inf&gt;) was similar. In the presence of isoproterenol (1Î¼M), peak I&lt;inf&gt;Ca&lt;/inf&gt; was ~48% larger and Ï&lt;inf&gt;inact&lt;/inf&gt; was ~144% higher in KO myocytes. With Ba&lt;sup&gt;2+&lt;/sup&gt; as the permeant ion, PLM enhanced voltage-dependent inactivation but had no effect on Ï&lt;inf&gt;deact&lt;/inf&gt;. To dissect the molecular determinants by which PLM regulated I&lt;inf&gt;Ca&lt;/inf&gt;, we expressed PLM mutants by adenovirus-mediated gene transfer in cultured KO myocytes. After 24h in culture, KO myocytes expressing green fluorescent protein (GFP) had significantly larger peak I&lt;inf&gt;Ca&lt;/inf&gt; and longer Ï&lt;inf&gt;inact&lt;/inf&gt; than KO myocytes expressing WT PLM; thereby independently confirming the observations in freshly isolated myocytes. Compared to KO myocytes expressing GFP, KO myocytes expressing the cytoplasmic domain truncation mutant (TM43), the non-phosphorylatable S68A mutant, the phosphomimetic S68E mutant, and the signature PFXYD to alanine (ALL5) mutant all resulted in lower peak I&lt;inf&gt;Ca&lt;/inf&gt;. Expressing PLM mutants did not alter expression of Î±&lt;inf&gt;1&lt;/inf&gt;-subunit of L-type Ca&lt;sup&gt;2+&lt;/sup&gt; channels in cultured KO myocytes. Our results suggested that both the extracellular PFXYD motif and the transmembrane domain of PLM but not the cytoplasmic tail were necessary for regulation of peak I&lt;inf&gt;Ca&lt;/inf&gt; amplitude. We conclude that PLM limits Ca&lt;sup&gt;2+&lt;/sup&gt; influx in cardiac myocytes by reducing maximal I&lt;inf&gt;Ca&lt;/inf&gt; and accelerating voltage-dependent inactivation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013936</affiliation-url><afid>60013936</afid><affilname>Temple University School of Medicine</affilname><name-variant>Temple Univ. Sch. Med.</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013936</affiliation-url><afid>60013936</afid><affilname>Temple University School of Medicine</affilname><name-variant>Temple Univ. Sch. Med.</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027671</affiliation-url><afid>60027671</afid><affilname>Penn State College of Medicine</affilname><name-variant>Pennsylvania State University College of Medicine</name-variant><affiliation-city>Hershey</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029418</affiliation-url><afid>60029418</afid><affilname>University of Virginia Health System</affilname><name-variant>University of Virginia Health System</name-variant><affiliation-city>Charlottesville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55957887600</author-url><authid>55957887600</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xue Qian</given-name><initials>X.Q.</initials><afid>60013936</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56070377200</author-url><authid>56070377200</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>JuFang</given-name><initials>J.</initials><afid>60013936</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56610951100</author-url><authid>56610951100</authid><authname>Song J.</authname><surname>Song</surname><given-name>Jianliang</given-name><initials>J.</initials><afid>60013936</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202369860</author-url><authid>7202369860</authid><authname>Rabinowitz J.</authname><surname>Rabinowitz</surname><given-name>Joseph</given-name><initials>J.</initials><afid>60013936</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34970836400</author-url><authid>34970836400</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xiongwen</given-name><initials>X.</initials><afid>60013936</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005937572</author-url><authid>7005937572</authid><authname>Houser S.</authname><surname>Houser</surname><given-name>Steven R.</given-name><initials>S.R.</initials><afid>60013936</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35511139400</author-url><authid>35511139400</authid><authname>Peterson B.</authname><surname>Peterson</surname><given-name>Blaise Z.</given-name><initials>B.Z.</initials><afid>60027671</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7202049771</author-url><authid>7202049771</authid><authname>Tucker A.</authname><surname>Tucker</surname><given-name>Amy L.</given-name><initials>A.L.</initials><afid>60029418</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35392025700</author-url><authid>35392025700</authid><authname>Feldman A.</authname><surname>Feldman</surname><given-name>Arthur M.</given-name><initials>A.M.</initials><afid>60013936</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7202072292</author-url><authid>7202072292</authid><authname>Cheung J.</authname><surname>Cheung</surname><given-name>Joseph Y.</given-name><initials>J.Y.</initials><afid>60013936</afid></author><authkeywords>Arrhythmia | Ca&lt;sup&gt;2+&lt;/sup&gt; channels | FXYD1 | Phospholemman</authkeywords><intid>1035835175</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928159253"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928159253?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928159253&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928159253&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1095643315000938"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928159253</prism:url><dc:identifier>SCOPUS_ID:84928159253</dc:identifier><eid>2-s2.0-84928159253</eid><dc:title>Temperature and species-specific effects on Ã&lt;inf&gt;3&lt;/inf&gt;-adrenergic receptor cardiac regulation in two freshwater teleosts: Channel catfish (Ictalurus punctatus) and common carp (Cyprinus carpio)</dc:title><dc:creator>Petersen L.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology</prism:publicationName><prism:issn>10956433</prism:issn><prism:eIssn>15314332</prism:eIssn><prism:volume>185</prism:volume><prism:pageRange>132-141</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpa.2015.04.005</prism:doi><pii>S1095643315000938</pii><dc:description>Â© 2015. Î²&lt;inf&gt;3&lt;/inf&gt;-adrenergic receptors (AR) are important in teleost cardiovascular regulation. To date, it is unknown whether temperature acclimation changes Ã&lt;inf&gt;3&lt;/inf&gt;-AR functionality and consequently the involvement of this AR subtype in teleost cardiac regulation. Common carp (Cyprinus carpio) were acclimated at 12Â°C or 23Â°C (minimum 3weeks) after which cardiovascular variables (cardiac output (Q), stroke volume (Sv) and heart rate (f&lt;inf&gt;H&lt;/inf&gt;)) were measured upon injection of the Ã&lt;inf&gt;3&lt;/inf&gt;-AR agonist, BRL&lt;inf&gt;37344&lt;/inf&gt;, and antagonist, SR&lt;inf&gt;59230A&lt;/inf&gt;. In both 12Â°C and 23Â°C acclimated carp, BRL&lt;inf&gt;37344&lt;/inf&gt; induced significant increases in f&lt;inf&gt;H&lt;/inf&gt; and Q whereas Sv was significantly decreased. While temperature did not affect the change (increase vs. decrease) in cardiac variables, the magnitude and on-set of responses differed. For instance, f&lt;inf&gt;H&lt;/inf&gt;, Sv and Q responded significantly faster to Ã&lt;inf&gt;3&lt;/inf&gt;-AR stimulation in 23Â°C carp. In contrast, maximum responses of f&lt;inf&gt;H&lt;/inf&gt; and Q were significantly higher in 23Â°C carp whereas the maximum response of Sv was significantly greater in 12Â°C carp. These findings suggest that temperature acclimation induced changes in Î²&lt;inf&gt;3&lt;/inf&gt;-AR receptor functionality (e.g. density and/or affinity).Stimulation of Î²&lt;inf&gt;3&lt;/inf&gt;-ARs in 23Â°C acclimated channel catfish (Ictalurus punctatus) caused significant increases in f&lt;inf&gt;H&lt;/inf&gt;, Sv and Q. The increase in Sv was opposite to the decrease observed in 23Â°C acclimated common carp. SR&lt;inf&gt;59230A&lt;/inf&gt; induced significant decreases in Sv and Q but had no effect in carp (23Â°C). Results suggest species diversity in the density and affinity or structure of Ã&lt;inf&gt;3&lt;/inf&gt;-ARs which may explain the different cardiac responses to Ã&lt;inf&gt;3&lt;/inf&gt;-AR ligands.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024438</affiliation-url><afid>60024438</afid><affilname>University of North Texas</affilname><name-variant>University of North Texas</name-variant><affiliation-city>Denton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100413757</affiliation-url><afid>100413757</afid><affilname>Waterborne Environmental Inc.</affilname><name-variant>Waterborne Environmental</name-variant><affiliation-city>Leesburg</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:13404535000</author-url><authid>13404535000</authid><authname>Petersen L.</authname><surname>Petersen</surname><given-name>L. H.</given-name><initials>L.H.</initials><afid>60024438</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003481498</author-url><authid>7003481498</authid><authname>Burleson M.</authname><surname>Burleson</surname><given-name>M. L.</given-name><initials>M.L.</initials><afid>60024438</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003344347</author-url><authid>7003344347</authid><authname>Huggett D.</authname><surname>Huggett</surname><given-name>D. B.</given-name><initials>D.B.</initials><afid>60024438</afid><afid>100413757</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003344347</author-url><authid>7003344347</authid><authname>Huggett D.</authname><surname>Huggett</surname><given-name>D. B.</given-name><initials>D.B.</initials><afid>60024438</afid><afid>100413757</afid></author><authkeywords>Cardiac output | Catecholamines | Teleosts | Temperature | Î²&lt;inf&gt;3&lt;/inf&gt;-adrenergic receptors</authkeywords><intid>1535733037</intid><source-id>3500148021</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928951403"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928951403?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928951403&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928951403&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001136"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928951403</prism:url><dc:identifier>SCOPUS_ID:84928951403</dc:identifier><eid>2-s2.0-84928951403</eid><dc:title>Myeloperoxidase impairs the contractile function in isolated human cardiomyocytes</dc:title><dc:creator>KalÃ¡sz J.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>116-127</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.036</prism:doi><pii>S0891584915001136</pii><dc:description>Â© 2015 The Authors. Published by Elsevier Inc. We set out to characterize the mechanical effects of myeloperoxidase (MPO) in isolated left-ventricular human cardiomyocytes. Oxidative myofilament protein modifications (sulfhydryl (SH)-group oxidation and carbonylation) induced by the peroxidase and chlorinating activities of MPO were additionally identified. The specificity of the MPO-evoked functional alterations was tested with an MPO inhibitor (MPO-I) and the antioxidant amino acid Met. The combined application of MPO and its substrate, hydrogen peroxide (H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;), largely reduced the active force (F&lt;inf&gt;active&lt;/inf&gt;), increased the passive force (F&lt;inf&gt;passive&lt;/inf&gt;), and decreased the Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity of force production (pCa&lt;inf&gt;50&lt;/inf&gt;) in permeabilized cardiomyocytes. H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; alone had significantly smaller effects on F&lt;inf&gt;active&lt;/inf&gt; and F&lt;inf&gt;passive&lt;/inf&gt; and did not alter pCa&lt;inf&gt;50&lt;/inf&gt;. The MPO-I blocked both the peroxidase and the chlorinating activities, whereas Met selectively inhibited the chlorinating activity of MPO. All of the MPO-induced functional effects could be prevented by the MPO-I and Met. Both H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; alone and MPO + H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; reduced the SH content of actin and increased the carbonylation of actin and myosin-binding protein C to the same extent. Neither the SH oxidation nor the carbonylation of the giant sarcomeric protein titin was affected by these treatments. MPO activation induces a cardiomyocyte dysfunction by affecting Ca&lt;sup&gt;2+&lt;/sup&gt;-regulated active and Ca&lt;sup&gt;2+&lt;/sup&gt;-independent passive force production and myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity, independent of protein SH oxidation and carbonylation. The MPO-induced deleterious functional alterations can be prevented by the MPO-I and Met. Inhibition of MPO may be a promising therapeutic target to limit myocardial contractile dysfunction during inflammation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004400</affiliation-url><afid>60004400</afid><affilname>Debreceni Egyetem</affilname><name-variant>University of Debrecen</name-variant><affiliation-city>Debrecen</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55208354400</author-url><authid>55208354400</authid><authname>KalÃ¡sz J.</authname><surname>KalÃ¡sz</surname><given-name>Judit</given-name><initials>J.</initials><afid>60004400</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12772866800</author-url><authid>12772866800</authid><authname>PÃ¡sztor E.</authname><surname>PÃ¡sztor</surname><given-name>Eniko T.</given-name><initials>E.T.</initials><afid>60004400</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37030780700</author-url><authid>37030780700</authid><authname>Fagyas M.</authname><surname>Fagyas</surname><given-name>MiklÃ³s</given-name><initials>M.</initials><afid>60004400</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202643497</author-url><authid>7202643497</authid><authname>Balogh Ã.</authname><surname>Balogh</surname><given-name>Ãgnes</given-name><initials>Ã.</initials><afid>60004400</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202905058</author-url><authid>7202905058</authid><authname>TÃ³th A.</authname><surname>TÃ³th</surname><given-name>Attila</given-name><initials>A.</initials><afid>60004400</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56017436300</author-url><authid>56017436300</authid><authname>CsatÃ³ V.</authname><surname>CsatÃ³</surname><given-name>ViktÃ³ria</given-name><initials>V.</initials><afid>60004400</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56015026000</author-url><authid>56015026000</authid><authname>Ãdes I.</authname><surname>Ãdes</surname><given-name>IstvÃ¡n</given-name><initials>I.</initials><afid>60004400</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56650235700</author-url><authid>56650235700</authid><authname>Papp Z.</authname><surname>Papp</surname><given-name>ZoltÃ¡n</given-name><initials>Z.</initials><afid>60004400</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56650175300</author-url><authid>56650175300</authid><authname>BorbÃ©ly A.</authname><surname>BorbÃ©ly</surname><given-name>Attila</given-name><initials>A.</initials><afid>60004400</afid></author><authkeywords>Antioxidants | Cardiomyocyte contractile function | Free radicals | Hydrogen peroxide | modifications | Myeloperoxidase | Oxidative posttranslational protein</authkeywords><intid>35877850</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929147581"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929147581?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929147581&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929147581&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167876015001683"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929147581</prism:url><dc:identifier>SCOPUS_ID:84929147581</dc:identifier><eid>2-s2.0-84929147581</eid><dc:title>Physiological correlates of the flow experience during computer game playing</dc:title><dc:creator>Harmat L.</dc:creator><prism:publicationName>International Journal of Psychophysiology</prism:publicationName><prism:issn>01678760</prism:issn><prism:eIssn>18727697</prism:eIssn><prism:volume>97</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>1-7</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijpsycho.2015.05.001</prism:doi><pii>S0167876015001683</pii><dc:description>Â© 2015 Elsevier B.V. Flow is the subjective experience of effortless attention, reduced self-awareness, and enjoyment that typically occurs during optimal task performance. Previous studies have suggested that flow may be associated with a non-reciprocal coactivation of the sympathetic and parasympathetic systems and, on a cortical level, with a state of hypofrontality and implicit processing. Here, we test these hypotheses, using the computer game TETRIS as model task. The participants (n= 77) played TETRIS under three conditions that differed in difficulty (Easy &lt; Optimal &lt; Difficult). Cardiac and respiratory activities, and the average oxygenation changes of the prefrontal cortex were measured continuously with functional near infrared spectroscopy (fNIRS) during performance. The Optimal condition was characterized by the highest levels of state flow, positive affect, and effortless attention. The associations between self-reported psychological flow and physiological measures were investigated using a series of repeated measures linear mixed model analyses. The results showed that higher flow was associated with larger respiratory depth and lower LF. The higher respiratory depth during high flow is indicative of a more relaxed state with an increased parasympathetic activity, and thus provides partial support for the main hypotheses. There was no association between frontal cortical oxygenation and flow, even at liberal thresholds; i.e. we found no support that flow is related to a state of hypofrontality.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028378</affiliation-url><afid>60028378</afid><affilname>Stockholms universitet</affilname><name-variant>Stockholm University</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24075792100</author-url><authid>24075792100</authid><authname>Harmat L.</authname><surname>Harmat</surname><given-name>LÃ¡szlÃ³</given-name><initials>L.</initials><afid>60012311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36023437200</author-url><authid>36023437200</authid><authname>de Manzano Ã.</authname><surname>de Manzano</surname><given-name>Ãrjan</given-name><initials>Ã.</initials><afid>60012311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102121079</author-url><authid>7102121079</authid><authname>Theorell T.</authname><surname>Theorell</surname><given-name>TÃ¶res</given-name><initials>T.</initials><afid>60012311</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507459196</author-url><authid>6507459196</authid><authname>HÃ¶gman L.</authname><surname>HÃ¶gman</surname><given-name>Lennart</given-name><initials>L.</initials><afid>60028378</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7403438477</author-url><authid>7403438477</authid><authname>Fischer H.</authname><surname>Fischer</surname><given-name>HÃ¥kan</given-name><initials>H.</initials><afid>60028378</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602870603</author-url><authid>6602870603</authid><authname>UllÃ©n F.</authname><surname>UllÃ©n</surname><given-name>Fredrik</given-name><initials>F.</initials><afid>60012311</afid></author><authkeywords>Autonomous nervous system | Effortless attention | Functional near-infrared spectroscopy | Heart rate variability | Hypofrontality | Psychological flow</authkeywords><intid>1535917345</intid><source-id>14902</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929192297"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929192297?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929192297&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929192297&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315009225"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929192297</prism:url><dc:identifier>SCOPUS_ID:84929192297</dc:identifier><eid>2-s2.0-84929192297</eid><dc:title>Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease</dc:title><dc:creator>Sakuragi S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>287-292</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.189</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: Cystatin C is an endogenous marker of kidney function that overcomes the limitations of serum creatinine. High serum cystatin C levels have been associated with increased cardiovascular mortality and morbidity. In this cross-sectional study, we aimed to determine the associations between serum cystatin C levels and structural and functional cardiac changes in patients with stage 2 or 3 chronic kidney disease (CKD). Methods and results: We enrolled 429 consecutive patients (aged 24-97 years) with CKD stage 2 or 3 and left ventricular (LV) ejection fraction (LVEF) N 40%. Echocardiographic parameters, including LV mass index (LVMI), early diastolic mitral annulus velocity (eâ² velocity), left atrial volume index (LAVI), and N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) were measured. Patients were categorized into quartiles according to serum cystatin C levels. Cystatin C was associated with LAVI (p= 0.0055), LVEF (p = 0.0432), LVMI (p = 0.0409), eâ² (p = 0.0051), E/eâ² (p = 0.0027), and log-transformed NT-proBNP (p b 0.0001) according to multivariate linear regression analysis, after adjustment for confounding factors including creatinine-based estimated glomerular filtration rate (eGFRcreat) and urinary albumin to creatinine ratio. Incidence of eccentric and concentric hypertrophy increased with increasing cystatin C (Q1, 38%; Q2 49%; Q3, 51%; Q4, 66%, p = 0.0008), mainly because of increasing concentric hypertrophy (Q1, 30%; Q2, 39%; Q3, 39%; Q4, 51%, p = 0.0187). Conclusion: A high serum cystatin C is strongly associated with structural cardiac abnormalities such as LVH and left atrial enlargement, impaired LV relaxation, and an increased NT-proBNP, independently of eGFRcreat in patients with stage 2 or 3 CKD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114851949</affiliation-url><afid>114851949</afid><affilname>Iwakuni Clinical Center</affilname><name-variant>National Hospital Iwakuni Clinical Center</name-variant><affiliation-city/><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023147</affiliation-url><afid>60023147</afid><affilname>Okayama University</affilname><name-variant>Okayama University</name-variant><affiliation-city>Okayama</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640960200</author-url><authid>56640960200</authid><authname>Sakuragi S.</authname><surname>Sakuragi</surname><given-name>Satoru</given-name><initials>S.</initials><afid>114851949</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640636000</author-url><authid>56640636000</authid><authname>Ichikawa K.</authname><surname>Ichikawa</surname><given-name>Keishi</given-name><initials>K.</initials><afid>114851949</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640226200</author-url><authid>56640226200</authid><authname>Yamada K.</authname><surname>Yamada</surname><given-name>Keiji</given-name><initials>K.</initials><afid>114851949</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640689800</author-url><authid>56640689800</authid><authname>Tanimoto M.</authname><surname>Tanimoto</surname><given-name>Masafumi</given-name><initials>M.</initials><afid>114851949</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640523000</author-url><authid>56640523000</authid><authname>Miki T.</authname><surname>Miki</surname><given-name>Takashi</given-name><initials>T.</initials><afid>114851949</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640677000</author-url><authid>56640677000</authid><authname>Otsuka H.</authname><surname>Otsuka</surname><given-name>Hiroaki</given-name><initials>H.</initials><afid>114851949</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640187000</author-url><authid>56640187000</authid><authname>Yamamoto K.</authname><surname>Yamamoto</surname><given-name>Kazuhiko</given-name><initials>K.</initials><afid>114851949</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640688100</author-url><authid>56640688100</authid><authname>Kawamoto K.</authname><surname>Kawamoto</surname><given-name>Kenji</given-name><initials>K.</initials><afid>114851949</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56640550100</author-url><authid>56640550100</authid><authname>Katayama Y.</authname><surname>Katayama</surname><given-name>Yusuke</given-name><initials>Y.</initials><afid>114851949</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:24436900100</author-url><authid>24436900100</authid><authname>Tanakaya M.</authname><surname>Tanakaya</surname><given-name>Machiko</given-name><initials>M.</initials><afid>114851949</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56640282600</author-url><authid>56640282600</authid><authname>Ito H.</authname><surname>Ito</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60023147</afid></author><authkeywords>Cystatin C | Left atrial enlargement | Left ventricular hypertrophy | LV relaxation</authkeywords><intid>35915655</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929172339"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929172339?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929172339&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929172339&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001431"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929172339</prism:url><dc:identifier>SCOPUS_ID:84929172339</dc:identifier><eid>2-s2.0-84929172339</eid><dc:title>Effect of myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity on Ca&lt;sup&gt;2+&lt;/sup&gt; wave propagation in rat ventricular muscle</dc:title><dc:creator>Miura M.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>84</prism:volume><prism:pageRange>162-169</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.04.027</prism:doi><pii>S0022282815001431</pii><dc:description>Â© 2015 Elsevier Ltd. Background: The propagation velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves determines delayed afterdepolarization and affects the occurrence of triggered arrhythmias in cardiac muscle. We focused on myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity, investigating how the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves responds to its increased sensitivity resulting from muscle stretch or the addition of a myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitizer, SCH00013. We further investigated whether production of reactive oxygen species (ROS) may be involved in the change in velocity. Methods: Trabeculae were obtained from rat hearts. Force, sarcomere length, and [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; were measured. ROS production was estimated from 2',7'-dichlorofluorescein (DCF) fluorescence. Trabeculae were exposed to a 10mM Ca&lt;sup&gt;2+&lt;/sup&gt; jet for the induction of Ca&lt;sup&gt;2+&lt;/sup&gt; leak from the sarcoplasmic reticulum in its exposed region. Ca&lt;sup&gt;2+&lt;/sup&gt; waves were induced by 2.5-Hz stimulus trains for 7.5s (24Â°C, 2.0mM [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;o&lt;/inf&gt;). Muscle stretch of 5, 10, and 15% was applied 300ms after the last stimulus of the train. Results: Muscle stretch increased the DCF fluorescence, the amplitude of aftercontractions, and the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves depending on the degree of stretch. After preincubation with 3Î¼M diphenyleneiodonium (DPI), muscle stretch increased only the amplitude of aftercontractions but not the DCF fluorescence nor the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves. SCH00013 (30Î¼M) increased the DCF fluorescence, the amplitude of aftercontractions, and the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves. DPI suppressed these increases. Conclusions: Muscle stretch increases the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves by increasing ROS production, not by increasing myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity. In the case of SCH00013, ROS production increases myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity and the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves. These results suggest that ROS rather than myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity plays an important role in the determination of the velocity of Ca&lt;sup&gt;2+&lt;/sup&gt; waves, that is, arrhythmogenesis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016416</affiliation-url><afid>60016416</afid><affilname>Tohoku University School of Medicine</affilname><name-variant>Tohoku University Graduate School of Medicine</name-variant><affiliation-city>Sendai</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56649522300</author-url><authid>56649522300</authid><authname>Miura M.</authname><surname>Miura</surname><given-name>Masahito</given-name><initials>M.</initials><afid>60016416</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640690500</author-url><authid>56640690500</authid><authname>Taguchi Y.</authname><surname>Taguchi</surname><given-name>Yuhto</given-name><initials>Y.</initials><afid>60016416</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55237367100</author-url><authid>55237367100</authid><authname>Nagano T.</authname><surname>Nagano</surname><given-name>Tsuyoshi</given-name><initials>T.</initials><afid>60016416</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640364600</author-url><authid>56640364600</authid><authname>Sasaki M.</authname><surname>Sasaki</surname><given-name>Mai</given-name><initials>M.</initials><afid>60016416</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641627900</author-url><authid>56641627900</authid><authname>Handoh T.</authname><surname>Handoh</surname><given-name>Tetsuya</given-name><initials>T.</initials><afid>60016416</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56649712400</author-url><authid>56649712400</authid><authname>Shindoh C.</authname><surname>Shindoh</surname><given-name>Chiyohiko</given-name><initials>C.</initials><afid>60016416</afid></author><authkeywords>Ca&lt;sup&gt;2+&lt;/sup&gt; waves | Muscle stretch | Myofilament Ca&lt;sup&gt;2+&lt;/sup&gt; sensitivity | ROS</authkeywords><intid>2035911335</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925263188"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925263188?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925263188&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925263188&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715003289"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925263188</prism:url><dc:identifier>SCOPUS_ID:84925263188</dc:identifier><eid>2-s2.0-84925263188</eid><dc:title>Noise sensitivity and future risk of illness and mortality</dc:title><dc:creator>Stansfeld S.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>520</prism:volume><prism:pageRange>114-119</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.03.053</prism:doi><pii>S0048969715003289</pii><dc:description>Â© 2015. Aircraft and road traffic noise exposure increase the risk of cardiovascular disease (CVD). Noise annoyance is the most frequent response to environmental noise. Noise annoyance has been shown to modify the association of transport noise exposure on CVD and noise sensitivity moderates the annoyance response to noise. This study uses prospective data from phases 1, 3, 5, 7 and 9 in 3630 male and female civil servants from the UK Whitehall II Study to examine whether a single question on noise sensitivity measured by annoyance responses to noise in general predicts physical and mental ill-health and mortality. Non-fatal myocardial infarction and stroke morbidity over the follow-up were defined by MONICA criteria based on study ECGs, hospital records, hospital admission statistics or General Practitioner confirmation. Depressive symptoms were measured by the Center for Epidemiologic Studies Depression Scale (CES-D) and psychological distress by the General Health questionnaire (GHQ). There was no association between noise sensitivity and CVD morbidity or mortality except in people from lower employment grades where there was an association with angina. Noise sensitivity was a consistent predictor of depressive symptoms and psychological distress at phases 3, 5 and 7. High noise sensitivity scores at baseline predicted GHQ caseness at phase 3 adjusting for age, sex, employment grade, self-rated health and GHQ caseness at baseline (OR. = 1.56 95% CI 1.29-1.88). Noise sensitivity has been identified as a predictor of mental ill-health. More longitudinal research is needed including measures of noise exposure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021435</affiliation-url><afid>60021435</afid><affilname>Barts and The London Queen Mary's School of Medicine and Dentistry</affilname><name-variant>Queen Mary University of London</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55666438900</author-url><authid>55666438900</authid><authname>Stansfeld S.</authname><surname>Stansfeld</surname><given-name>S. A.</given-name><initials>S.A.</initials><afid>60021435</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7103265845</author-url><authid>7103265845</authid><authname>Shipley M.</authname><surname>Shipley</surname><given-name>M.</given-name><initials>M.</initials><afid>60022148</afid></author><authkeywords>Annoyance | Coronary heart disease | Depression | Mortality | Noise | Sensitivity</authkeywords><intid>1535276234</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926381489"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926381489?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926381489&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926381489&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0160412015000823"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926381489</prism:url><dc:identifier>SCOPUS_ID:84926381489</dc:identifier><eid>2-s2.0-84926381489</eid><dc:title>Chronic disease prevalence in women and air pollution - A 30-year longitudinal cohort study</dc:title><dc:creator>To T.</dc:creator><prism:publicationName>Environment International</prism:publicationName><prism:issn>01604120</prism:issn><prism:eIssn>18736750</prism:eIssn><prism:volume>80</prism:volume><prism:pageRange>26-32</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.envint.2015.03.017</prism:doi><pii>S0160412015000823</pii><dc:description>Â© 2015 Elsevier Ltd. Background: Air pollution, such as fine particulate matter (PM&lt;inf&gt;2.5&lt;/inf&gt;), can increase risk of adverse health events among people with heart disease, diabetes, asthma and chronic obstructive pulmonary disease (COPD) by aggravating these conditions. Identifying the influence of PM&lt;inf&gt;2.5&lt;/inf&gt; on prevalence of these conditions may help target interventions to reduce disease morbidity among high-risk populations. Objectives: The objective of this study is to measure the association of exposure of PM&lt;inf&gt;2.5&lt;/inf&gt; with prevalence risk of various chronic diseases among a longitudinal cohort of women. Methods: Women from Ontario who enrolled in the Canadian National Breast Screening Study (CNBSS) from 1980 to 1985 (n=29,549) were linked to provincial health administrative data from April 1, 1992 to March 31, 2013 to determine the prevalence of major chronic disease and conditions (heart disease, diabetes, asthma, COPD, acute myocardial infarction, angina, stroke and cancers). Exposure to PM&lt;inf&gt;2.5&lt;/inf&gt; was measured using satellite data collected from January 1, 1998 to December 31, 2006 and assigned to resident postal-code at time of entry into study. Poisson regression models were used to describe the relationship between exposure to ambient PM&lt;inf&gt;2.5&lt;/inf&gt; and chronic disease prevalence. Prevalence rate ratios (PRs) were estimated while adjusting for potential confounders: baseline age, smoking, BMI, marital status, education and occupation. Separate models were run for each chronic disease and condition. Results: Congestive heart failure (PR=1.31, 95% CI: 1.13, 1.51), diabetes (PR=1.28, 95% CI: 1.16, 1.41), ischemic heart disease (PR=1.22, 95% CI: 1.14, 1.30), and stroke (PR=1.21, 95% CI: 1.09, 1.35) showed over a 20% increase in PRs per 10Î¼g/m&lt;sup&gt;3&lt;/sup&gt; increase in PM&lt;inf&gt;2.5&lt;/inf&gt; after adjusting for risk factors. Risks were elevated in smokers and those with BMI greater than 30. Conclusions: This study estimated significant elevated prevalent rate ratios per unit increase in PM&lt;inf&gt;2.5&lt;/inf&gt; in nine of the ten chronic diseases studied.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030319</affiliation-url><afid>60030319</afid><affilname>Hospital for Sick Children University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017829</affiliation-url><afid>60017829</afid><affilname>Institute for Clinical Evaluative Sciences</affilname><name-variant>Institute for Clinical Evaluative Sciences</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106208720</affiliation-url><afid>106208720</afid><affilname>Dalla Lana School of Public Health</affilname><name-variant>Dalla Lana School of Public Health</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017592</affiliation-url><afid>60017592</afid><affilname>Carleton University</affilname><name-variant>Carleton University</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112584373</affiliation-url><afid>112584373</afid><affilname>Public Health Ontario</affilname><name-variant>Public Health Ontario</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002494</affiliation-url><afid>60002494</afid><affilname>McGill University</affilname><name-variant>McGill University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005851925</author-url><authid>7005851925</authid><authname>To T.</authname><surname>To</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60030319</afid><afid>60017829</afid><afid>106208720</afid><afid>60016849</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005851925</author-url><authid>7005851925</authid><authname>To T.</authname><surname>To</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60030319</afid><afid>60017829</afid><afid>106208720</afid><afid>60016849</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005851925</author-url><authid>7005851925</authid><authname>To T.</authname><surname>To</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60030319</afid><afid>60017829</afid><afid>106208720</afid><afid>60016849</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005851925</author-url><authid>7005851925</authid><authname>To T.</authname><surname>To</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60030319</afid><afid>60017829</afid><afid>106208720</afid><afid>60016849</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56428145900</author-url><authid>56428145900</authid><authname>Zhu J.</authname><surname>Zhu</surname><given-name>Jingqin</given-name><initials>J.</initials><afid>60030319</afid><afid>60017829</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56428145900</author-url><authid>56428145900</authid><authname>Zhu J.</authname><surname>Zhu</surname><given-name>Jingqin</given-name><initials>J.</initials><afid>60030319</afid><afid>60017829</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102602822</author-url><authid>7102602822</authid><authname>Villeneuve P.</authname><surname>Villeneuve</surname><given-name>Paul J.</given-name><initials>P.J.</initials><afid>60017592</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55416018800</author-url><authid>55416018800</authid><authname>Simatovic J.</authname><surname>Simatovic</surname><given-name>Jacqueline</given-name><initials>J.</initials><afid>60030319</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56428547800</author-url><authid>56428547800</authid><authname>Feldman L.</authname><surname>Feldman</surname><given-name>Laura</given-name><initials>L.</initials><afid>60030319</afid><afid>106208720</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56428547800</author-url><authid>56428547800</authid><authname>Feldman L.</authname><surname>Feldman</surname><given-name>Laura</given-name><initials>L.</initials><afid>60030319</afid><afid>106208720</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56580940400</author-url><authid>56580940400</authid><authname>Gao C.</authname><surname>Gao</surname><given-name>Chenwei</given-name><initials>C.</initials><afid>60030319</afid><afid>60017829</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56580940400</author-url><authid>56580940400</authid><authname>Gao C.</authname><surname>Gao</surname><given-name>Chenwei</given-name><initials>C.</initials><afid>60030319</afid><afid>60017829</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56580768200</author-url><authid>56580768200</authid><authname>Williams D.</authname><surname>Williams</surname><given-name>Devon</given-name><initials>D.</initials><afid>60030319</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56216266400</author-url><authid>56216266400</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hong</given-name><initials>H.</initials><afid>60017829</afid><afid>106208720</afid><afid>112584373</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56216266400</author-url><authid>56216266400</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hong</given-name><initials>H.</initials><afid>60017829</afid><afid>106208720</afid><afid>112584373</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56216266400</author-url><authid>56216266400</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hong</given-name><initials>H.</initials><afid>60017829</afid><afid>106208720</afid><afid>112584373</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:16318118900</author-url><authid>16318118900</authid><authname>Weichenthal S.</authname><surname>Weichenthal</surname><given-name>Scott</given-name><initials>S.</initials><afid>60002494</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102194693</author-url><authid>7102194693</authid><authname>Wall C.</authname><surname>Wall</surname><given-name>Claus</given-name><initials>C.</initials><afid>106208720</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35352027700</author-url><authid>35352027700</authid><authname>Miller A.</authname><surname>Miller</surname><given-name>Anthony B.</given-name><initials>A.B.</initials><afid>106208720</afid></author><authkeywords>Air pollution | Chronic disease prevalence | Environmental exposures</authkeywords><intid>1785431191</intid><source-id>20912</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929465251"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929465251?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929465251&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929465251&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0010482515001316"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929465251</prism:url><dc:identifier>SCOPUS_ID:84929465251</dc:identifier><eid>2-s2.0-84929465251</eid><dc:title>Image-based computational simulation of sub-endothelial LDL accumulation in a human right coronary artery</dc:title><dc:creator>Nouri M.</dc:creator><prism:publicationName>Computers in Biology and Medicine</prism:publicationName><prism:issn>00104825</prism:issn><prism:eIssn>18790534</prism:eIssn><prism:volume>62</prism:volume><prism:pageRange>206-221</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>July 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.compbiomed.2015.04.013</prism:doi><pii>S0010482515001316</pii><dc:description>Â© 2015 Published by Elsevier Ltd. Accumulation of low density lipoproteins (LDL) in the vessel wall is suggested as the initiator of atherosclerosis and coronary stenosis. This process is associated with the performance of endothelium layer that regulates entering of macromolecules to the vessel wall. Therefore, the present study aims to investigate sub-endothelial accumulation of LDL molecules in a coronary tree and predict atherosclerosis prone sites. Non-Newtonian blood flow is simulated for normal and hypertensive conditions through the lumen of a right coronary artery reconstructed from computed tomography (CT) images. A three-pore model is implemented as the endothelium boundary condition and hence, plasma flow and LDL transport are simulated within the arterial wall. Based on the pore model, endothelium pathways divide into normal junctions, vesicles and leaky junctions. Most of LDL molecules pass through the leaky junctions that arise at locations with low wall shear stress (WSS). Results indicate that increase in the number of leaky junctions at branch points with low WSS can lead to both elevated levels of sub-endothelial LDL accumulation and atherosclerosis risk. Findings reveal that at the branch points with disturbed flow, sub-endothelial concentration of LDL for the hypertensive condition is higher than the normal condition, however for the rest of regions with uniform geometry and unidirectional flow, this is reversed. Comparisons of non-Newtonian and Newtonian flows show mean increases of 34% and 13% in the sub-endothelial concentrations of Newtonian flows during the normal and hypertensive conditions, respectively.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022927</affiliation-url><afid>60022927</afid><affilname>University of Tehran</affilname><name-variant>University of Tehran</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026914</affiliation-url><afid>60026914</afid><affilname>Shiraz University</affilname><name-variant>Shiraz University</name-variant><affiliation-city>Shiraz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010550</affiliation-url><afid>60010550</afid><affilname>Namazi Hospital</affilname><name-variant>Shiraz University of Medical Sciences</name-variant><affiliation-city>Shiraz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56647738300</author-url><authid>56647738300</authid><authname>Nouri M.</authname><surname>Nouri</surname><given-name>Mohammad</given-name><initials>M.</initials><afid>60022927</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603931463</author-url><authid>6603931463</authid><authname>Jalali F.</authname><surname>Jalali</surname><given-name>Farhang</given-name><initials>F.</initials><afid>60022927</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55390849000</author-url><authid>55390849000</authid><authname>Karimi G.</authname><surname>Karimi</surname><given-name>Gholamreza</given-name><initials>G.</initials><afid>60026914</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9737884300</author-url><authid>9737884300</authid><authname>Zarrabi K.</authname><surname>Zarrabi</surname><given-name>Khalil</given-name><initials>K.</initials><afid>60010550</afid></author><authkeywords>Blood flow | Leaky junctions | Sub-endothelial LDL accumulation | Three-pore model | Wall shear stress</authkeywords><intid>35963277</intid><source-id>17957</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929168009"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929168009?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929168009&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929168009&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008591"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929168009</prism:url><dc:identifier>SCOPUS_ID:84929168009</dc:identifier><eid>2-s2.0-84929168009</eid><dc:title>Left atrial myxoma presenting as acute coronary syndrome</dc:title><dc:creator>CannavÃ  G.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>148-150</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.136</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112774345</affiliation-url><afid>112774345</afid><affilname>Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte</affilname><name-variant>Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte</name-variant><affiliation-city>Messina</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641835700</author-url><authid>56641835700</authid><authname>CannavÃ  G.</authname><surname>CannavÃ </surname><given-name>G.</given-name><initials>G.</initials><afid>112774345</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23982063600</author-url><authid>23982063600</authid><authname>CurrÃ² A.</authname><surname>CurrÃ²</surname><given-name>A.</given-name><initials>A.</initials><afid>112774345</afid></author><authkeywords>Acute coronary syndrome | Coronary embolization | Left atrial myxoma | Transoesophageal echocardiography</authkeywords><intid>35916871</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929191797"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929191797?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929191797&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929191797&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008566"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929191797</prism:url><dc:identifier>SCOPUS_ID:84929191797</dc:identifier><eid>2-s2.0-84929191797</eid><dc:title>Incremental value of copeptin to highly sensitive cardiac Troponin i for rapid rule-out of myocardial infarction</dc:title><dc:creator>Wildi K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>190</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>170-176</prism:pageRange><prism:coverDate>2015-07-01</prism:coverDate><prism:coverDisplayDate>1 July 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.133</prism:doi><dc:description>Â© 2015 Elsevier Ireland Ltd. All rights reserved. Background: The incremental value of copeptin, a novel marker of endogenous stress, for rapid rule-out of non- ST-elevation myocardial infarction (NSTEMI) is unclear when sensitive or even high-sensitivity cardiac troponin cTn (hs-cTn) assays are used. Methods: In an international multicenter study we evaluated 1929 consecutive patients with symptoms suggestive of acute myocardial infarction (AMI). Measurements of copeptin, three sensitive and three hs-cTn assays were performed at presentation in a blinded fashion. The final diagnosis was adjudicated by two independent cardiologists using all clinical information including coronary angiography and levels of hs-cTnT. The incremental value in the diagnosis of NSTEMIwas quantified using four outcomemeasures: area under the receiver-operating characteristic curve (AUC), integrated discrimination improvement (IDI), sensitivity and negative predictive value (NPV). Early presenters (b4 h since chest pain onset) were a pre-defined subgroup. Results: NSTEMI was the adjudicated final diagnosis in 358 (18.6%) patients. As compared to the use of cTn alone, copeptin significantly increased AUC for two (33%) and IDI (between 0.010 and 0.041 (all p b 0.01)), sensitivity and NPV for all six cTn assays (100%); NPV to 96-99% when the 99th percentile of the respective cTnI assay was combinedwith a copeptin level of 9 pmol/l (all p b 0.01). The incremental value in early presenterswas similar to that of the overall cohort. Conclusion: When used for rapid rule-out of NSTEM in combination with sensitive or hs-cTnI assays, copeptin provides a numerically small, but statistically and likely also clinically significant incremental value.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028287</affiliation-url><afid>60028287</afid><affilname>Universitatsspital Basel</affilname><name-variant>University Hospital Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113733586</affiliation-url><afid>113733586</afid><affilname>Parc de Salut Mar-IMIM-UPF</affilname><name-variant>Parc de Salut Mar-IMIM-UPF CIBERES (ISC Iii)</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101378299</affiliation-url><afid>101378299</afid><affilname>Emergency Department</affilname><name-variant>Emergency Department</name-variant><affiliation-city>Barcelona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028287</affiliation-url><afid>60028287</afid><affilname>Universitatsspital Basel</affilname><name-variant>University Hospital Basel</name-variant><affiliation-city>Basel</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113736637</affiliation-url><afid>113736637</afid><affilname>Emergency Department</affilname><name-variant>Emergency Department</name-variant><affiliation-city>Liestal</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37102901200</author-url><authid>37102901200</authid><authname>Wildi K.</authname><surname>Wildi</surname><given-name>Karin</given-name><initials>K.</initials><afid>60028287</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54682513800</author-url><authid>54682513800</authid><authname>Zellweger C.</authname><surname>Zellweger</surname><given-name>Christa</given-name><initials>C.</initials><afid>60028287</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34067894400</author-url><authid>34067894400</authid><authname>Twerenbold R.</authname><surname>Twerenbold</surname><given-name>Raphael</given-name><initials>R.</initials><afid>60028287</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56222001300</author-url><authid>56222001300</authid><authname>Jaeger C.</authname><surname>Jaeger</surname><given-name>Cedric</given-name><initials>C.</initials><afid>60028287</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24451019600</author-url><authid>24451019600</authid><authname>Reichlin T.</authname><surname>Reichlin</surname><given-name>Tobias</given-name><initials>T.</initials><afid>60028287</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37053943100</author-url><authid>37053943100</authid><authname>Haaf P.</authname><surname>Haaf</surname><given-name>Philip</given-name><initials>P.</initials><afid>60028287</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55499209600</author-url><authid>55499209600</authid><authname>Faoro J.</authname><surname>Faoro</surname><given-name>Jonathan</given-name><initials>J.</initials><afid>60028287</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>GimÃ©nez M.</authname><surname>GimÃ©nez</surname><given-name>Maria Rubini</given-name><initials>M.R.</initials><afid>60028287</afid><afid>113733586</afid><afid>101378299</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>GimÃ©nez M.</authname><surname>GimÃ©nez</surname><given-name>Maria Rubini</given-name><initials>M.R.</initials><afid>60028287</afid><afid>113733586</afid><afid>101378299</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55326114700</author-url><authid>55326114700</authid><authname>GimÃ©nez M.</authname><surname>GimÃ©nez</surname><given-name>Maria Rubini</given-name><initials>M.R.</initials><afid>60028287</afid><afid>113733586</afid><afid>101378299</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:25623200300</author-url><authid>25623200300</authid><authname>Fischer A.</authname><surname>Fischer</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60028287</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56641481900</author-url><authid>56641481900</authid><authname>Nelles B.</authname><surname>Nelles</surname><given-name>Berit</given-name><initials>B.</initials><afid>60028287</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56576278300</author-url><authid>56576278300</authid><authname>Druey S.</authname><surname>Druey</surname><given-name>Sophie</given-name><initials>S.</initials><afid>60028287</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:50262192500</author-url><authid>50262192500</authid><authname>Krivoshei L.</authname><surname>Krivoshei</surname><given-name>Lian</given-name><initials>L.</initials><afid>60028287</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56222093500</author-url><authid>56222093500</authid><authname>Hillinger P.</authname><surname>Hillinger</surname><given-name>Petra</given-name><initials>P.</initials><afid>60028287</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56222163700</author-url><authid>56222163700</authid><authname>Puelacher C.</authname><surname>Puelacher</surname><given-name>Christian</given-name><initials>C.</initials><afid>60028287</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56640774200</author-url><authid>56640774200</authid><authname>Herrmann T.</authname><surname>Herrmann</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60028287</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:6602466078</author-url><authid>6602466078</authid><authname>Campodarve I.</authname><surname>Campodarve</surname><given-name>Isabel</given-name><initials>I.</initials><afid>101378299</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7004197043</author-url><authid>7004197043</authid><authname>Rentsch K.</authname><surname>Rentsch</surname><given-name>Katharina</given-name><initials>K.</initials><afid>60028287</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:34067899600</author-url><authid>34067899600</authid><authname>Steuer S.</authname><surname>Steuer</surname><given-name>Stephan</given-name><initials>S.</initials><afid>113736637</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:55825305800</author-url><authid>55825305800</authid><authname>Osswald S.</authname><surname>Osswald</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60028287</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:55694346400</author-url><authid>55694346400</authid><authname>Mueller C.</authname><surname>Mueller</surname><given-name>Christian</given-name><initials>C.</initials><afid>60028287</afid></author><authkeywords>Acute myocardial infarction | Copeptin | Highly sensitive Troponin I | Sensitivity and specificity</authkeywords><intid>1535917904</intid><source-id>23774</source-id></entry></search-results>
